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Abstract 
Rotator cuff disorders encompass a range of impairments from tendinopathy to partial- 
or full-thickness rotator cuff tears, and represent the largest subgroup of shoulder pain. 
Rotator cuff tears, most of which are atraumatic, are common in adults with shoulder 
pain and are strongly associated with increasing age. Conservative treatment including 
physiotherapy is the first-line treatment, but some patients do not respond, and 
ultimately require surgery. Early predictions of response could allow individuals’ care 
pathways to be optimised, preventing unnecessary delays and suffering and benefiting 
patients and healthcare providers alike.  
My primary aim was to develop a prognostic model for the outcome of physiotherapy in 
adults with painful atraumatic partial-thickness tears (PTTs) of the rotator cuff. This was 
addressed by a prospective prognostic model study. The study was underpinned by a 
systematic review of prognostic models in adults undergoing physiotherapy for painful 
rotator cuff disorders and was further informed and complemented by the following 
work: the development and validation of the physiotherapy protocol for the prognostic 
study; the identification, selection and definition of the candidate prognostic factors for 
the prognostic study; the estimation of the Minimal Important Difference (MID) of the 
study’s primary outcome measure (the Western Ontario Rotator Cuff Index, WORC); 
and an exploratory responder analysis of the WORC outcome scores. The prognostic 
systematic review, prognostic study, MID analysis and responder analysis are original 
contributions to knowledge. 
The prognostic systematic review revealed important methodological deficiencies in the 
five included studies, and no clinically usable model. No study addressed a distinct 
PTT population. The process of identifying factors for my own prognostic model study 
revealed a lack of knowledge about the prognostic relevance of factors. All of the 
candidate models I explored in my prognostic study (n sample = 65, n analysed = 61) 
had low performance and precision. The estimated MID of the WORC was -300. The 
responder analysis resulted in different proportions of responders to treatment 
depending on the responder definition. 
My results highlight the difficulties involved in predicting outcomes in the field of 
shoulder pain and rotator cuff disorders, and the need for methodologically sound 
prognosis research. 
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INTRODUCTION AND BACKGROUND 
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CHAPTER 1 
General introduction, aims, content 
and structure of the thesis 
1.1 TOPIC  
The shoulder joint is the primary link between the upper extremity and upper body. Its 
exceptional mobility, the greatest of any human joint (Kapandji 1992 p. 2), facilitates 
positioning of the upper extremity and, ultimately, the hand in space. Painless and 
unimpaired shoulder functioning is indispensible for many activities of daily living, such 
as washing, putting on a coat or combing one’s hair, and an important prerequisite for 
participation in occupational and recreational activities (Figure 1.1).  
 
Figure 1.1: Functional relevance of the shoulder 
  (Silhouettes modified from cliparts available at www.all-silhouettes.com) 
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The particular anatomical composition of the glenohumeral joint, with its large humeral 
articular surface in relation to the significantly smaller surface of the glenoid socket, 
makes it highly dependent on its non-osseous components, specifically its shoulder 
muscles, which thus play a key role in normal kinematics (Hess 2000).  
Shoulder pain is common, with an estimated point prevalence of 7-26%, one-year 
prevalence of 5-47% and lifetime prevalence of 7-67% in the general population, as 
most recently reviewed by (Luime et al. 2004). Painful shoulder complaints are the 
second to third commonest type of musculoskeletal pain seen in general medical 
practice (Kooijman et al. 2013, Urwin et al. 1998). They can be persistent and can lead 
to increased use of healthcare resources and prolonged sick leave, consistently 
placing a cost burden on the individual and society (Leps et al. 2012, Paloneva et al. 
2013, van der Windt et al. 1996, Virta et al. 2012). In the context of the International 
Classification of Diseases, 10th revision (ICD-10) (WHO 2016), shoulder lesions  
(ICD-10 code M75) consistently rank among the 10 diseases that cause most time off 
work in Germany (DAK Forschung 2015, AOK 2008)3. No current data are available on 
the precise (direct and indirect) costs of shoulder lesions in Germany, but an economic 
analysis of data from 2002 estimated the overall annual costs at 2.1 billion euros 
(approximately 6% of the overall costs of all musculoskeletal diseases). Of these, 
approximately 60% (1.25 billion euros) represented indirect costs related to lost 
working days due to inability to work (Leps et al. 2012).  
Shoulder pain can be due to various problems and pathologies, but most cases (29% 
to 85%) involve the subacromial-subdeltoid bursa and the rotator cuff (Cadogan et al. 
2011, Dorrestijn et al. 2011, Juel & Natvig 2014, Östör et al. 2005, Tekavec et al. 2012, 
van der Windt et al. 1995). The programme of research that is presented within this 
thesis aimed to inform the conservative treatment of adults with shoulder pain in the 
presence of a specific disorder of the rotator cuff: a painful, partial-thickness rotator cuff 
tear (PTT). 
1.2 AIMS AND CONTENT  
This thesis reports a body of research aimed at informing the conservative treatment of 
people with painful PTTs. The primary aim was to develop a prognostic model for the 
outcome of a phase of conservative treatment with physiotherapy in adults with painful, 
atraumatic PTTs.  
                                            
3
 Throughout this thesis there is a focus on German data (where available) because the 
prognostic study was conducted in Germany. 
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The research comprises the following components: 
1) a systematic review of the evidence for the effectiveness of physiotherapy 
interventions for patients with impingement-related shoulder pain;  
2) a systematic review of the evidence on prognostic models for predicting outcomes 
in adults undergoing physiotherapy for painful rotator cuff disorders; 
3) a prognostic cohort study to develop a prognostic model for predicting the outcome 
of a phase of conservative treatment with physiotherapy in adults with painful 
atraumatic PTTs; and  
4) an analysis to estimate the Minimal Important Difference (MID) of the Western 
Ontario Rotator Cuff Index (WORC), the primary outcome measure used in the 
prognostic study. This analysis is complemented by an exploratory responder 
analysis.  
1.3 STRUCTURE  
The thesis is structured into four parts and eight chapters. The structure, content and 
specific aims are summarised in Orientation Table Chapter 1 (see next page). As an 
aid to navigation through the thesis, a similar orientation table is placed on the page 
before each new chapter (Orientation Tables Chapters 2 to 8). As in Orientation Table 
Chapter 1, the chapters to which these respectively pertain are emphasised by bold 
and unshaded font. The references are provided at the end of each chapter. The thesis 
is presented in two volumes: Volume 1 includes Parts One to Three (Chapters 1-8), 
and Volume 2 includes Part Four (Appendices). 
The research is presented in Part Two. The prognostic systematic review (Chapter 3) is 
reported first because it contextualises and justifies my prognostic study. The review 
was formally conducted in 2014 to 15, but builds on systematic literature searches 
which I conducted at the beginning of my PhD to determine the rationale for my 
planned study and to inform its design. The two subsequent chapters (Chapters 4 and 
5) further underpin the prognostic study, which is reported in Chapter 6. Chapter 7, 
which reports on the MID and responder analyses, relates to the observed primary 
outcome of the prognostic study. 
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Orientation Table Chapter 1   
Part Ch. Title  Aims 
ONE 
1 General introduction, aims, 
content and structure of the 
thesis 
1. To provide a general introduction to 
the topic 
2. To summarise the aims, content and 
structure of the thesis 
2 Background To provide the relevant topical and 
conceptual background to the programme 
of research 
TWO 
 
3 Prognostic models in adults 
undergoing physiotherapy for 
rotator cuff disorders - a 
systematic review 
To establish the state of evidence on 
prognostic models in adults 
undergoing physiotherapy for painful rotator 
cuff disorders 
4 Developing and validating the 
physiotherapy protocol for the 
prognostic study 
1. To establish the state of evidence on the 
effectiveness of physiotherapy 
interventions for adults with painful 
atraumatic PTTs  
2. To develop and validate the 
physiotherapy treatment protocol  
5 Selecting and defining the 
candidate prognostic factors 
for the prognostic study  
1. To identify and select the candidate 
factors for the prognostic model study 
2. To define the specific measures for the 
selected factors 
6 Predicting the outcome of 
physiotherapy in adults with 
painful partial-thickness rotator 
cuff tears (PTTs) – a 
prognostic model study 
To develop a prognostic model for the 
outcome of a period of conservative 
treatment with physiotherapy in adult 
patients with painful atraumatic PTTs 
7 Drawing meaningful 
magnitude-based inferences 
from the prognostic study –  
Minimal Important Difference 
(MID) and responder analysis 
1. To establish an estimate of the MID of 
the Western Ontario Rotator Cuff Index 
(WORC), the primary outcome of the 
prognostic model study  
2. To apply the estimated MID to an 
exploratory responder analysis  
THREE 
8 Overall summary and 
conclusions 
1. To summarise the research 
2. To provide overall conclusions and 
consider implications  
FOUR  Appendices Appendices to Chapters 3-7 
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1.4 NOTE ON LANGUAGE OF DOCUMENTATION AND 
MATERIALS WITHIN THE THESIS 
Unless stated otherwise, all German-language documentation and materials are 
appended in English translation.  
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CHAPTER 2 
Background 
2.1 FUNCTIONAL RELEVANCE OF THE ROTATOR CUFF 
The rotator cuff is a deep cuff of four tendons around the shoulder through which the 
supraspinatus, infraspinatus, teres minor and subscapularis muscles (Figure 2.1) 
attach to the humeral tuberosities. The rotator cuff holds a primary role in the dynamic 
stabilisation of the glenohumeral joint (Escamilla et al. 2009, Hess 2000, Labriola et al. 
2005), mediating important, complex contributions to shoulder movement and providing 
dynamic glenohumeral compression. By counteracting the superiorly directed forces of 
shoulder muscles such as deltoid, the rotator cuff prevents superior migration of the 
humeral head (Escamilla et al. 2009, Magarey & Jones 2003). The rotator cuff, but 
specifically supraspinatus, has a close positional relationship to other structures of the 
shoulder such as the subacromial-subdeltoid bursa (Figure 2.1) and the 
acromioclavicular (AC) joint (not shown). The long head of biceps (LHB), despite its 
proximity, is usually viewed not as part of the rotator cuff but a separate anatomical 
entity, with distinct pathophysiologies (Ejnisman et al. 2010). 
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Figure 2.1: Anatomy of the rotator cuff.  
 (Modified from: Schünke M., Schulte E., Schumacher U. (eds.) (2005). 
Allgemeine Anatomie und Bewegungssystem (Prometheus Lernatlas der 
Anatomie). Stuttgart: Thieme, pp. 232 & 263) 
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2.2 PARTIAL-THICKNESS ROTATOR CUFF TEARS  
Rotator cuff tears are characterised by either partial or complete discontinuity of the 
affected tendon (Hedtmann 2009). They are accordingly termed partial-thickness tears 
(PTTs) or full-thickness tears (FTTs). The supraspinatus is the most frequently affected 
tendon by far (Matava et al. 2005), and is involved in between 63% (Yamanaka & 
Matsumoto 1994) and 100% (Maman et al. 2009) of PTTs. It is also usually the first 
tendon to tear (Beaudreuil et al. 2007, Hedtmann 2009). Supraspinatus PTTs may 
extend into the infraspinatus, teres minor and rarely also into the subscapularis, but 
isolated tears of these other tendons are rare, as is the involvement of all (Beaudreuil 
et al. 2007, Hedtmann 2009) 
PTTs are commonly classified by their location into articular-sided, bursal-sided or 
intratendinous tears (Finnan & Crosby 2010, Smith et al. 2010). Articular-sided tears 
represent the commonest type. They are twice as common as bursal-sided tears 
(Hedtmann 2009, Matava et al. 2005, Smith et al. 2010). Other classifications further 
consider the extent of the tear (Ellman 1990, Habermeyer et al. 2006, Snyder et al. 
1991).  
2.3 PREVALENCE  
The precise prevalence of PTTs is unclear (Finnan & Crosby 2010, Shin 2011) and 
varies across the literature depending on the type of study (which may involve 
cadavers, symptomatic patients or asymptomatic participants) and the methods used 
to determine tears (direct visualisation at dissection or open surgery, arthroscopy, 
ultrasonography (US) or magnetic resonance imaging (MRI)). Very few imaging studies 
have investigated the prevalence of PTTs in painful (symptomatic) clinical populations 
(Cadogan et al. 2011, Reilly et al. 2006, Yamaguchi et al. 2006). Reilly et al. (2006), in 
a systematic review of prevalence studies, reported a prevalence of PTTs in shoulder 
pain populations of 7% as determined by US (based on 9 studies, 1038 participants, 
mean age 50 years), and of 9% as determined by MRI (12 studies, 490 participants, 
mean age 44 years). Two more recent studies (Cadogan et al. 2011, Yamaguchi et al. 
2006) found significantly higher rates of 23% (Cadogan et al. 2011) and 24% 
(Yamaguchi et al. 2006) as determined by US (in 203 and 588 participants with a mean 
age of 42 and 63 years, respectively). However, PTTs and FTTs alike are also 
frequently present in asymptomatic individuals: for PTTs, Reilly et al. (2006) reported a 
prevalence of 17% as determined by US and of 16% as determined by MRI. To date 
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(May 2016), no data are publicly available on the prevalence of rotator cuff tears in the 
German population. 
The prevalence of degenerative, atraumatic rotator cuff tears is associated with 
increasing age (Lashgari & Redziniak 2012, Tashjian 2012), and they are very rare 
below the age of 40 years (Beaudreuil et al. 2007, Hedtmann 2009). The reported 
mean age of study populations with painful PTTs ranges from 43 (Gartsman & Milne 
1995) to 61 (Yamanaka & Matsumoto 1994). There are no clear data on the gender 
distribution of painful atraumatic PTTs.  
2.4 LINKING PTTs AND SHOULDER PAIN 
The fact that PTTs are common in both symptomatic and asymptomatic shoulders 
suggests that PTTs may be clinically irrelevant unless associated with shoulder pain 
and disability (Reilly et al. 2006). The precise source of pain in the presence of rotator 
cuff tears is yet unclear (Khan et al. 2000). It is recognised, though, that the pain 
cannot be unambiguously attributed to the tendon itself: some studies have found an 
association between pain and the presence and extent of a (subacromial) “bursal 
reaction”, evidenced by increased amounts of substance P (a nociceptive 
neurotransmitter) and histological findings (Gotoh et al. 1998, Ishii et al. 1997). Several 
studies (Fukuda 2000, Gotoh et al. 1998, Gschwend et al. 1988, Heers et al. 2005) 
have observed higher levels of pain in people with PPTs compared with FTTs, which 
suggests that symptomatic PTTs may be more painful than FTTs. It has been 
supposed that this difference may be related to the amount of bursal tissue or the 
distribution of substance P (Gotoh et al. 1998). The relationship between the size of 
PTTs and shoulder pain is also largely unclear. Based on limited evidence there is no 
association between the size and thickness of PTTs and pain severity (Curry et al. 
2015).  
Throughout this thesis, the term “painful PTTs” (or “painful rotator cuff tears”) is used to 
concisely label the population of interest: adults with shoulder pain in the presence of 
PTTs. The uncertainties regarding the link between shoulder pain and PTTs are 
acknowledged, however.  
2.5 CLINICAL PRESENTATION  
The clinical presentation of painful PTTs is essentially that of “shoulder impingement” 
(Bayam et al. 2011, Finnan & Crosby 2010, Fukuda 2003, Hedtmann 2009). The pain 
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commonly occurs in the anterolateral aspect of the shoulder; it is often perceived as 
sharp and may be accompanied by a dull pain in the lower arm or forearm (Bayam et 
al. 2011). The pain is provoked or aggravated with various movements or activities of 
the arm at or above shoulder level. People with PTTs commonly have nocturnal pain 
(Finnan & Crosby 2010; Fukuda 2003). While the ability to move the arm may be 
limited through pain inhibition, both shoulder passive range of movement (ROM) and 
strength are usually largely preserved (Hedtmann 2009).  
2.6 INDIVIDUAL AND SOCIOECONOMIC BURDEN  
Rotator cuff tears can significantly affect people’s lives by impairing shoulder function, 
activities and health-related quality of life (HRQoL) (Piitulainen et al. 2012, Ryliskis et 
al. 2009). A recent qualitative study (Minns Lowe et al. 2014), though limited to people 
with FTTs, provides an impression of patients’ perspectives of living with a painful 
rotator cuff tear. Analysis of semi-structured interviews with 20 patients revealed that 
rotator cuff tears can cause severe pain and significantly affect sleep, mobility, 
strength, activities of daily living, recreational or occupational tasks and emotional 
wellbeing, as well as imposing a financial burden due to inability to work and private 
healthcare costs.  
No data are publicly available on the burden of costs associated with rotator cuff tears 
(or any other subgroup of shoulder lesions (ICD-10 code M75)) in the German 
population (Leps et al. 2012), but German hospital data show a growing trend. The 
number of admissions for rotator cuff lesions (ICD-10 code M75.1) almost doubled 
between 2005 (24,500) and 2014 (46,600) (Statistisches Bundesamt 2016). These 
data may represent the tip of an iceberg, because more than 90% of patients with 
shoulder complaints are treated in the outpatient setting (Leps et al. 2012).  
2.7 AETIOLOGY AND PATHOGENESIS 
Over 90% of rotator cuff tears are considered to be caused by degeneration rather than 
by trauma (Mall et al. 2013, Oh et al. 2007, Petersen & Murphy 2011). The aetiology of 
the degeneration is probably multifactorial (Factor & Dale 2014, Seitz et al. 2010). 
Potential factors are commonly grouped into “extrinsic” and “intrinsic” mechanisms 
(Lohr & Uhthoff 2007, Riley 2004, Seitz et al. 2010). Extrinsic mechanisms relate to 
factors acting from outside the tendon and include anatomical aspects such as 
acromial shape, subacromial impingement, internal impingement (i.e. impingement of 
CHAPTER 2 15 
 
 
 
the rotator cuff against the superior glenoid rim), altered shoulder kinematics (e.g. 
glenohumeral instability), traumatic events or aspects of physical loading (e.g. 
overload). Intrinsic factors relate to vascular and morphological changes within the 
tendon, which may be caused e.g. by age (i.e. age-related degeneration), poor 
vascularity or genetics.  
Regarding the different types of PTTs (see section 2.2), it has been proposed that 
bursal-sided PTT may primarily be associated with external mechanisms and articular-
sided and intratendinous tears with intrinsic mechanisms (Seitz et al. 2010). Overall, 
though, the definitive aetiological relevance of these mechanisms and their interactions 
in the individual remain unclear.  
The development of PTTs has commonly been viewed as part of a degenerative 
continuum (Factor & Dale 2014, Finnan & Crosby 2010, Matava et al. 2005). With his 
classification of “the progressive stages of [shoulder] impingement”, Neer (1983) 
provided an early description of the progressive degenerative transition of pain-free 
and structurally intact tendons through to FTTs, which reflected his view of the 
pathogenesis at that time. His model encompassed three consecutive stages, each of 
which reflected specific changes within the tendon (Neer 1983 p. 72): “edema and 
haemorrhage” (stage 1), “fibrosis and tendinitis” (stage 2) and “bone spurs and tendon 
rupture” (stage 3). In the course of time, Neer’s classification has been refined by him 
and others (e.g. Bigliani & Levine 1997, Cook & Purdam 2009, Jobe & Jobe 1983). In 
2009, Cook & Purdam proposed “a new model of tendon pathology” (Cook & Purdam 
2009 p. 410) based on a more contemporary understanding of the pathogenesis of 
rotator cuff degeneration. They also proposed three consecutive stages (Figure 2.2), 
which they described as follows (pp. 410-11): “reactive tendinopathy” (stage 1), defined 
as a “non-inflammatory proliferative response in the cell and matrix”; “tendon disrepair” 
(stage 2), defined as the “attempt at tendon healing, similar to reactive tendinopathy 
but with greater matrix breakdown”; and “degenerative tendinopathy” (stage 3), defined 
as “progression of both matrix and cell changes”. The addition or removal of load is 
considered the primary stimulus for moving the tendon forward or backward along this 
continuum. Apart from a refinement of the pathophysiological processes, a notable 
change from Neer’s model was the redesignation of tendinitis as “reactive 
tendinopathy”, which was based on the view that rotator cuff tendinopathy is non-
inflammatory. Histological studies had shown inflammatory cells to be absent in 
tendinopathy (Khan et al. 2002). This view has been challenged again by further 
research findings (Dean et al. 2016, Millar et al. 2016). The precise role of inflammation 
in tendon pathology, however, remains controversial and unclear (Rees 2016, Rees et 
al. 2014). Moreover, Cook and Purdam themselves, in a recently published review of 
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their model (Cook et al. 2016), acknowledge the complexities of the processes involved 
and state that “it is unlikely that any one model fully explains all aspects of the 
pathoaetiology of tendon pathology…” (p. 5). 
 
Figure 2.2: Outline of continuum of tendon pathology by Cook & Purdam (2009) 
2.8 HEALING, NATURAL HISTORY AND TEAR PROGRESSION  
2.8.1 HEALING OF PTTs  
It is generally held that most PTTs do not heal spontaneously, though this is supported 
by little epidemiological and histological data (Fukuda 2003, Smith et al. 2010, Wolff et 
al. 2006). The putatively limited capacity for PTTs to heal has traditionally been 
attributed in part to hypovascularity within the affected tendon, but this view has been 
challenged by more recent findings from in-vivo studies of hypervascularity and 
hyperaemia at the site of pathology in symptomatic PTTs (Hegedus et al. 2010, Smith 
et al. 2010). In addition, in their follow-up studies of non-surgically treated PTTs, 
Maman et al. (2009) and Yamanaka and Matsumoto (1994) have found a decrease in 
tear size or even the complete disappearance of previously observed PTTs in small 
proportions ( 10%) of their populations. The issue of self-healing is thus contentious 
(Fukuda 2003).  
2.8.2 NATURAL HISTORY AND PROGRESSION  
Very little information is available on the natural history of painful PTTs in terms of their 
structural evolution and their clinical course over time. No data are available on the 
history of painful PTTs over a period with either no treatment or no formal treatment. 
Only two studies have followed populations of painful PTTs over a course of 
conservative treatment (Maman et al. 2009, Yamanaka & Matsumoto 1994). Both 
studies suggest an association between the incidence of progression of PTTs (same 
1. Reactive 
tendinopathy 
2. Tendon  
disrepair 
3. Degenerative 
tendinopathy 
Progression 
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as of FTTs) and increasing age (Maman et al. 2009, Yamanaka & Matsumoto 1994), 
but otherwise their findings are very discrepant. Maman et al. (2009) used MRI to 
evaluate 59 shoulders (in 54 participants, mean age 59 years) with painful rotator cuff 
tears (PTTs and FTTs) who were treated with physiotherapy, activity restriction and 
corticosteroid injections, and reported tear progression in 8% of the PTTs at a mean 
follow-up of 20 months. They presented no accompanying data on the course of pain 
and other symptoms, unfortunately. Yamanaka & Matsumoto (1994) evaluated 40 
conservatively treated PTTs (36 participants, mean age 61 years; the content of 
treatment was unspecified) with arthrography, and noted that 80% had progressed at a 
mean follow-up (period between the initial and follow-up arthrography) of 412 days 
(approximately 14 months). They found that the incidence of progression was higher in 
initially larger PTTs and in those involving more than one tendon. On average (only the 
mean was presented), symptoms improved from 68 to 80 points on the Japanese 
Orthopaedic Association (JOA) score (0-100 points, 100 = best). In summary, the 
overall incidence of PTT progression is very uncertain, although the data suggest that it 
is not inevitable and that smaller PTTs and PTTs involving only one tendon may be 
less likely to progress, as may PTTs in younger patients. The course of symptoms over 
time either without or with conservative treatment is unknown.  
2.8.3 POTENTIAL CONSEQUENCES OF TEAR PROGRESSION  
Concerns about the progression of PTTs primarily relate to the development of FTTs, 
which can eventually cause significant permanent shoulder disability through extensive 
structural damage (Feeley et al. 2009, Kuzel et al. 2013, Laron et al. 2012). Mechanical 
detachment and retraction of the torn tear ends can induce irreversible fatty 
degeneration and atrophy of the affected muscles, developments which are associated 
with inferior outcomes of surgical repair (Kuzel et al. 2013, Laron et al. 2012). 
Moreover, longstanding massive rotator cuff tears can lead to glenohumeral arthritis 
and, as a rare but serious final stage, to cuff tear arthropathy, which is characterised by 
severe glenohumeral and acromioclavicular damage (Feeley et al. 2009, Neer et al. 
1983).  
2.9 DIAGNOSIS 
The diagnosis of a painful PTT is usually based on clinical history, physical 
assessment and diagnostic imaging.  
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2.9.1 CLINICAL HISTORY AND PATIENT-REPORTED QUESTIONNAIRES 
The purpose of the history in addition to evincing characteristics of impingement is to 
screen for other problems. The history-taking may involve patient-reported 
questionnaires, i.e. patient-reported outcome measures (PROMs), which are 
increasingly used to assess the impact of musculoskeletal symptoms on activities, 
participation and health-related quality of life (Vodicka et al. 2015). A large number of 
PROMs is available for use in shoulder pain populations (Roy & Esculier 2011, Wright 
& Baumgarten 2010). These can be divided into “upper extremity-specific”, “shoulder-
specific” and “condition-specific” instruments (Roy & Esculier 2011 p. 341). Two rotator 
cuff-specific PROMs are available: the Rotator Cuff Quality of Life index (R-QoL) 
(Hollinshead et al. 2000) and the Western Ontario Rotator Cuff index (WORC) (Kirkley 
et al. 2003).  
2.9.2 PHYSICAL ASSESSMENT  
The physical assessment also includes a screening component for other causes of 
shoulder pain, such as cervical radiculopathy or frozen shoulder. The “impingement” 
element of the physical assessment involves tests to reproduce the pain of 
impingement (e.g. painful arc or Hawkins-Kennedy test) and tests to assess the 
painfulness and function of the rotator cuff muscles (isometric contractions and lag 
signs) (Hanchard et al. 2013, Hermans et al. 2013, Matava et al. 2005). Numerous 
physical tests have been proposed for diagnosing rotator cuff related disorders 
(Alqunaee et al. 2012, Hanchard et al. 2013, Hermans et al. 2013). There is, though, 
yet no agreement on the “best tests”, as most have been found to either lack accuracy 
or reliability or to be insufficiently researched (Hanchard et al. 2013, May et al. 2010).  
2.9.3 DIAGNOSTIC IMAGING 
Due to the largely nonspecific clinical presentation of painful PPTs, verification of the 
presence of a PTT ultimately requires diagnostic imaging. For this purpose, US and 
MRI are the most widely available and most commonly applied imaging techniques in 
clinical practice (Lenza et al. 2013, Smith et al. 2012). Magnetic resonance 
arthrography (MRA) is another option, but is invasive through intra-articular injection of 
a radiopaque contrast medium (Lenza et al. 2013). US and MRI are both noninvasive. 
A key advantage of US is that it allows dynamic visualisation of the rotator cuff during 
shoulder movements (Lenza et al. 2013). It is widely available, allowing for convenient, 
rapid assessment, and it is relatively inexpensive (Dinnes et al. 2003). It is also 
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generally covered by the (German) statutory health insurance. Generally accepted 
limitations of US are its long learning curve and related operator-dependence (Lenza et 
al. 2013). A key advantage of MRI is that it allows for high-resolution images in multiple 
planes (Dinnes et al. 2003). MRI has some contraindications, though, such as 
implanted ferromagnetic metallic devices; also, although MRI is widely viewed as a 
safe technique, the risks associated with exposure to the applied magnetic and 
radiofrequency fields have not yet been fully explored (Dill 2008). MRI further is more 
time-consuming and also more expensive (Lenza et al. 2013).  
The evidence on the diagnostic accuracy of US, MRI and MRA for the detection of 
rotator cuff tears has been synthesised in various systematic reviews (de Jesus et al. 
2009, Dinnes et al. 2003, Kelly & Fessell 2009, Lenza et al. 2013, Roy et al. 2015, 
Smith et al. 2011). Table 2.1 provides summary data on the accuracy of US and MRI 
for both PTTs and FTTs from a recent comprehensive systematic review (Roy et al. 
2015 Tables 2 & 3) which included overall 35 studies (2,774 shoulders) on US and 21 
studies (1,575 shoulders) on MRI. The reference standard was surgery (either 
arthroscopic or open).  
Table 2.1: Summary US and MRI accuracy statistics from Roy et al. (2015) 
Type of tear SN or SP US MRI 
PTT 
 
SN 68 (54 to 83) 67 (50 to 82) 
SP 94 (90 to 97) 94 (88 to 99) 
FTT 
SN 91 (86 to 94) 90 (85 to 95) 
SP 93 (91 to 96) 93 (89 to 97) 
Values are % (95% CI); SN = sensitivity; SP = specificity  
The data show that US and MRI have a similar diagnostic accuracy for the detection of 
PTTs and FTTs. Both have high specificity but, especially where PTTs are concerned, 
lower sensitivity. Thus, either imaging technique allows a PTT to be ruled in with a high 
degree of confidence, while neither allows a PTT to be confidently ruled out. 
Interobserver agreement regarding the detection of PTTs by US, when performed by 
experienced assessors, has been found to be high (Jeyam et al. 2008, Middleton et al. 
2004). 
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2.10 TREATMENT 
2.10.1 TREATMENT OPTIONS 
Various conservative and surgical interventions are available for the treatment of PTTs 
(Huisstede et al. 2011, Seida et al. 2010). Both conservative and surgical treatment 
aim to alleviate pain and restore shoulder function and thereby aim to enable patients 
to achieve best-possible participation in their everyday life. They also aim to eliminate 
potential extrinsic causes for the PTT (e.g. by addressing altered scapular kinematics 
through physiotherapy or by arthroscopic subacromial decompression).  
2.10.1.1 Conservative treatment 
Conservative treatment most commonly encompasses advice (e.g. on temporary rest 
or activity modifications), physiotherapy, oral pain medication and/or subacromial 
injections (Finnan & Crosby 2010, Fukuda 2003, Wolff et al. 2006).  
Physiotherapy 
Physiotherapy offers a range of approaches and techniques (Finnan & Crosby 2010, 
Fukuda 2003, Wolff et al. 2006) that are essentially the same as those for subacromial 
impingement (Braun et al. 2013, Dong et al. 2015, Hanratty et al. 2012). Exercises are 
a mainstay of the treatment of patients with impingement-related shoulder pain 
(Bernhardsson et al. 2015, Johansson et al. 1999, Struyf et al. 2012); they may be 
supplemented by manual therapy and further modalities such as thermo- or 
electrotherapy. The precise biological responses to mechanical stimuli on tendon are 
yet insufficiently understood, but recent research suggests that controlled physical 
loading, i.e. in particular exercises, may play an important role in the stimulation of 
cellular proliferation and matrix remodelling, thereby promoting the regeneration of 
tendon and other musculoskeletal tissues (Huang et al. 2013, Khan & Scott 2009, 
Thompson et al. 2016). Table 2.2 summarises common types and elements of the 
physiotherapy treatment for PTTs (i.e. impingement-related shoulder pain) 
(Bernhardsson et al. 2015, Johansson et al. 1999, Struyf et al. 2012), along with their 
main aims and assumed effects (Dölken 2005, van den Berg 2001). The table is not 
intended to present an exhaustive list and focuses on modalities that may be practiced 
by physiotherapists in Germany. 
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Table 2.2: Types and elements of physiotherapy for painful PTTs 
Type Elements Main aims/assumed effects 
Exercises Coordinative exercises  
(e.g. complex movements) 
To improve function through improvement of 
the coordinative abilities of the arm and 
shoulder 
Postural correction  
(e.g. spinal posture) 
To improve pain and function by 
correcting/improving posture and to eliminate 
potential external factors fostering 
“impingement”, e.g. excessive thoracic 
kyphosis 
Strengthening  
(e.g. concentric, eccentric, 
with/without equipment…) 
To improve function in terms of the selective 
functioning of the affected or residual rotator 
cuff muscle(s) or of other shoulder or 
shoulder girdle muscles and to improve the 
overall functioning of the shoulder 
Scapular exercises  
(e.g. scapular positioning) 
To improve function through normalisation or 
improvement of impaired scapular kinematics  
Stabilisation exercises (e.g. 
closed kinetic chain 
exercises) 
To improve function through restoration or 
improvement of the stability of the 
glenohumeral joint 
Stretching exercises To improve function through elimination or 
improvement of restrictions, e.g. shortened 
muscles, and to restore or improve ROM 
Manual  
techniques 
Manual mobilisations  
(articular) 
To alleviate pain through application of 
mechanical stimuli to painful or restricted 
joints in the shoulder area (or at the cervical 
or thoracic spine), e.g. AC joint and to 
improve function by eliminating/improving 
movement restrictions 
Soft tissue mobilisations  
(e.g. deep transverse 
friction massage) 
To alleviate pain and to decrease stiffness, 
i.e. increase flexibility/mobility of soft tissues 
at or around the shoulder 
Stretching (passive) See stretching exercises 
Electrotherapy Therapeutic ultrasound To reduce pain (and to promote structural 
regeneration and repair) 
Transcutaneous Electrical 
Nerve Stimulation (TENS) 
To reduce pain 
Thermotherapy Cold (e.g. ice packs) To reduce pain (and to modulate metabolic 
processes) 
Heat (e.g. hot packs) To reduce pain and to enhance soft tissue 
flexibility and mobility (and to modulate 
metabolic processes) 
Taping Elastic taping, 
e.g. “kinesiotape” 
To reduce pain and improve shoulder 
function by modulating muscle activity and 
soft tissue mobility  
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Injections and oral medication 
The most commonly provided type of injections are subacromial corticosteroid 
injections, and the most common type of oral medication are nonsteroidal anti-
inflammatory drugs (NSAIDs) (Finnan & Crosby 2010, Fukuda 2003, Wolff et al. 2006).  
2.10.1.2 Surgical treatment 
Surgical treatment options for PTTs include acromioplasty (subacromial 
decompression), debridement with or without acromioplasty or bursectomy, or tendon 
repair (Franceschi et al. 2012, Strauss et al. 2011). Surgery may be arthroscopic, mini-
open or open, though arthroscopy appears to be the current standard (Franceschi et al. 
2012). The rates of rotator cuff surgery, but in particular of arthroscopic surgery, have 
considerably increased internationally in recent years (Colvin et al. 2012, Judge et al. 
2014, Svendsen et al. 2012, Yu et al. 2010).  
2.10.2 EVIDENCE FOR THE EFFECTIVENESS OF DIFFERENT 
TREATMENT OPTIONS 
The effectiveness of both conservative and surgical treatment approaches has been 
addressed by several recent systematic reviews on rotator cuff tears (Huisstede et al. 
2011, Seida et al. 2010, Strauss et al. 2011) or rotator cuff tendinopathy (including 
PTTs) (Boudreault et al. 2014, Braun et al. 2013, Toliopoulos et al. 2014, van der 
Sande et al. 2013). Both have been shown to be effective in improving clinical 
outcomes. Due to a scarcity of follow-up studies on exclusive PTT populations, the 
evidence presented relates to mixed populations of impingement or rotator cuff 
tendinopathy, which, though, mostly incorporate PTTs.  
2.10.2.1 Physiotherapy 
The evidence for the effectiveness of exercises and manual therapy is detailed in 
Chapter 4.  
The evidence for the effectiveness of supplementary physical modalities such as 
electrotherapies, thermotherapy or kinesio taping is overall limited and partly 
inconclusive (Desjardins-Charbonneau et al. 2015, Desmeules et al. 2015, Desmeules 
et al. 2016, Dong et al. 2015, Kromer et al. 2009, Yu et al. 2015). Most of these 
modalities appear to be either no more effective than placebo or of very limited benefit.  
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2.10.2.2 Corticosteroid injections and NSAIDs 
The effectiveness of corticosteroid injections and NSAIDs for the treatment of rotator 
cuff disorders (including PTTs) appears unclear. Two systematic reviews (Coombes et 
al. 2010, van der Sande et al. 2013) found insufficient and conflicting evidence for the 
effectiveness of corticosteroid injections in improving outcomes such as pain and 
function compared to placebo or other interventions in both the short- and long-term. 
Based on limited evidence there is no difference in effectiveness between 
corticosteroid injections and physiotherapy (Foster 2015). Van der Sande et al. (2013) 
found a lack of evidence for the effectiveness of NSAIDs. According to another 
systematic review (Boudreault et al. 2014), oral NSAIDs may be effective in reducing 
pain in the short-term. The effectiveness of newly proposed injection therapies such as 
sodium hyaluronate injections remains to be established (Coombes et al. 2010).  
2.10.2.3 Surgical treatment 
Regarding the effectiveness of surgery for PTTs, a recent systematic review on the 
arthroscopic management of PTTs (Strauss et al. 2011) found widely varying rates 
(29% to 93%) of “excellent postoperative outcomes” (p. 573) across the 16 included 
studies. Limited evidence was found in favour of debridement with or without 
acromioplasty for smaller PTTs (involving < 50% of the tendon) and repair for larger 
PTTs (involving > 50% of the tendon). There was no evidence in favour of any specific 
repair technique. Postoperative complications were reported for 3% to 12% of cases 
and included post-surgical stiffness, persistent symptoms due to AC joint pathology, 
subcoracoid impingement and scapulothoracic bursitis. Further reported complications 
of arthroscopic rotator cuff repair include failure of repair, stiffness and infection 
(Randelli et al. 2012). Although shoulder arthroscopy is generally considered a safe 
procedure, it carries a small but real potential for life-threatening complications such as 
thromboembolism (Marecek & Saltzman 2010, Osti et al. 2012, Randelli et al. 2012).  
2.10.2.4 Conservative versus surgical treatment 
Direct comparisons of conservative versus surgical treatment as investigated in 
populations of impingement-related shoulder pain (Ketola et al. 2013, Saltychev et al. 
2015) or FTTs (Kukkonen et al. 2015, Lambers Heerspink et al. 2015, Moosmayer et 
al. 2014) have mostly shown no clinically relevant differences in patient-centred 
outcomes such as pain or self-reported shoulder function. Compared with exercises, 
surgery has been found to be more expensive (Saltychev et al. 2015, Toliopoulos et al. 
CHAPTER 2 24 
 
 
 
2014) and to involve more income transfers and sick leave (Toliopoulos et al. 2014). As 
yet, no such comparative study has investigated a specific population of patients with 
PTTs (Saltychev et al. 2015, Seida et al. 2010).  
2.10.3 GUIDELINES AND INDICATIONS FOR TREATMENT 
Current evidence-based guidelines on the management of rotator cuff tears (or 
impingement-related shoulder pain including PTTs) recommend conservative treatment 
(including various interventions) as the first-line treatment, with surgery to be 
considered where conservative treatment fails to yield satisfactory improvement 
(American Academy of Orthopaedic Surgeons (AAOS) 2010, Beaudreuil et al. 2010, 
Diercks et al. 2014). The optimal length of a trial of conservative treatment is unknown, 
with no specific recommendations given by the guidelines. Currently, no German 
national guideline on the management of rotator cuff disorders is available. 
The recommendations of the guidelines reflect the considerable uncertainty about the 
specific indications for any treatment for PTTs, whether conservative or surgical. The 
often-mentioned “50% rule”, which asserts that PTTs involving 50% or more of tendon 
thickness should be treated surgically (Finnan & Crosby 2010, Fukuda 2003) lacks 
scientific support (Pedowitz et al. 2011). The prognosis of outcomes of treatment is 
addressed further below. 
2.10.4 THE PATIENT PATHWAY IN THE GERMAN HEALTHCARE SYSTEM  
In Germany, patients consult a medical practitioner in the first instance. This is usually 
a general practitioner (GP; “Hausarzt”), although patients are at liberty to self-refer to a 
specialist physician or surgeon. Medical practitioners may prescribe a course of 
physiotherapy. Self-referral to a physiotherapist is generally not allowed. Thus, a 
prescription is prerequisite for physiotherapy. For physiotherapy under the statutory 
health insurance system („Gesetzliche Krankenversicherung“, GKV), which covers 
87% of the German population (GKV-Spitzenverband 2016), the allowable standard 
modalities and amount of physiotherapy for any complaint are regulated by the 
“Heilmittelrichtlinie” (“Healthcare directive”), which includes the “Heilmittelkatalog” 
(“Healthcare catalogue”) (GKV-Heilmittelrichtlinie 2011). PTTs generally fall under 
disease category “EX2” (“Injuries, operations and diseases of the limbs and pelvis”). 
The standard maximum number of treatment sessions is 18 (three sets of six 
sessions), the recommended frequency  2 sessions per week. Treatment may include 
“general physiotherapy” (“Allgemeine Krankengymnastik”), manual therapy (“Manuelle 
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Therapie”) or therapeutic training (“Krankengymnastik am Gerät”), and a limited 
amount of supplementary modalities, e.g. electrotherapy or massage. Exceeding this 
limit may require the health insurer to approve a formal request. Physiotherapy under 
the private health insurance system is generally less regulated, but provision varies 
depending on the insurer and tariff. Injections and acupuncture are not within the scope 
of practice of physiotherapists in Germany. 
Currently, no data are publicly available on the consumption of physiotherapy 
treatment for patients with rotator cuff tears in Germany. Meanwhile, the uptake of 
surgery appears to be increasing (see section 2.6).  
2.11 PROGNOSIS AND PROGNOSIS RESEARCH  
2.11.1 INTRODUCTION  
It would benefit both patients and health care providers if likely responders and, by 
corollary, non-responders to conservative interventions, could be identified at the 
commencement of their care pathway. This would save time, effort and suffering, limit 
exposure to the risks of surgery and promote the optimal distribution of available 
resources.  
In general, the importance of predicting which patients will respond to particular 
interventions is increasingly recognised and has stimulated a growing interest in 
prognosis and prognosis research (Croft et al. 2015, Moons et al. 2009a, Stanton et al. 
2010). There has been a corresponding development in related prognosis research 
methodology (Cochrane Prognosis Methods Group 2016, Moons et al. 2009a, 
PROGRESS 2016). Prognosis in the context of clinical medicine is defined as “the risk 
of future health outcomes in people with a given disease or health condition” 
(PROGRESS_Research 2016), prognosis research consequentially as “the 
investigation of the relations between future outcomes (“endpoints”) among people with 
a given baseline health state (“startpoint”) in order to improve health” 
(PROGRESS_Research 2016). Estimates of prognosis are context-dependent, with 
relevant contextual factors being existing diagnostic and treatment practices, time and 
place. In the last few years, several initiatives have been established which focus on 
the contemporary advancement of prognosis research methodology; these include in 
particular the PROGnosis RESearch Strategy Partnership (PROGRESS 2016), a UK-
based interdisciplinary collaboration of international researchers funded by the UK 
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Medical Research Council (MRC), and the Cochrane Prognosis Methods group 
(Cochrane Prognosis Methods Group 2016). It is widely acknowledged that prognosis 
research to date largely falls behind the high methodological standards of other areas 
of research (Altman 2009, Hayden et al. 2009, Hemingway 2006, Hemingway et al. 
2009, Riley et al. 2007). Many prognostic studies in various areas of medicine and 
health have been found to show serious methodological deficiencies which critically 
affect the validity of their findings (Altman 2009, Hayden et al. 2009).  
The design and conduct of this PhD programme of research was informed by relevant 
methodological publications which were available at its inception (e.g. Altman 2009, 
Altman et al. 2009, Moons et al. 2009a&b, Royston et al. 2009) and more recent 
publications relating to the work of or being proposed by PROGRESS 
(PROGRESS_Publications 2016) and the Cochrane Prognosis Methods Group 
(Cochrane Prognosis Methods Group 2016). In this thesis I use, as far as possible, the 
terminology recommended by PROGRESS, such as “prognosis research”, “prognostic 
factor”, “prognostic model research”, “startpoint” and “endpoint” (Hemingway et al. 
2013, PROGRESS 2016).  
The basic elements of prognosis research, as outlined by PROGRESS (adapted from 
Hemingway et al. (2013)), are shown in Figure 2.3. 
 
Figure 2.3: The basic elements of prognosis research (note that estimates of 
prognosis are context-specific)  
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PROGRESS have proposed a framework for prognosis research which encompasses 
four key interrelated research themes relating to the prognosis of clinical outcomes in 
people with a given health condition (Hemingway et al. 2013, Hingorani et al. 2013, 
Riley et al. 2013, Steyerberg et al. 2013). Table 2.3 summarises the themes and 
provides an example for each based on a review on the prognosis of low back pain 
(Hayden et al. 2010). 
Table 2.3: The PROGRESS framework for prognosis research 
No Theme Description Example 
1 Fundamental 
prognosis 
research 
The investigation of “the course of 
health related conditions in the 
context of the nature and quality of 
current care” (Hemingway et al. 
2013), i.e. of the average prognosis 
of a subsequent clinical outcome in 
people with a given health related 
condition. 
75-90% of patients presenting 
with an acute episode of low 
back pain for care will recover 
within a few weeks (Hayden et 
al. 2010). 
2 Prognostic 
factor  
research 
The investigation of prognostic 
factors, i.e. of „any measure that, 
among people with a given health 
condition, is associated with a 
subsequent clinical outcome.” 
(PROGRESS_Research 2016) 
Sciatica (referred leg pain) is 
associated with poor outcomes 
in acute or subacute low back 
pain (Hayden et al. 2010). 
3 Prognostic 
model  
research 
The investigation of prognostic 
models, i.e. of “multiple prognostic 
factors in combination to predict the 
risk of future clinical outcomes in 
individual patients” 
(PROGRESS_Research 2016) 
The STarTBack Tool (Hill et al. 
2008) aims to predict the risk 
(low, medium or high) of 
persistent symptoms and 
disability in patients with non-
specific low back pain based on 
nine prognostic factors: 
bothersomeness, referred leg 
pain, comorbid pain, disability 
(two items), catastrophizing, fear, 
anxiety, and depression (Hayden 
et al. 2010). 
4 Stratified 
medicine  
research 
The investigation of targeting 
therapeutic decisions to subgroups 
of individuals based on the 
baseline prognosis of a clinical 
outcome (as established through 
prognostic factor or (ideally) 
prognostic model research). 
Targeting treatment according to 
the risk (low, medium or high) of 
persistent symptoms and 
disability (based on the Start 
Back Tool, see above) improves 
outcomes in patients with low 
back pain (Hill et al. 2011). 
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2.11.2 PROGNOSTIC MODEL RESEARCH 
The programme of research presented within this thesis focuses on prognostic model 
research (see Chapter 1 for the primary research question). The key consideration for 
the choice of this type of prognosis research was the intention to predict the clinical 
outcome as accurately as possible by considering the real-life clinical complexities 
among individual patients. Prognostic models are best placed to do this because they 
account for interactions between multiple factors (Hemingway et al. 2013, Steyerberg 
et al. 2013). In the context of painful shoulder complaints, these typically include 
demographic or clinical factors, such as age, duration of symptoms or disability at 
baseline. The basic design of prognostic model research is outlined in Figure 2.4.  
 
 
Figure 2.4: Basic design of prognostic model research  
  (adapted from 2014 PROGRESS prognosis research summer school, 
Keele University, UK, course materials)   
Prognostic model research encompasses three consecutive key phases (Figure 2.5) 
(Harrell 2001, Steyerberg et al. 2013):  
1) Model development: the initial determination of a prognostic model, which includes 
the internal validation of the model, i.e. the evaluation of its performance by use of 
data from the primary sample.  
2) Model validation: the evaluation of the model’s performance by use of data from 
independent samples, i.e. different clinical settings and populations. External 
validation is a crucial step before a model can be considered usable in clinical 
practice (Steyerberg et al. 2013). 
3) Investigation of clinical impact: the evaluation of the model’s effectiveness and 
cost-effectiveness in improving outcomes.  
Time 
Source 
population 
Study population: 
defined health 
condition or 
disease 
 
Baseline    
assessment 
of prognostic 
factors 
Outcome 
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Figure 2.5: The phases of prognostic model research  
  (adapted from 2014 PROGRESS prognosis research summer school, 
Keele University, UK, course materials) 
These three research phases show that the determination of a valid and usable 
prognostic model requires a comprehensive programme of research, from initial 
development through to the evaluation of clinical impact. The majority of published 
prognostic model studies are limited to model development, with few investigations of 
external validity and very few investigations of clinical impact (Altman 2009, Steyerberg 
& Harrell 2016, Steyerberg et al. 2013).  
2.11.3 EVIDENCE ON THE PROGNOSIS OF OUTCOMES OF 
CONSERVATIVE TREATMENT OF ROTATOR CUFF DISORDERS 
At the time when this programme of research was planned, only limited evidence was 
available on the prognosis of outcomes of conservative treatment with physiotherapy 
for rotator cuff disorders. In particular, no study was available that investigated a 
prognostic model for the outcome of a phase of treatment with physiotherapy in 
patients with painful PPTs, and no systematic review was available that specifically 
addressed prognostic models in rotator cuff disorders. The available evidence is 
addressed in Chapter 3. 
2.12 RESEARCH GAPS AND NEEDS 
In 2013, the US Agency for Healthcare Research and Quality (AHRQ) published a 
report of a comprehensive investigation of “future research needs” in the area of 
DEVELOPMENT VALIDATION IMPACT 
Evaluation of the 
impact of the  
use of the 
model on 
decision making 
and health  
outcomes 
Identification and 
combination of  
factors associated 
with outcome 
 
Time 
Evaluation of the 
model’s validity in 
a different 
population 
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conservative and surgical treatments for rotator cuff tears (Butler et al. 2013), which 
provided strong support of the relevance of the research presented in this thesis. This 
investigation encompassed an updated systematic review on interventions by Seida et 
al. (2010) and input from a group of stakeholders representing clinicians, researchers, 
professional organisations, research funders, payers and consumers. “Which treatment 
is best for which patient, and when?” was the „important overarching question” (p. 17) 
as identified by the stakeholders. “Understanding which patients do best with non-
operative treatment” (p. 10) was rated as a top priority scientific research question. The 
main goal of consumers was to “return patients to full physical function” (p. 12). A top 
methods issue was “What is a minimally important difference in key outcomes?” (p. 9). 
The literature review also revealed that the majority of published research on the 
treatment for rotator cuff tears relates to surgical rather than non-surgical treatment. 
The initial review by Seida et al. (2010), which covered the literature from 1990 to 
2009, had yielded a proportion of 82% of studies on surgical approaches or techniques 
(Butler et al. 2013). 
2.13 SUMMARY AND CONTRIBUTIONS TO KNOWLEDGE 
2.13.1 SUMMARY 
In this chapter, I have provided the context and justification for the programme of 
research that is presented within the remainder of this thesis. The key aspects 
underpinning the relevance of the topic and field of research, i.e. of studying the 
prognosis of the outcome of a period of conservative treatment with physiotherapy in 
adults with painful PTTs, as presented in this and the precedent chapter (Chapter 1), 
are summarised in Table 2.4.  
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Table 2.4: Summary of background: underpinning the relevance of the topic 
and field of research 
Aspect (related section) Key details 
Functional relevance of 
the rotator cuff (2.1) 
The rotator cuff holds a primary role in the dynamic stabilisation 
of the glenohumeral joint. 
Prevalence (1.1, 2.3, 2.7) Most cases of shoulder pain involve the subacromial-subdeltoid 
bursa and the rotator cuff. The reported prevalence of PTTs in 
shoulder pain populations is up to 24%. The prevalence of 
PTTs, most of which are non-traumatic, is associated with 
increasing age. 
Symptoms and burden of 
disease (2.4-2.6) 
Painful rotator cuff tears can significantly affect shoulder function 
and health-related quality of life. People with PTTs may 
experience higher levels of pain than those with FTTs. 
Healing, natural history 
and tear progression (2.8) 
PTTs are unlikely to heal spontaneously and may progress over 
time. Progression may eventually lead to extensive structural 
damage to the shoulder. 
Diagnosis (2.9) US is highly specific for the detection of PTTs.  
Treatment (2.10) Patients with painful PTTs may profit from both conservative and 
surgical treatment. Conservative treatment (which usually 
includes physiotherapy) is recommended as the first-line 
treatment, but there is but there is insufficient knowledge on who 
responds (best) to what treatment. Thus, the precise indications 
for the different available treatment options are unclear. 
Prognosis and prognostic 
research (2.11) 
Being able to predict the clinical outcome of conservative 
treatment at the commencement of the patient’s care pathway 
could save time, effort and suffering, limit exposure to the risks 
of surgery, and promote the optimal distribution of available 
resources.  
Prognostic models aim to predict future clinical outcomes in 
individuals by multiple factors in combination, thereby 
considering real-life clinical complexities among individual 
patients.  
There is a lack of both primary and secondary research on 
prognostic models for predicting the outcome of conservative 
treatment with painful PTTs. While PTTs are commonly included 
in study populations of impingement-related shoulder pain, there 
is a lack of research on exclusive PTT populations. 
Prognosis research methodology is developing and guidance is 
increasingly available. 
Research gaps and needs 
(2.12) 
A comprehensive investigation by (Butler et al 2013) yielded 
important issues and questions for research, including e.g.: 
 “Which treatment is best for which patient, and when?” 
(“important overarching question”, p. 17) and 
 “Understanding which patients do best with non-operative 
treatment” (p. 10, top priority scientific research question), and 
 “What is a minimally important difference in key outcomes?” 
(top methods issue, p. 9) 
CHAPTER 2 32 
 
 
 
2.13.2 CONTRIBUTIONS TO KNOWLEDGE  
This programme of research was designed to provide substantial, original contributions 
to knowledge. The prognostic systematic review, the prognostic study, the MID 
analysis and the responder analysis (as outlined in Chapter 1) each represent original 
contributions to knowledge, as explained in the respective chapters.   
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CHAPTER 3 
Prognostic models in adults undergoing physiotherapy 
for rotator cuff disorders – a systematic review 
3.1 INTRODUCTION 
As set out in the background chapter (Chapter 2), the precise treatment indications for 
PTTs remain unclear. “Understanding which patients [with rotator cuff tears] do best 
with nonoperative treatment” (Butler et al. 2013 p. 10) has been rated a high priority 
research issue. Multivariable prognostic models aim to predict clinical outcomes in 
individual patients (PROGRESS_Research 2016), thus enabling the identification of 
likely responders and, by corollary, nonresponders to (conservative) treatment. The 
availability of clinically usable prognostic models for predicting outcomes in people with 
painful PTTs would benefit patients for whom a course of conservative treatment with 
physiotherapy (the usual first-line approach) was being considered, potentially avoiding 
unnecessary delays and suffering, and reducing uncertainty and anxiety. Equally, 
where surgery is contemplated as a first resort, a usable model might limit unnecessary 
exposure to the associated small but serious risks (Osti et al. 2012).  
Comprehensive literature searches, which I conducted up to March 2012 during the 
planning stage of my PhD, revealed a lack of research on prognostic models for 
predicting outcomes in adults undergoing conservative treatment with physiotherapy 
for painful PTTs. Further, there was no systematic review to synthesise the available 
evidence on prognostic models for the outcome of conservative treatment in adults with 
painful rotator cuff disorders.  
3.2 AIMS 
The aim was to systematically review the available evidence on primary studies 
exploring prognostic models for predicting clinical outcomes in adults with painful 
rotator cuff disorders undergoing conservative treatment with physiotherapy. This also 
aimed to provide context for my own prognostic model study.  
This systematic review was published online in Physical Therapy in December 2015 
(Braun et al. 2015). The reader is directed to Appendix 3.1 for the full article, which 
comprises the review report and supplementary materials (eTables 1-5). This chapter 
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summarises the review and expands the discussion, with a focus on aspects related to 
risk of bias and the use of PROBAST (the instrument with which I assessed risk of bias 
and applicability of the included studies, see further). Additionally, reference is made to 
unpublished materials related to the review such as the review protocol, which are 
enclosed in the appendices to this chapter.  
3.3 Methods 
3.3.1 PROTOCOL AND REGISTRATION 
The review was based on an a priori protocol (Appendix 3.2) and was registered in 
PROSPERO, the International Prospective Register of Systematic Reviews  
(PROSPERO 2016) (registration nr. CRD42014008973). Upon its completion (2 April 
2014), and prior to the conduct of the review, the protocol was lodged with the chair of 
the Research Governance and Ethics Committee of the School of Health and Social 
Care at Teesside University (Dr Alasdair Macsween). Differences between the protocol 
and the review were documented (see Appendix 3.1 eTable 1). 
3.3.2 CRITERIA FOR CONSIDERING STUDIES FOR INCLUSION 
The review included primary studies, reported in English, exploring prognostic models, 
at any stage of prognostic model research, in adults undergoing physiotherapy, with or 
without other conservative measures, for painful rotator cuff disorders (any type). 
Primary outcomes were pain, shoulder disability, assessed via a validated PROM, and 
adverse events. Inclusion was limited to prospective investigations of prognostic 
factors elicited at the baseline assessment. Studies had to evaluate a prognostic 
model, i.e. multiple factors in combination. This practical criterion was given 
precedence over whether studies were strictly classifiable as prognostic model or 
prognostic factor studies. No restriction was placed on the type of multivariable 
analysis. A full description of the inclusion criteria are reported in the published review 
and also documented in the eligibility form (see further). 
3.3.3 DATA SOURCES AND SEARCHES 
The comprehensive search, which is documented in the published review (Appendix 
3.1 eTable 2; the presented Medline search strategie was modified for the other 
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databases), included searches of Medline, Embase, Cinahl, Cochrane Central, PEDro 
and the World Health Organization (WHO) International Clinical Trials Registry 
Platform (ICTRP) from inception up to 19 October 2015. I supplemented the search 
with hand searches of the reference lists of relevant studies. Additionally, I matched the 
compilation of eligible studies with the findings from my previous searches. 
3.3.4 STUDY SELECTION 
Study selection was done independently by two people, i.e. me (CB) and Dr Hanchard 
(NH) or Dr Handoll (HH), with arbitration where disagreement persisted through 
involvement of a third person (NH, HH or Prof Batterham, AMB. We used a filter to 
assist the screening of titles and abstracts (Appendix 3.3) and a purpose-developed 
pilot-tested eligibility form to assist the screening of full texts (Appendix 3.4). 
3.3.5 DATA EXTRACTION 
Data extraction was done independently by two people (CB and NH), using two 
purpose-developed and pilot-tested data extraction forms: one for developmental 
studies (Appendix 3.5) and one for validation studies (Appendix 3.6). Based on our 
initial assessment of the poor quality of the eligible studies, we extracted only one 
prognostic model per study. This was either the reportedly final model or the most 
complete model including the main effects for all prognostic factors. We did not impute 
any data. Author contact was limited to the clarification of issues related to study 
eligibility. 
3.3.6 ASSESSMENT OF RISK AND BIAS AND APPLICABILITY 
Risk of bias and applicability were assessed independently by two people (CB and 
NH), with any persisting disagreement being resolved through involvement of a third 
person (AMB). We piloted early versions of PROBAST, the Prediction Study Risk of 
Bias Assessment Tool (Wolff et al. 2015), for the assessment of risk of bias and 
applicability of the included studies, and then redid the assessment using the latest 
version available provided by its lead developer, Dr Robert Wolff (version 10/09/2014, 
see Appendix 3.7)4. The final tool, which is similar to the one we used, is pending 
publication (personal communication with Dr Wolff, 23/05/2016).  
                                            
4The inclusion of this PROBAST version in the thesis appendices was approved by Dr Wolff 
(personal communication, 17/12/2015). 
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PROBAST is designed to assess risk of bias and applicability of primary studies 
evaluating (developing or validating) prognostic models. It is domain-based, the five 
domains being: participant selection, predictors (i.e. prognostic factors), outcome, 
sample size and participant flow, and analysis. Each domain comprises a set of 
“signalling questions” to facilitate judgements about risk of bias: low, high, or unclear. 
Additionally, the first three domains are assessed for concerns (low, high, or unclear) 
about the applicability of the study’s design and characteristics to the review question. 
A summative judgement across all domains leads to an overall rating of low, high or 
unclear risk of bias. Lastly, the usability of the model is rated as either “yes” or “no”. We 
based the PROBAST assessment on an a priori developed coding manual (Appendix 
3.8). At the time when the review was conducted, no formal guidance was available 
from the developers, but Dr Wolff assisted with the clarification of questions. The 
assessment was done with reference to the selected model (see section 3.3.5).  
3.3.7 DATA SYNTHESIS AND ANALYSIS 
The characteristics and results of all included studies were tabulated and narratively 
synthesised. In the absence of sufficient good-quality, comparable and externally 
validated models, we did not undertake quantitative data synthesis. 
3.4 RESULTS 
We screened the titles and abstracts of 5,899 articles and 54 full texts. We included 
five studies (Hallgren et al. 2014, Hung et al. 2010, Kromer et al. 2014, Merolla et al. 
2011, Taheriazam et al. 2005). We obtained unpublished full multivariable model data 
relating to the trial of Hallgren et al. (2014). My own study and seven other potentially 
relevant ongoing studies were also identified (see Appendix 3.1 eTable 4).  
3.4.1 SUMMARY OF THE CHARACTERISTICS OF INCLUDED STUDIES 
All included studies were cohort studies, but in two studies the cohort was derived from 
pooled data from a randomised controlled trial (RCT). Four studies (Hallgren et al. 
2014, Hung et al. 2010, Kromer et al. 2014, Taheriazam et al. 2005) were classified as 
model development, and one was reported as a validation study (Merolla et al. 2011). 
Four studies (Hallgren et al. 2014, Hung et al. 2010, Kromer et al. 2014, Taheriazam et 
al. 2005) investigated mixed populations with impingement-related shoulder pain, and 
one study (Merolla et al. 2011) investigated a rotator cuff tear population (without 
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differentiating between PTTs and FTTs). Initial sample sizes ranged from 33 (Hung et 
al. 2010) to 102 (Hallgren et al. 2014, Taheriazam et al. 2005). Although varying in 
duration, content and dosage, physiotherapy was provided to all study participants; 
steroid injections were provided to all participants of one study (Hallgren et al. 2014) 
and were optional in another study (Taheriazam et al. 2005). 
The studies were heterogeneous in many of their characteristics, such as the number 
of outcome events (for binary outcomes) or individuals (for continuous outcomes) (23 
to 89) and the number of initially considered prognostic factors (eight to presumably > 
60). Prognostic factors mainly involved demographic and clinical characteristics; one 
study (Kromer et al. 2014) investigated psychosocial factors. Each study used different 
outcome measures; the commonality, though, being that all used PROMs. Follow-up 
ranged from six weeks (Hung et al. 2010) to 12 months (Hallgren et al. 2014, Kromer et 
al. 2014, Taheriazam et al. 2005). 
The methods for selecting prognostic factors for inclusion in the multivariable analysis, 
where specified, varied across the studies; two studies (Hung et al. 2010, Kromer et al. 
2014) explicitly reported using an automated statistical method (e.g. analysis of 
univariable correlations between the prognostic factors and the outcome). Likewise, the 
approaches to multivariable modelling varied. Three studies (Hung et al. 2010, Kromer 
et al. 2014, Taheriazam et al. 2005) used an automated statistical method (e.g. 
stepwise regression). 
Further details of the included studies are tabulated in the published report (Appendix 
3.1 Table 1 and eTable 5).  
3.4.2 RISK OF BIAS AND APPLICABILITY 
The summary of the PROBAST ratings for all included studies is shown in Table 3.1. A 
more detailed table including the ratings for the signalling questions as part of the risk 
of bias assessment can be viewed in Appendix 3.9. All studies were rated as at high 
risk of bias, which was mainly due to issues within the PROBAST domains 3 to 5 
(outcome, sample size and participant flow and analysis). The ratings were affected by 
numerous issues, namely: inclusion of prognostic factors in the outcome definition 
(Kromer et al. 2014, Merolla et al. 2011, Taheriazam et al. 2005); unclear or lack of 
blinding of outcome determination to prognostic factor information (Hung et al. 2010, 
Merolla et al. 2011); an unreasonable number (> 5) of prognostic factors in relation to 
the number of outcome events or individuals reported in the selected model (Hallgren 
et al. 2014, Merolla et al. 2011); unclear handling of missing data (Hallgren et al. 2014, 
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Hung et al. 2010, Kromer et al. 2014, Merolla et al. 2011, Taheriazam et al. 2005); use 
of univariable analyses to select prognostic factors (Hung et al. 2010, Kromer et al. 
2014); unclear (Hallgren et al. 2014) or unspecified (Merolla et al. 2011) modelling 
methods; and failure to consider overfitting of data, complexities in the data, evaluation 
of performance measures or non-linear relationships (Hallgren et al. 2014, Hung et al. 
2010, Kromer et al. 2014, Merolla et al. 2011, Taheriazam et al. 2005). Notably, the 
only validation study (Merolla et al. 2011) was at high risk of bias in most domains. 
Concerns about applicability were rated as low for two studies, unclear for one study, 
and high for two studies (see Table 3.1) and mainly related to the PROBAST domain 2 
(“predictors”, otherwise referred to as prognostic factors in this thesis). Both risk of bias 
and applicability ratings were affected by inadequate reporting. We rated all models as 
not usable in clinical practice. 
Table 3.1: PROBAST (risk of bias and applicability) ratings 
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Björnsson 
Hallgren 
2014 
    ?       
Hung 2010  ?  ?  ?  ?    
Kromer 
2014    ?        
Merolla 
2011 ? ?   ? ?  ?    
Taheriazam 
2005    ? ? ? ?   ?  
ID = first author, yr;  = low risk/concerns; ? = unclear risk/concerns;  = high risk/concerns  
3.4.3 RESULTS OF INCLUDED STUDIES 
The presented models were heterogeneous in various aspects, including the number 
and composition of prognostic factors, and in terms of the presented statistics. A 
summary table presenting the characteristics and results of the studies is available in 
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the supplementary materials to the published report (Appendix 3.1 eTable 5). None of 
the four developmental studies reported any form of model validation, and none of 
these studies were followed by an external validation. Finally, none of the models 
evaluated in the included studies were assessed for clinical impact. 
3.5 DISCUSSION 
This systematic review included five studies (387 participants) which aimed to either 
develop or validate prognostic models for predicting outcomes in adults undergoing 
physiotherapy, with or without other conservative measures, for painful rotator cuff 
disorders. The studies were heterogeneous in many characteristics. The heterogeneity 
ruled out meaningful quantitative synthesis and imposed major limitations on the 
narrative synthesis. All included studies were rated as at high risk of bias, and most 
raised unclear or high concerns about applicability. The assessment of the studies was 
affected by reporting deficiencies. We considered none of the five models as usable in 
practice. 
3.5.1 APPLICABILITY 
The study populations were broadly relevant to the review question. Four studies 
investigated populations with impingement-related shoulder pain which implicitly 
included rotator cuff tears of any completeness, except for one study (Hung et al. 2010) 
which excluded FTTs. One study (Merolla et al. 2011) exclusively studied rotator cuff 
tears, although it is unclear whether PTTs were included. Applicability was 
compromised by unclear eligibility criteria in some studies, pertaining, for example, to 
frozen shoulder (Hung et al. 2010) or rotator cuff tears (Hallgren et al. 2014, Kromer et 
al. 2014, Taheriazam et al. 2005). In two studies, the patient populations were selected 
by virtue of their agreement to participate in an RCT (Hallgren et al. 2014, Kromer et al. 
2014), which may have reduced external validity. No study investigated an exclusive 
population of people with PTTs. 
The physiotherapy treatment was generally consistent with standard clinical practice; it 
was insufficiently reported to allow for a judgement in one study (Taheriazam et al. 
2005). 
The selection of prognostic factors was diverse and generally unjustified. Applicability 
was compromised by various issues. In one study (Hung et al. 2010), specialised 
equipment (a special motion analysis system) was used which would not be available 
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in most clinical settings. The reproducibility of some of the models is likely to be 
compromised by the questionable measurement properties of some prognostic factor 
measurements (e.g. posterior shoulder tightness in Hung et al. (2010) and 
categorisation of continuous prognostic factors (Hallgren et al. 2014, Hung et al. 2010, 
Merolla et al. 2011, Taheriazam et al. 2005). 
Of our pre-specified outcomes, the following were reported by the included studies: 
pain (Merolla et al. 2011), shoulder disability (Kromer et al. 2014, Merolla et al. 2011, 
Taheriazam et al. 2005), global perceived change (Hung et al. 2010) and need for 
surgery (Hallgren et al. 2014).  
The lack of validation of any models in the four developmental studies (Hallgren et al. 
2014, Hung et al. 2010, Kromer et al. 2014, Taheriazam et al. 2005), as well as of any 
investigation of clinical impact, presents a major obstacle to the usability of the models.  
3.5.2 RISK OF BIAS 
We evaluated risk of bias in five domains: participant selection, predictors (i.e. 
prognostic factors), outcome, sample size and flow, and analysis. Various 
methodological issues affected our judgement of risk of bias (see results section). Of 
these, some issues, especially those relating to the number of outcome events or 
individuals in relation to the number of prognostic factors and the use of univariable 
analysis to select prognostic factors, have been shown to result in biased and 
unreliable models (Harrell et al. 1996). 
Prognostic models have been shown to produce overoptimistic (i.e. exaggerated) 
predictions under a number of conditions. One occurs where samples have a small 
number of outcome events or individuals per studied prognostic factor (Harrell 2001 pp. 
60-1, Moons et al. 2014, Steyerberg et al. 2013). Others include selection of factors for 
inclusion in the multivariable analysis based on the statistical significance of their 
univariable associations with the outcome (Bouwmeester et al. 2012, Harrell et al. 
1996, Royston et al. 2009); and selection of factors within the multivariable analysis by 
automated procedures which rely entirely on statistical significance testing, such as 
stepwise regression (Flom & Cassell 2007, Harrell 2001 pp. 56–8, Miles & Shevlin 
2001 pp. 38-9). Given that one or more of these aspects applied to all four 
developmental studies (Hallgren et al. 2014, Hung et al. 2010, Kromer et al. 2014, 
Taheriazam et al. 2005), the presented models are highly unlikely to produce valid and 
reliable predictions. The fifth study (Merolla et al. 2011), although reportedly a 
validation study, was seriously flawed in both concept and design. 
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Furthermore, the categorisation, but in particular the dichotomisation, of continuous 
prognostic factors has been found to produce various problems, such as a 
considerable loss of information, the consequential reduction of statistical power to 
detect a relationship between the prognostic factor and the outcome and the 
underestimation of the variation in the outcome between the groups (Altman 2006, 
Royston et al. 2006). Thus, the models of the four studies in which continuous 
prognostic factors were categorised (Hallgren et al. 2014, Hung et al. 2010, Merolla et 
al. 2011, Taheriazam et al. 2005) are likely to be biased. 
Deficiencies such as unclear handling of missing data and the failure to consider 
overfitting of data, complexities in the data, evaluation of performance measures or 
non-linear relationships hampered the judgement of the quality of the data and of the 
models’ performance. 
One key issue is the inclusion of prognostic factors in the outcome definition. This is 
the problem of incorporation bias through mathematical coupling, and represents a 
conflict between risk of bias and applicability. The literature on incorporation bias 
primarily relates to diagnostic research, where it relates to the interaction between 
index and references tests (Reitsma et al. 2009). Mathematical coupling, which 
inherently occurs “when one variable directly or indirectly contains the whole or part of 
another” (Tu & Gilthorpe 2007 p. 444), may either erroneously purport a relationship 
between the prognostic factors and the outcome or overestimate an existing 
relationship. The conflict with applicability arises specifically because baseline and 
endpoint evaluation of a given outcome measure is standard clinical practice. This 
approach particularly relates to the increased use of patient-reported outcome 
measures (PROMs) in clinical practice and research (Vodicka et al. 2015). Moreover, in 
the present context, PROMs are among the very few prognostic factors that have a 
basis in evidence (Chester et al. 2013, Kuijpers et al. 2004). This conflict was 
encountered in two studies (Kromer et al. 2014, Taheriazam et al. 2005) which were 
both downgraded for risk of bias in the outcome domain as no adjustments were made 
in their study design or analysis to address incorporation bias.  
3.5.3 POTENTIAL BIASES IN THE REVIEW PROCESS 
This systematic review was based on an a priori protocol which was registered with 
PROSPERO. The protocol was lodged with the chair of the Research Governance and 
Ethics Committee of the School of Health and Social Care at Teesside University. Any 
deviations from the protocol were documented. 
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Although failure to identify relevant studies, especially unpublished articles or those in 
non-indexed journals, cannot be ruled out, the searches were comprehensive and 
included several supplementary sources. The yield of included studies from the initial 
search results was < 0.1%, which illustrates the known difficulties with the identification 
of prognosis research (Chatterley & Dennett 2012, Geersing et al. 2012) which include 
the lack of appropriate indexing functions in databases and of current validated search 
filters. I identified several search filters for prognosis research (e.g. Altman 2001, 
Geersing et al. 2012, Walker-Dilks et al. 2008, Wilczynski & Haynes 2004, 2005). 
However, I had concerns about the currentness of all but one (Geersing et al. 2012) 
which was purposely designed to identify prognostic model studies for systematic 
reviews. The use of this search filter appeared to be very helpful as it significantly 
decreased the number of results in Medline but still retrieved all five studies that were 
included in this review.  
The identification of studies was further hampered by uninformative titles and abstracts 
and use of inconsistent terminology, as has been noted by others (Hemingway et al. 
2013, Steyerberg et al. 2013). This lack of clarity similarly applied to the formulation of 
the developmental studies’ objectives, which made it difficult to establish whether they 
intended to develop a prognostic model or whether they were interested in the 
identification of individual factors. In anticipation of this difficulty, any study was 
considered for inclusion in which two or more factors of interest were analysed in 
combination within the multivariable modelling. 
Although inclusion of studies was limited to reports in English, there was no language 
restriction applied in the searches. Nonetheless, I did not identify any non-English but 
clearly relevant studies. The identified ongoing studies provide an indication of 
potentially relevant studies that may be published in the nearer future, although, due to 
insufficient provision of details in the majority, the eventual relevance of most of them 
to the question of this review is unclear. 
Systematic reviewing of prognostic studies is an evolving field, and the methodology is 
work in progress. Nonetheless, I designed and conducted this review to the best 
possible standards, as far as possible: thus, in consideration of the contemporary 
guidance available from the PROGRESS partnership (PROGRESS 2016) and relevant 
recent methodological publications. This included evaluating the included studies using 
PROBAST, which is the first instrument that has specifically been designed to assess 
risk of bias and applicability of prognostic model studies. PROBAST was in 
development during the conduct of the systematic review, and my contact with the lead 
developer of the tool, Robert Wolff, resulted in my involvement in pilot-testing several 
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versions. This led to mutually useful discussions with Dr Wolff, who was generous in 
providing support and feedback on the use of PROBAST throughout. Moreover, 
Dr Wolff further shared my questions and feedback with the members of the PROBAST 
steering group, which, according to Dr. Wolff, helped to further improve the tool; 
examples are the inclusion of “justification for risk of bias (and applicability)” fields, 
improvements of the wording of the signalling questions and the identification of 
aspects that require specification or clarification in the background to the tool (personal 
communication with Dr Wolff, 13/01/2016). 
Clearly, using an intermediate version of PROBAST, together with our own coding 
manual in the absence of a guidance document, means that there may be some 
variation in our interpretation and judgement of some of the items from that resulting 
from the use of the final version of the tool. This is unlikely to be a problem and 
anyway, since systematic reviewing of prognostic model studies is an evolving field 
and the methodology is work in progress, increasing knowledge is likely to affect the 
critical assessment of prognostic model studies.  
3.5.4 AGREEMENT AND DISAGREEMENT WITH OTHER SYSTEMATIC 
REVIEWS 
To my knowledge, this is the first systematic review of the evidence on primary 
prognostic model studies in adults with painful rotator cuff disorders undergoing 
conservative treatment with physiotherapy. I identified two other prognostic systematic 
reviews addressing shoulder pain (Chester et al. 2013, Kuijpers et al. 2004), both of 
which, though, aimed to synthesise evidence on individual prognostic factors rather 
than on prognostic models. Both reviews did not provide any subgroup analyses to 
allow for inferences about rotator cuff disorders.  
3.5.5 IMPLICATIONS FOR PRACTICE AND RESEARCH 
The systematic review demonstrated that there is no prognostic model ready to inform 
clinical practice on the prognosis of outcomes in adults undergoing physiotherapy, with 
or without other conservative measures, for painful rotator cuff disorders. It thus 
endorsed the need for my own primary study.  
The complexity of prognostic modelling demands a high level of methodological 
expertise and clinical judgement, but particularly calls for the involvement, from the 
outset, of a statistician with expertise in the field. The composition of both primary and 
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secondary research teams should reflect this need. Researchers should be receptive 
to developing methodologies. Crucially, more attention should be paid to model 
validation, and ultimately, to the assessment of clinical impact. 
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Orientation Table Chapter 4 
Part Ch. Title  Aims 
ONE 
1 General introduction, aims, 
content and structure of the 
thesis 
1. To provide a general introduction to the 
topic 
2. To summarise the aims, content and 
structure of the thesis 
2 Background To provide the relevant topical and 
conceptual background to the programme 
of research 
TWO 
 
3 Prognostic models in adults 
undergoing physiotherapy for 
rotator cuff disorders - a 
systematic review 
To establish the state of evidence on 
prognostic models in adults 
undergoing physiotherapy for painful 
rotator cuff disorders 
4 Developing and validating 
the physiotherapy protocol 
for the prognostic study 
1. To establish the state of evidence on 
the effectiveness of physiotherapy 
interventions for adults with painful 
atraumatic PTTs  
2. To develop and validate the 
physiotherapy treatment protocol  
5 Selecting and defining the 
candidate prognostic factors for 
the prognostic study  
1. To identify and select the candidate 
factors for the prognostic model study 
2. To define the specific measures for the 
selected factors 
6 Predicting the outcome of 
physiotherapy in adults with 
painful partial-thickness rotator 
cuff tears (PTTs) – a 
prognostic model study 
To develop a prognostic model for the 
outcome of a period of conservative 
treatment with physiotherapy in adult 
patients with painful atraumatic PTTs 
7 Drawing meaningful 
magnitude-based inferences 
from the prognostic study – 
Minimal Important Difference 
(MID) and responder analysis 
1. To establish an estimate of the MID of 
the Western Ontario Rotator Cuff Index 
(WORC), the primary outcome of the 
prognostic model study  
2. To apply the estimated MID to an 
exploratory responder analysis  
THREE 
8 Overall summary and 
conclusions 
1. To summarise the research 
2. To provide overall conclusions and 
consider implications 
FOUR  Appendices Appendices to Chapters 3-7 
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CHAPTER 4 
Developing and validating the physiotherapy  
protocol for the prognostic study  
4.1 BACKGROUND, AIMS AND OBJECTIVES  
Physiotherapy is a standard conservative treatment for impingement-related shoulder 
complaints, including PTTs (see Chapter 2), and background searches of the research 
and descriptive literature on PTTs revealed that exercises and manual therapy are 
considered its principal components (Finnan & Crosby 2010, Fukuda 2003, Wolff et al. 
2006). The prognostic study (Chapter 6) was designed to develop a prognostic model 
for the outcome of a phase of conservative treatment with physiotherapy in adults with 
painful atraumatic PTTs. I aimed to base the physiotherapy protocol for this study on 
the best evidence regarding exercises and manual therapy.  
I had previously conducted a systematic review on “manual therapy and exercises for 
impingement-related shoulder pain” (Braun & Hanchard 2010). Although published 
prior to my PhD programme, Braun & Hanchard (2010) was thus highly relevant. 
However, during the development of the prognostic study protocol (May 2011 to May 
2012), my routine searches revealed that several RCTs had been published since my 
2010 review. I therefore conducted formal electronic searches (Cochrane Library, 
Medline, Embase, Cinahl, and PEDro) and hand-searches of the reference lists of 
relevant articles up to February 2012 to identify any systematic reviews postdating my 
own that might have incorporated some or all of these RCTs. These searches focused 
on systematic reviews explicitly addressing physiotherapy interventions including 
exercises or manual therapy, and identified five (Kelly et al. 2010, Littlewood et al. 
2012, Dewhurst 2010, Kromer et al. 2009, Kuhn 2009). All addressed impingement-
related shoulder pain, and all apparently included PTTs. Four of the reviews (Kelly et 
al. 2010, Littlewood et al. 2012, Dewhurst 2010, Kuhn 2009) explored the effectiveness 
of exercises, whereas one (Kromer et al. 2009) took a broader scope on physiotherapy 
interventions including exercises and manual therapy. Regarding these reviews’ search 
cut-off dates, the most recent was November 2010 (Littlewood et al. 2012). Since I was 
aware of some RCTs that had been published subsequent to this, an update was 
indicated. I decided to build upon and update my own 2010 review (Braun & Hanchard 
2010) in a further systematic review (Braun et al. 2013) which forms part of my PhD 
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programme of research and was also published in Physical Therapy Reviews (see 
further). 
At issue was whether the most recent evidence would provide conclusive guidance on 
the optimal type, composition or dosage of exercises and manual therapy, which 
previous reviews, including my own (Braun & Hanchard 2010), could not (see further). 
The objectives were thus to identify and synthesise the evidence as to the 
effectiveness of manual therapy and exercises in general, and the most effective type, 
composition and dosage of manual therapy and exercise interventions in particular; 
and to document any reports of adverse events (such as exacerbations of symptoms, 
progression of PTTs). 
This chapter summarises the two systematic reviews concerned and their implications 
for the prognostic study protocol. The emphasis is on the methods, results and 
agreement and disagreement with other systematic reviews. The reader is directed to 
Appendix 4.1 for the published full report of the updated review (Braun et al. 2013). 
Because Braun et al. (2013) and Braun & Hanchard (2010) are complementary, they 
are aggregated as far as possible for the following summary which also draws out key 
points of interest. The review report (sections 4.2 to 4.5) is followed by an account of 
the development and validation of the physiotherapy protocol for the prognostic study 
(sections 4.6 to 4.8).  
4.2 METHODS OF THE SYSTEMATIC REVIEWS  
4.2.1 REVIEW DESIGN AND REPORTING 
As Braun et al. (2013) was an explicit systematic review update, the methods were 
largely predefined by my previous review (Braun & Hanchard 2010). The reporting of 
Braun et al. (2013) followed the standards set out by the PRISMA (Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses) statement (Moher et al. 2010). 
4.2.2 REVIEW CRITERIA 
4.2.2.1 Types of research 
Braun & Hanchard (2010) was a methodologically composite systematic review. It 
included systematic reviews of RCTs or quasi-RCTs, but also RCTs or quasi-RCTs that 
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post-dated the included reviews’ search dates. Braun et al. (2013) specifically focussed 
on subsequent RCTs and quasi-RCTs. Both Braun & Hanchard (2010) and Braun et al. 
(2013) required reports to be in full, published form, in English or German.  
4.2.2.2 Participants  
The population of interest was defined as shoulder impingement rather than PTTs per 
se. There has been only minimal research specific to PTTs, but the clinical 
presentation of patients with painful PTTs is conventionally considered to be essentially 
that of shoulder impingement (see also Chapter 2 section 2.5), and shoulder 
impingement populations would be expected to largely incorporate people with painful 
PTTs. The population of interest was broadly operationalised as “patients with pain 
arising locally in [non-operated, non-traumatic] shoulders with grossly normal mobility” 
(Braun & Hanchard 2010 p. 63) in the presence of standard diagnostic criteria for 
shoulder impingement (Braun & Hanchard 2010; Braun et al. 2013). Trials exclusively 
considering FTTs were not included in Braun et al (2013), reflecting the more specific 
motivation for that review.  
4.2.2.3 Interventions 
Manual therapy was defined as any type of manual mobilisation or manipulation, which 
could be supplemented by therapeutic exercises. Exercises encompassed any type of 
active therapeutic regime, and could involve either supervised or home exercises, or 
both. Interventions combining manual therapy and exercises were acceptable. The 
interventions had to be delivered by physiotherapists. Additional physical therapy 
modalities, such as electrotherapy, were accepted only if they were supplementary to 
the manual therapy and exercise intervention. As comparator, any other treatment or 
no treatment was accepted.  
4.2.2.4 Outcomes 
The primary outcomes were pain, disability and self-perceived change of symptoms 
(Braun & Hanchard 2010; Braun et al. 2013), shoulder function (Braun & Hanchard 
2010) and health-related quality of life (Braun et al. 2013). Further, adverse events 
were documented in both reviews. 
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4.2.3 SEARCHES AND SELECTION 
Electronic searches were made of the Cochrane Library, Medline, Embase, Cinahl and 
PEDro and additionally, for Braun et al. (2013), two German databases, Thieme 
Connect and Physiotherapeuten.de. The searches were supplemented by hand 
searches of the reference lists of relevant articles. The cut-off date of the searches for 
the initial review was October 2008. The searches for the update covered the period to 
September 2012.  
4.2.4 QUALITY ASSESSMENT, DATA EXTRACTION AND SYNTHESIS 
The methodological quality of the included research was assessed with the AMSTAR 
checklist (systematic reviews) and the PEDro scale (RCTs and quasi-RCTs). Purpose-
designed forms were used for the extraction of data on the key characteristics and 
results of the reviews and trials. Where possible, missing confidence intervals (CIs) 
were calculated using the Cochrane Collaboration’s Review Manager (RevMan) 
software (version 5.1.7) (Cochrane Review Manager no date). To enhance 
interpretation of the findings’ clinical relevance, estimates of the MID for any of the 
outcome measures, either as reported or imputed from the literature, were obtained 
and documented in the process of the update. Braun et al. (2013) further involved 
independent duplicate screening and assessment of methodological quality and data 
extraction by two reviewers. In cases of disagreement, consensus was sought through 
discussion, for which a third person was also available. All findings were analysed 
narratively. Meta-analysis was proposed where applicable. 
4.3 RESULTS 
4.3.1 CHARACTERISTICS OF THE INCLUDED RESEARCH 
Braun & Hanchard (2010) identified eight systematic reviews and six subsequent RCTs 
as at October 2008, and Braun et al. (2013) identified nine further RCTs in the update 
period (see Table 4.1 for the complete list). The systematic reviews were published 
between 2002 and 2006, with searches spanning 1966 to 2005. Five explicitly 
addressed impingement-related shoulder pain, one addressed rotator cuff tears and 
two addressed general shoulder pain but reported on subgroups of impingement-
related shoulder pain (see Table 4.1). Two reviews (Desmeules et al. 2003, Trampas & 
Kitsios 2006) focussed on exercises and manual therapy, while the others had a 
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broader scope on interventions including exercises and manual therapy. The reviews 
covered any type of comparison such as no treatment, different types of manual 
therapy or exercises or surgery. The reviews were heterogeneous in terms of the 
definition of outcomes of interest, with two (Desmeules et al. 2003; Green & Alexander 
2002) not defining any, and thus covered a variety of outcomes such as pain, disability 
functional limitations (including range of motion and strength), quality of life, sick leave, 
return to work, use of medication or adverse events (or side effects). The reviews 
included between five and 27 studies, only nine of which (represented by 10 reports, 
and totalling 562 participants) were RCTs or quasi-RCTs evaluating exercises or 
manual therapy.  
The 15 RCTs (see Table 4.1), which were published between 2005 and 2012, totalled 
1,072 participants. Thus, the participants in the systematic reviews and RCTs in 
combination totalled 1,634.  
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Table 4.1: Overview of systematic reviews and RCTs included in Braun & 
Hanchard (2010) and Braun et al. (2013)   
  Articles are ordered by publication type and year of publication. 
Article ID Publication type Populations 
Green 2002 SR Shoulder pain 
Johansson 2002 SR Shoulder impingement 
Desmeules 2003 SR Shoulder impingement 
Green 2003 SR Shoulder pain 
Ejnisman 2004 SR Rotator cuff tears 
Michener 2004 SR Shoulder impingement 
Faber 2006 SR Shoulder impingement 
Trampas 2006 SR Shoulder impingement 
Dickens 2005 RCT Shoulder impingement 
Giombini 2006 RCT Shoulder impingement 
Haahr 2006 RCT Shoulder impingement 
Senbursa 2007 RCT Shoulder impingement 
Cloke 2008 RCT Shoulder impingement 
Lombardi 2008 RCT Shoulder impingement 
Barbosa 2008 RCT Shoulder impingement 
Ketola 2009 RCT Shoulder impingement 
Engebretsen 2009, 2011 RCT Shoulder impingement 
Baskurt 2011 RCT Shoulder impingement 
Beaudreuil 2011 RCT Shoulder impingement 
Senbursa 2011 RCT Shoulder impingement 
Holmgren 2012 RCT Shoulder impingement 
Maenhout 2013* RCT Shoulder impingement 
Subasi 2012 RCT Shoulder impingement 
ID = first author, yr; SR = systematic review; *date of final print version - the report was available 
online 2012 before the systematic review cut date 
The diagnostic labels and criteria varied across the included reviews and RCTs, but all 
were compatible with a spectrum of impingement-related shoulder pain including PTTs. 
None of the included reviews or RCTs was specific to PTTs, however. The evidence 
primarily related to subacute (six weeks to three months) and chronic (more than three 
months) complaints; acute complaints were not represented. Implicitly, most of the 
RCTs were conducted in outpatient secondary care settings.  
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Numerous exercise or manual therapy interventions, or combinations of exercises and 
manual therapy, were investigated. Most of the RCTs or quasi-RCTs reviewed by 
others and us investigated exercise interventions. The interventions differed widely in 
terms of their overall duration; the number, frequency and duration of treatment 
sessions; the type, amount and composition of exercises and/or manual therapy 
techniques; and the intensity of exercises or grade of manual mobilisation. The 
spectrum of studied interventions included a variety of approaches to the strengthening 
of the rotator cuff, shoulder and scapular muscles; active and passive stretching of 
shoulder muscles and soft tissues; scapular positioning and stabilisation; humeral 
centring exercises; and active and passive (manual) mobilisation of the shoulder and 
shoulder region joints and soft tissues. In some studies, supplementary modalities such 
as cold packs or therapeutic ultrasound were applied. Each of the studied interventions 
was unique. Likewise, the interventions were compared with a variety of approaches 
such as waiting list controls; placebo treatment (e.g. sham ultrasound); a different type 
of exercises; the addition of manual therapy techniques to exercises; electrotherapeutic 
interventions (e.g. ultrasound); corticosteroid injections; or arthroscopic subacromial 
decompression surgery.  
The most commonly assessed outcomes included pain, disability and shoulder 
function, and quality of life. These outcomes were variably defined and were assessed 
with a variety of outcome measures. Follow-up varied across the studies ranging from 
a few weeks to two and a half years. 
Most of the systematic reviews synthesised their findings narratively. Only two reviews 
included meta-analyses of some results, but these did not relate to the outcomes of 
interest as defined for Braun & Hanchard (2010). The clinical heterogeneity of the 
supplementary trials made the synthesis of their findings difficult and, in combination 
with the heterogeneity of outcome measures, precluded meta-analysis.  
4.3.2 METHODOLOGICAL QUALITY OF THE INCLUDED RESEARCH 
The systematic reviews and the subsequent RCTs were of variable methodological 
quality as assessed by the AMSTAR checklist (Shea et al. 2007) and PEDro scale 
(Sherrington et al. 2000), respectively. All of the RCTs were affected by methodological 
limitations, i.e. carried some risk of bias.  
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4.3.3 EVIDENCE FOR THE EFFECTIVENESS OF EXERCISES AND 
MANUAL THERAPY 
The following summary is presented separately for the systematic reviews and the 
subsequent trials to accommodate these studies’ different levels of focus.  
All of the systematic reviews in Braun & Hanchard (2010) concluded that some 
evidence (reportedly “weak” or “limited”) supported the use of exercises; and all but 
one that there was support, though weak, for using exercises and manual therapy in 
combination. The exception was Ejnisman et al. (2004), who reported that the evidence 
was insufficient to enable a conclusion. None of the systematic reviews was able to 
establish optimal manual therapy or exercise parameters. None found sufficient 
evidence to conclude on the effectiveness of manual therapy as a stand-alone 
treatment. None reported on adverse events. 
The RCTs included in Braun & Hanchard (2010) and Braun et al. (2013), which 
supplemented my review of reviews, supported those general consensus positions 
without establishing the additional certainty and detail required to justify development 
of a prescriptive treatment protocol (specifying the type, composition and dosage of 
exercises and manual therapy). Specifically, three RCTs compared exercises to no 
intervention or to different electrotherapies, of which two (Engebretsen et al. 2011, 
Lombardi et al. 2008), both well conducted, found evidence in favour of exercises for at 
least one important outcome; the third (Giombini et al. 2006) favoured electrotherapy 
but was at some risk of bias. One supplemental RCT (Barbosa et al. 2008) investigated 
the addition of manual mobilisation techniques to exercises and found that this 
significantly enhanced outcomes; however, the RCT was at high risk of bias. Three 
supplemental RCTs compared combinations of exercises and manual therapy 
techniques with or without adjunctive physical modalities to waiting list controls and 
found greater benefits in the intervention groups. Between group differences were 
statistically significant in two of these RCTs (Senbursa et al. 2007; Dickens et al. 
2005), although Senbursa et al. (2007) was at high risk of bias and reported with 
internal inconsistencies; while the third RCT, by Cloke et al. (2008), was at some risk of 
bias. Two RCTs (Haahr & Andersen 2006, Ketola et al. 2009) compared exercise-
based physiotherapy interventions with surgical decompression and found no 
significant differences. There were several head-to-head comparisons of different types 
of exercises. These were mostly inconclusive, although, based on well conducted 
single studies, “dynamic humeral centring” significantly improved pain at three months 
compared to nonspecific shoulder mobilisation exercises (Beaudreuil et al. 2011), and 
a specific strengthening strategy for the rotator cuff and scapular stabilisers conferred 
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significant benefit over a nonspecific home exercise programme on a number of 
patient-important outcomes (Holmgren et al. 2012). No supplemental RCT evaluated 
manual therapy as a stand-alone intervention. 
Only three RCT reports covering two trials (Engebretsen et al. 2009 & 2011, Giombini 
et al. 2006) reported an a priori plan for collecting adverse events data and very few 
adverse events were reported. These related to exacerbations of pain. Meta-analysis 
of the RCTs was precluded by their clinical heterogeneity. 
4.4 CONCLUSIONS 
Braun & Hanchard (2010) and Braun et al. (2013) provided evidence from eight 
systematic reviews and 15 subsequent RCTs supporting, in principle, the use of 
exercises or exercises in combination with manual therapy in adults with subacute or 
chronic impingement-related shoulder pain, including PTT. Clinical heterogeneity and 
methodological deficiencies in the RCTs hindered synthesis and warranted cautious 
interpretation of the findings, such that it was not possible to conclude on the optimal 
type, composition or dosage of the interventions. In this regard, the update by Braun et 
al. (2013) failed to provide any conclusive advancement of the evidence as established 
by Braun & Hanchard (2010). In summary, while the body of available research 
evidence supports a combination of manual therapy and exercises for impingement-
related shoulder pain, it provides no guidance on detail. Clinicians must therefore draw 
on their judgement to inform their choice of exercises, manual therapy techniques and 
treatment parameters.  
Braun & Hanchard (2010) and Braun et al. (2013) revealed a need for further RCTs to 
establish the optimal type, composition and dosage of manual therapy and exercise 
interventions for impingement-related shoulder pain as a basis for a coherent body of 
evidence. Both reviews further noted a lack of studies on acute and rotator cuff tear 
(PTT) populations. Improvements in the quality of methods and reporting are essential.  
4.5 AGREEMENT WITH OTHER SYSTEMATIC REVIEWS 
The findings of my updated systematic review (Braun et al. 2013) overall largely agree 
with the further systematic reviews (November 2008 onwards) that I had identified from 
the literature (Kelly et al. 2010; Littlewood et al. 2012; Dewhurst 2010; Kromer et al. 
2009; Kuhn 2009). Of these, only one (Kromer et al. 2009) conducted a meta-analysis 
on a relevant outcome, and then in a single instance. This was the pain outcome from 
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two trials evaluating the addition of manual therapy to exercises (standardized mean 
difference (95% CI): 0.88 (0.36-1.40)), which favoured the addition. The 
appropriateness of this pooling is questionable and the imprecision of the estimate 
perhaps unsurprising, considering the extent of clinical heterogeneity as well as the 
small sample size (n = 66). Indeed, Kromer et al. (2009) precluded pooling of other 
results, and Kelly et al. (2010) ruled out pooling any results on the grounds of clinical 
heterogeneity.  
Two reviews (Dewhurst 2010, Kuhn 2009) presented an “evidence-based exercise 
protocol” derived from their syntheses. However, each of the protocols involved over-
reaching from, or over-interpretation of, the evidence. Dewhurst (2010) provided a 
compilation of exercises with “an evidence-base from randomized controlled trials to 
improve symptoms of patients with subacromial impingement syndrome” (p. 112). The 
three systematic reviews and four RCTs from which the exercises were derived had 
been critically assessed and found to comply with some predefined quality criteria 
including “the standards of the Critical Appraisal Skills Programme (CASP)” (p. 112). 
However, five of these reports had been included in the reviews by Braun & Hanchard 
(2010) or Braun et al. (2013), and most had revealed methodological deficiencies 
warranting cautious interpretation. Beyond this, it seems that Dewhurst (2010) 
extracted any exercises that had been used in the studies’ intervention groups without 
considering further aspects such as whether any of the exercises had been 
investigated by more than a single study. Kuhn (2009) presented a protocol “based on 
the best evidence demonstrating a beneficial effect for exercise in the treatment of 
rotator cuff tendonitis” (p. 156), derived from an arbitrary cut-off of “clinical significance” 
(p < 0.05 and difference of the effect size or difference between groups  20%). There 
seems to be no rational justification for this approach. 
4.6 DRAFTING THE PHYSIOTHERAPY PROTOCOL 
4.6.1 CONTENT OF PHYSIOTHERAPY 
Braun & Hanchard (2010) and Braun et al. (2013) provided the basis for the treatment 
protocol for the prognostic model study (see Chapter 6). Without over-reaching from 
the inconclusive research evidence, there was no justification for defining any specific 
selection of exercises or manual therapy techniques which the collaborating 
physiotherapists would have to use in their treatment of study participants. Instead, the 
protocol rested upon the broad principles that: 
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1) exercises, preferably in combination with manual therapy, would be the key 
components of treatment; and 
2) flexibility in the detail of the interventions as well as in the provision of adjunctive 
modalities would be allowed. 
These principles lent themselves to a domain-based approach to the physiotherapy 
protocol, which was embodied in a study-specific physiotherapy report form (Appendix 
4.2). In the form, implicit broad domains (e.g. exercises, mobilisations) were exploded 
into typical “indicative” intervention categories, e.g. “strengthening exercises focusing 
on the rotator cuff muscles”, “stabilisation exercises”, “manual mobilisation techniques 
(shoulder)” and “soft tissue techniques (shoulder or shoulder girdle)”, which comprised 
the final categories. These final categories were informed by screening for and 
extracting “typical interventions” from Braun & Hanchard (2010) and Braun et al. 
(2013), initially in its unpublished form, the other systematic reviews identified from the 
literature (Kelly et al. 2010, Littlewood et al. 2012, Dewhurst 2010, Kromer et al. 2009, 
Kuhn 2009) and the descriptive literature on PTTs and impingement-related shoulder 
pain (see Chapter 2 section 2.10). On the report form, a tick box was provided adjacent 
to each category. This was to facilitate documentation of physiotherapy treatments. 
Individual categories were not intended to be prescriptive or mandatory, and the list 
was not intended to be exclusive (an “anything else” box was provided).  
4.6.2 PROVISION OF PHYSIOTHERAPY 
Although the content of sessions within the evidence-based framework was intended to 
be discretionary, the amount of physiotherapy and provision of adjunctive modalities 
and the maximum number of physiotherapy sessions could not be entirely so. This was 
not based on the research evidence, which was equivocal in both respects, but on the 
need for practitioners to comply with German healthcare regulations. As outlined in the 
background (Chapter 2 section 2.10.4), the standard maximum number of 
physiotherapy sessions for patients with a diagnosis of a PTT within the German 
statutory health insurance is 18 (three sets of of six sessions), with a recommended 
frequency of two or more sessions per week (GKV-Heilmittelrichtlinie 2011). Exceeding 
this limit may require the health insurer to approve a formal request. Adherence to the 
healthcare regulations is the responsibility of the treating doctor, and was in the context 
of the prognostic study thus the responsibility of Dr Betthäuser. Based on 
Dr Betthäuser’s clinical experience and my own, we anticipated that the majority of the 
participants would require approximately 12 sessions (i.e. two prescriptions of six 
sessions), while some patients would require fewer, and some more. Further assuming 
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that the most common frequency of physiotherapy is one to two sessions per week, we 
anticipated that the length of observation of around three months would overall well fit 
within the statutory framework.  
The duration of a single physiotherapy session in Germany is not strictly regulated, but 
the remuneration agreements between the German statutory health insurers and the 
German physiotherapy associations include recommended values for the different 
types of treatment. For standard physiotherapy or manual therapy, the current value is 
15 to 25 minutes (vdek 2016). Many physiotherapy practices schedule a single session 
with 20 minutes (Gutefrage.net 2013). Some practices have longer sessions, and the 
common schedule of a single session for privately insured patients is 30 minutes 
(Privatpreise.de 2008). Thus, we expected the duration of single sessions of standard 
physiotherapy or manual therapy to mainly range from 20 to 30 minutes.  
4.7 PILOTING THE REPORT FORM 
I invited six colleagues to pilot the form and to provide feedback. All were practicing 
clinicians and three held Master degrees. Thus, clinical and academic perspectives 
were represented. I asked them to consider the content of the form, i.e. whether they 
thought it covered all relevant domains, or whether anything relevant was missing or 
redundant, as well as its usability, i.e. whether they found it quick and easy to use and 
complete. I asked them whether they would suggest any changes, either to the content 
or to the design of the form. All six colleagues piloted the form and provided feedback. 
Regarding the content, all found that it covered most of the domains that they 
considered relevant. Three colleagues suggested the addition of “spinal mobilisation” 
as a further domain, because they regularly applied manual mobilisations to the 
cervical or thoracic spine to their patients with impingement-related shoulder pain. 
Although the use of cervical or thoracic mobilisations for improving clinical outcomes in 
patients with impingement-related shoulder pain was not backed by evidence and 
hardly mentioned in the literature at that time, I considered it reasonable to allow for the 
addition of spinal mobilisations or other contingencies, and did so by adding a line titled 
“anything else”. Regarding the usability of the form, all six colleagues found that it was 
very easy and quick to complete, and that they did not experience any problems with 
completing it. Thus, no further changes were necessary. 
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4.8 VALIDATION BY COLLABORATING PHYSIOTHERAPY 
PRACTICES 
I initially approached, by telephone, leads from a convenience sample of eleven 
practices over the wider Hamburg area with a view to recruitment (further details are 
provided in Chapter 6), but also with a view to determining whether the protocol 
reflected their usual approach to the treatment of patients with impingement-related 
shoulder pain. Of these, seven were eligible and agreed to collaborate, and the leads 
of these practices confirmed that the protocol, and the domain structure of the 
physiotherapy report form, complied with their usual approach to the treatment of 
patients with impingement-related shoulder pain (with or without PTTs). This endorsed 
my strategy. 
4.9 SUMMARY 
The physiotherapy protocol for the prognostic model study as part of this PhD 
programme of research was based on the available evidence on exercises and manual 
therapy for adults with impingement-related shoulder pain (including PTTs) and took 
into account the relevant German healthcare regulations. The level of detail of the 
available evidence only lent itself to a broad domain-based protocol, which, though, 
fitted perfectly with clinical practice. Piloting and feedback from targeted practice 
endorsed the protocol and the implicit domain structure of the physiotherapy report 
form.  
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CHAPTER 5 
Selecting and defining the candidate prognostic factors 
for the prognostic study  
5.1 INTRODUCTION 
Central to the design of my prognostic model study (Chapter 6) was the selection of a 
set of candidate prognostic factors. Numerous factors were potentially relevant, 
meaning that choices had to be made. The number of candidate factors to be 
investigated in the prognostic study was limited to 10 at the outset (as explained in 
Chapter 6). In this chapter, I describe the selection process for the candidate factors, 
including the specific measures and/or measurement systems for their use in the 
prognostic study. 
5.2 AIMS AND OBJECTIVES 
The overarching aim was to maximise the chances of developing a valid, high-
performing prognostic model by optimising the selection of the candidate factors. To 
achieve this, a three-stage approach comprising identification, critical assessment and 
final selection of prognostic factors was taken.  
5.3 METHODS 
5.3.1 SELECTION APPROACH  
The three-stage selection approach is outlined in Figure 5.1. 
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considered. No restrictions were made on the study design or analysis methods. 
Further, I considered studies such as Delphi studies or surveys which aimed to 
establish expert consensus on potentially relevant prognostic factors. Inclusion 
was restricted to publications in English or German. There was no restriction on 
the publication type. 
 Participants  
The review focussed on populations of adults with any type of painful rotator cuff 
disorder. Evidence from general shoulder pain populations was also considered for 
systematic reviews and expert consensus studies. 
 Interventions  
Inclusion of prognostic studies was limited to studies in which participants were 
followed over a course of conservative treatment. Studies in which not all 
participants received conservative treatment, or where this was unclear, were not 
considered. There was no restriction on the type or duration of treatment. 
 Prognostic factors  
Prognostic factors were only considered if they were assessable at the baseline 
assessment. No restriction was made on the type of factors (e.g. demographic, 
physical, psychological). 
 Outcomes  
Any outcome was considered. 
 Data sources and searches  
Searches were made of Medline, Embase, Cinahl, Cochrane Library and PEDro 
databases. These were supplemented by hand searches of the reference lists in 
relevant articles. The primary search strategy is shown in Appendix 5.1. The terms 
and component strings (population, interventions, prognosis) were used in all 
possible permutations. All searches were conducted by me, and up to February 
2012.  
 Study selection and data extraction  
All publications that met the above criteria were included. From each included 
study (or review of studies), I extracted any prognostic factors available at baseline 
that were considered by the study investigators (or review authors) to have a 
relevant association with a study outcome. I placed no restriction on the outcome 
other than it needed to be clinically relevant. 
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5.3.2.2 Additional suggestions of candidate factors 
When I started to plan the prognostic study, I had in mind several factors that I 
considered of potential interest. These arose from my clinical experience, discussion 
with clinicians and knowledge of the literature on rotator cuff disorders. Among these 
factors were age, disability and symptom duration, which I knew had some support of 
their prognostic relevance from clinical evidence.  
Two other factors that I considered as potentially relevant were diabetes and smoking. 
The detrimental effects of both these on many aspects of health are well-known 
(Alberg 2008, Hoogwerf et al. 2006). I was also aware that both diabetes and smoking 
had been linked with the prevalence of various musculoskeletal complaints including 
shoulder pain (Gauri & Fatima 2009, Palmer et al. 2003, Porter & Hanley 2001), and I 
found there was some evidence for a higher prevalence of rotator cuff disorders in 
smokers (Baumgarten et al. 2010, Viikari-Juntura et al. 2008) and in people with 
diabetes (Miranda et al. 2005, Ranger et al. 2015, Viikari-Juntura et al. 2008). 
Both diabetes and smoking had been shown to impair the healing of musculoskeletal 
tissues such as bone (Gaston & Simpson 2007). And while I did not find specific 
evidence in relation to tendon healing, this seemed plausible. Although I found no 
evidence relating to the role of diabetes and smoking in predicting clinical outcomes in 
people with rotator cuff disorders, there was limited evidence for inferior functional 
outcomes after surgical repair of rotator cuff tears in smokers (Mallon et al. 2004) and 
in people with diabetes (Clement et al. 2010). I thus concluded that there was a strong 
rationale for including both smoking and diabetes as candidate factors and put these 
forward for inclusion in the list of putative prognostic factors, regardless of whether or 
not they were identified through the searches.  
All factors that were identified from the literature search and the additionally suggested 
factors were taken together; these formed the initial compilation of potential candidate 
factors. 
5.3.3 STAGE 2 - CRITICAL ASSESSMENT OF IDENTIFIED FACTORS 
Each of the above factors was critically assessed by me for its compliance with the 
following criteria:  
 Relevance to my study: the factor had to be relevant to the population and setting 
of the prognostic study. 
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 Measurement properties: the factor had to be assessable with a sufficiently valid 
and reliable measurement. In the case of PROMS, this included the availability of 
validated German versions.  
 Applicability/practicability in clinical practice: the factor had to be applicable in most 
clinical settings, i.e. should not require any special equipment, diagnostic skills or 
techniques beyond those commonly available and covered by standard statutory 
health care. Also, the factor had to be applicable within Dr Betthäuser’s routine 
clinical practice. 
Following their assessment, the factors that met all three criteria were then placed into 
two broad groups. (The criteria were derived in the knowledge of the availability of the 
expert consensus study.)  
1) Group A: These were factors with reasonably consistent support for their 
prognostic relevance, either clinical evidence from three or more studies, or from 
both clinical evidence and expert consensus.  
2) Group B: These were factors with either limited support for their relevance from 
clinical evidence but no support from expert consensus; factors with no support 
from clinical research but support from expert consensus; or any additionally 
suggested factors for which there was no support from clinical evidence or expert 
consensus.  
5.3.4 STAGE 3 - CONSENSUS ON FINAL TEN FACTORS 
All factors that had been retained at the second screening stage were discussed with 
Dr Betthäuser and Dr Hanchard to achieve consensus on the 10 factors to be included 
in the prognostic study.  
The findings from the selection process were documented and summarised by text and 
tabulation. 
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5.4 RESULTS 
5.4.1 STAGE 1 - IDENTIFICATION OF FACTORS  
5.4.1.1 Literature review 
Clinical evidence 
After screening overall around 3,900 records from the searches and checking 
reference lists, I identified 23 primary study reports for 22 studies that met the pre-
specified inclusion criteria. The study reports (same as any other identified reports) and 
their references are listed in Appendix 5.2. For completeness, the references are also 
included in the reference list of this chapter. Only two of these studies, one published in 
full (Yamanaka & Matsumoto 1994) and the other published in a conference abstract 
only (Selvanetti et al. 1998) exclusively involved patients with PTTs. I also identified 
one systematic review of primary prognostic studies on populations of patients with 
various shoulder complaints (Kuijpers et al. 2004). The overlap between the systematic 
review and my compilation of primary studies was two studies (Brox & Brevik 1996, 
Morrison et al. 1997).  
I extracted 34 factors from the primary studies. The systematic review did not provide 
any factors additional to those reported in the primary studies. Diabetes and smoking 
were not among these 34 factors. The evidence base for the majority of the factors 
consisted only of one or two clinical studies. The factors were very heterogeneous, as 
were the approaches used for their measurement. For only three factors - namely, age, 
disability and symptom duration - was there reasonably consistent evidence of 
prognostic value from several (five or more) studies pertaining to clinical outcomes of 
conservative treatment in patients with rotator cuff disorders. The systematic review 
(Kuijpers et al. 2004) provided some evidence in support of the prognostic relevance of 
pain, age, duration of symptoms and baseline disability in painful shoulder disorders.  
Expert consensus 
I found one study which involved a Delphi expert consensus approach on the 
“prediction of persistent shoulder pain in general practice” (Vergouw et al. 2011). 
Through a three-round Delphi process, a multidisciplinary panel of health professionals 
(general practitioners, orthopaedists, physiotherapists and manual therapists), all of 
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whom were “involved in or having thorough knowledge of shoulder pain in clinical 
practice” (Methods para.1), selected and consented a set of 10 factors which were 
considered as most important to predict the persistence of shoulder pain in the general 
practice setting. These factors were: symptom duration, history of symptoms/shoulder 
pain, severity of shoulder disability, age, shoulder pain intensity, coexisting neck pain, 
multisite pain, fear-avoidance beliefs, illness perceptions and pain catastrophizing 
(Table 2). The last five of these were factors which were not identified from the primary 
studies. 
5.4.1.2 Additionally suggested factors 
As planned, diabetes and smoking were retained for further consideration despite not 
being identified via the literature review. 
5.4.1.3 Initial compilation of potentially relevant factors 
In summary, 36 factors formed the initial compilation. They are presented in Table 5.1. 
The factors are grouped according to various categories: 
 Demographic factors  
 Activity-related factors  
 Symptom-related factors  
 Factors related to history of symptoms/shoulder pain  
 Factors from physical examination  
 Factors related to comorbidities and (self-reported) health status 
 Psychosocial/psychological factors 
 Structural factors  
 Rotator-cuff specific factors  
 Interventional factors  
 Economical factors  
Table 5.1 also shows the sources of support for each factor (i.e. clinical evidence 
and/or expert consensus).   
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Table 5.1: Compilation of factors, grouped by type, showing source of 
supporting evidence and results of the selection  
  See foot of table for key 
No Factor Clinical evidence (article IDs) 
Expert  
consensus 
Stage 2 
out-
come 
Stage 3 
out- 
come 
Demographic factors 
1 Age Ekeberg 2010;  
Kennedy 2006a,b; 
Maman 2009; Morrison 
1997; Selvanetti 1998; 
Yamanaka 1994; 
SR Kuijpers 2004 
E A  
2 Education Engebretsen 2010 
 B  
3 Sex Ekeberg 2010; 
Kennedy 2006a,b  
B
  
Activity-related factors 
4 Dominant arm  
(affected) 
Chard 1988 
 B  
5 Patient’s physical 
demands (overhead 
athletes) 
Selvanetti 1998 
 B  
Symptom-related factors 
6 Coexisting neck pain  E B  
7 Disability (shoulder-
related) 
Bartolozzi 1994; 
Ekeberg 2010; 
Engebretsen 2010; 
Hung 2010; Kennedy 
2006a,b; Taheriazam 
2005; 
SR Kuijpers 2004 
E A  
8 Pain  Ekeberg 2010;  
Kennedy 2006a,b;  
SR Kuijpers 2004 
E A  
9 Patient’s global rating 
of (severity of) 
problem  
Kennedy 2006a,b 
 B  
10 Quality of sleep 
(sleep loss due to 
shoulder pain) 
Hawkins 1995 
 B  
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No Factor Clinical evidence (article IDs) 
Expert  
consesus  
Stage 2 
out-
come 
Stage 3 
out- 
come 
Factors related to history of symptoms/shoulder pain 
11 Aetiology of 
symptoms (including 
history of trauma to 
the shoulder, type of 
rotator cuff disease 
and overuse) 
Chard 1988; Selvanetti 
1998; Yamanaka 1994 
   
12 History of (previous) 
shoulder pain 
Engebretsen 2010 E A  
13 Symptom duration Bartolozzi 1994; Chard 
1988; Kennedy 
2006a,b; Morrison 
1997; Taheriazam 
2005; 
SR Kuijpers 2004 
E A  
Factors from physical examination 
14 Impingement sign 
(presence/absence) 
Tanaka 2010 
   
15 Muscle strength 
(serratus anterior; 
abduction; rotation) 
Hung 2010; Itoi & 
Tabata 1992; Vad 2002    
16 Range of motion 
(active: abduction, 
external rotation; 
passive) 
Ekeberg 2010; Itoi & 
Tabata; Minagawa 
2003; Tanaka 2010; 
Vad 2002  
   
17 Scapular kinematics: 
internal rotation 
Hung 2010 
   
Factors related to comorbidities and (self-reported) health status  
18 Diabetes None direct; see text 
(section 5.3.2.2)  
B
  
19 Glenohumeral 
arthritis 
Vad 2002 
   
20 Health status (self 
reported) 
Engebretsen 2010; 
Kennedy 2006a,b  
B
  
21 Multisite pain  E   
22 Smoking None direct; see text 
(section 5.3.2.2)  
B
  
Psychosocial/psychological factors 
23 Fear-avoidance 
beliefs 
 E   
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No Factor Clinical evidence (article IDs) 
Expert  
consesus  
Stage 2 
out-
come 
Stage 3 
out- 
come 
24 Illness perceptions  E B  
25 Pain catastrophizing  E B  
Structural factors (shoulder) 
26 Acromion 
type/morphology 
Morrison 1997; 
Taheriazam 2005; 
Wang 2000 
   
27 Humeral head 
migration 
Vad 2002 
   
28 Osseous 
abnormalities (not 
further specified)  
Selvanetti 1998 
   
Rotator cuff specific factors 
29 Fatty infiltration  Maman 2009 
   
30 Muscle atrophy Tanaka 2010; Vad 
2002    
31 Tear size (extent) Selvanetti 1998; 
Yamanaka 1994    
32 Type of rotator cuff 
pathology or tear; 
tendon integrity 
Bartolozzi 1994; 
Maman 2009; Tanaka 
2010 
   
Interventional factors 
33 Corticosteroid 
injections (response 
to initial injection; 
previous) 
Cummins 2009; 
Ekeberg 2010 
   
34 Medication (regular 
medication; over-the-
counter medication) 
Ekeberg 2010, 
Kennedy 2006a    
Economical factors 
35 Insurance (worker’s 
compensation) claims 
Hawkins 1995, 
Kennedy 2006a,b    
36 Sick leave Ekeberg 2010 
   
Article ID = first author, yr; E = expert consensus; = included (retained); A= reasonably 
consistent support for prognostic relevance (see section 5.3.3); B= limited support for prognostic 
relevance (see 5.3.3);  = excluded; SR = systematic review. 
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5.4.2 STAGE 2 - CRITICAL ASSESSMENT 
The results of the screening at stage 2 are presented in the column “stage 2” in  
Table 5.1. Nineteen factors were excluded at this step; these are listed together with 
the main reason for exclusion for each factor in Appendix 5.3.  
As described above, the remaining 17 factors were placed into one of two groups (A or 
B) according to the extent of the supporting evidence (see section 5.3.3). Five factors 
(age, disability, pain, duration of symptoms and history of shoulder pain) were 
supported by evidence (group A), whereas the remaining factors were not (group B) 
(see Table 5.1).  
5.4.3 STAGE 3 – FINAL SELECTION STAGE FOR THE TEN CANDIDATE 
FACTORS 
Discussions with Dr Betthäuser and Dr Hanchard resulted in the final selection of 10 
candidate factors. These included all five factors in group A. The results of the 
consensus process are presented in the column “stage 3” in Table 5.1. The 10 
candidate factors for inclusion in the prognostic study are separately presented in 
Table 5.2.  
Table 5.2: Final selection of candidate prognostic factors  
No Factor Category / type 
1 Age Demographic 
2 Sex Demographic 
3 Physical demands Activity-related 
4 Disability Symptom-related 
5 Pain Symptom-related 
6 History of shoulder pain History of symptoms 
7 Symptom duration History of symptoms 
8 Diabetes Comorbidities  
9 Smoking Comorbidities 
10 Pain catastrophizing Psychological 
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5.5 SELECTION AND RATIONALE FOR THE SPECIFIC 
MEASURES AND MEASUREMENT OF THE CANDIDATE 
PROGNOSTIC FACTORS 
The selection of the 10 candidate prognostic factors was followed by the careful 
consideration of specific measures and measurement systems for each factor for use 
in the prognostic study. Although Dr Betthäuser assessed all of the factors as part of 
his usual practice, these were not usually measured in a suitable way for the purposes 
of the prognostic study. The heterogeneity in the measures (e.g. PROMS to measure 
disability) and measurement systems (e.g. different cut-offs for age) used in the 
primary clinical studies meant these were of very limited use as a guide.  
Table 5.3 provides an overview of the measure/measurement system used for each of 
the 10 candidate factors in the prognostic study. The factors were mostly assessed 
through a self-report questionnaire (this is further explained in the report of the 
prognostic study, see Chapter 6). With the exception of self-explanatory demographic 
factors (i.e. age and sex), the rationale for the selection of the measure/measurement 
system for each factor is detailed below.  
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Table 5.3: The candidate factors and their measures used in the study 
No Predictor variable Measure / measurement system 
1 Age Age at initial presentation (yr) 
2 Sex  Sex (female, male) 
3 Physical demands ”Before you had your current shoulder problem, did a 
typical week include one or more of the following 
activities:  
 Repetitive or prolonged use of the affected arm for 
strength effort (e.g. lifting, carrying or moving heavy 
loads, athletic sports, strength-demanding skilled 
manual work) 
 Repetitive or prolonged use of the arm above shoulder 
height (e.g. overhead work, overhead sports, throwing 
sports, work as a hairdresser)?” (yes/no) 
4 Disability  Western Ontario Rotator Cuff Index (WORC) (Kirkley et al. 
2003a); validated German version (Huber et al. 2005) 
(score) 
5 Pain  “What is the worst amount of pain that you have 
experienced within the past week?” (100 mm visual 
analogue scale VAS) 
6 History of shoulder pain 
(incl. previous treatment) 
“Prior to the current episode, have you ever seen a 
medical doctor or therapist for pain in this shoulder?” (yes, 
no)  
7 Symptom duration  “For how long have you been having your current 
shoulder complaints?” (weeks) 
8 Diabetes  “Do you have diabetes?” (yes/no) 
9 Smoking “Are you a smoker? Please tick “yes” if you regularly 
smoke at least once a week any amount of tobacco” 
(yes/no) 
10 Pain catastrophizing  Pain Catastrophizing Scale (PCS; Sullivan et al. 1995); 
validated German version (Meyer et al. 2008) (score) 
 
5.5.1 ACTIVITY-RELATED FACTORS 
5.5.1.1 Physical demands 
The measurement of this factor was based on clinical knowledge; these are typical 
questions when taking a patient history. The intention was to capture any of the key 
activities that typically provoke or increase pain in patients with impingement-related 
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shoulder pain. The question was pre-tested by Dr Betthäuser in a small sample of 
patients to ensure sufficient comprehensibility. No problems were encountered. 
5.5.2 SYMPTOM-RELATED FACTORS 
5.5.2.1 Disability 
This factor was measured by use of a PROM. In order to select a suitable measure for 
use in the prognostic study I searched the literature for PROMS assessing shoulder 
disability (with or without inclusion of additional aspects such as HRQoL). The aim was 
to find, if available, a rotator cuff specific PROM that ideally satisfied several pre-
defined criteria which are presented in Table 5.4. I intended to use the selected PROM 
both for the assessment of disability as a prognostic factor and as the primary outcome 
of the prognostic study. 
Table 5.4: Criteria for selecting a disability PROM 
No Criteria 
1 Is the PROM rotator-cuff specific, or, if not, does it appear suitable for use in the study 
population? 
2 Does it assess disability (with or without additional aspects such as pain or HRQoL)? 
3 Does it have satisfactory psychometric properties? 
4 Is a validated German version available? 
5 Is the PROM easy for patients to understand and complete (availability and quality of 
instructions)? 
6 Is it sufficiently quick to complete? 
7 Does it appear to be well accepted by patients (any data on problems)? 
8 Is it available free of charge?  
9 Is it sufficiently easy and quick to analyse? 
 
To gain a comprehensive overview of available instruments, I focussed on reviews of 
any shoulder disability measures, and identified three (Bot et al. 2004, Kirkley et al. 
2003b, Michener & Leggin 2001, Wright & Baumgarten 2010). A book on 
“classifications and scores of the shoulder” (Habermeyer et al. 2006) as well as several 
further more focussed publications on shoulder disability measures (Desai et al. 2010, 
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Ekeberg et al. 2008, Michener & Leggin 2001, Oh et al. 2009, Razmjou et al. 2006, 
Roy & Esculier 2011, Roy et al. 2009) served as additional sources of information. 
I extracted all reported PROMs from the publications. I identified 26, which can be 
viewed in Appendix 5.4. I categorised them into “general” (further sub-grouped into 
either “upper extremity-related” or “shoulder-related” measures) and “specific” (further 
sub-grouped into “condition-specific” and “disease-specific”) instruments. Of the 26 
PROMS, only four were disease-specific and only two had been developed specifically 
for use in people with rotator cuff disorders (see also Chapter 2 section 2.9.1): the 
Western Ontario Rotator Cuff Index (WORC) (Huber et al. 2005, Kirkley et al. 2003a) 
and the Rotator Cuff Quality of Life measure (RC_QOL) (Hollinshead et al. 2000).  
Both the WORC and the RC_QOL appeared suitable for consideration. After initially 
inspecting the questionnaires I decided to further inspect the WORC for compatibility 
with the pre-specified criteria to determine its suitability for use in my study, the primary 
reason being that the RC_QOL appeared to be very long (34 items compared to 21 
items of the WORC), meaning that it would take longer for patients to complete. The 
results can be viewed in Table 5.5 and show that the WORC was well suited for use in 
the prognostic study.  
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Table 5.5: Assessing the suitability of the WORC  
No Criteria /  Details 
1 Is the PROM rotator cuff specific, 
or, if not, does it appear suitable 
for use in the study population? 
 The WORC was specifically designed for 
use in people with rotator cuff pathologies 
(including tendinitis, tears (PTT and FTT) 
and cuff arthropathy) (Kirkley et al. 
2003a). 
2 Does it assess disability (with or 
without additional aspects such 
as pain or HRQoL)? 
 The WORC assesses disability in 
combination with pain and QoL. 
3 Does it have satisfactory 
psychometric properties? 
 The WORC has been shown to be a 
valid, reliable and responsive PROM for 
use in people with rotator cuff disorders 
(Huber et al. 2005, Kirkley et al. 2003a,b, 
Roy & Esculier 2011, Wright & 
Baumgarten 2010). 
4 Is a validated German version 
available? 
 Huber et al. (2005) 
5 Is the PROM easy for patients to 
understand and complete 
(availability and quality of 
instructions)? 
 The WORC comes along with very helpful 
instructions on each item. 
6 Is it sufficiently quick to 
complete? 
 On average 7.5 min as reported by Huber 
et al. (2005) 
7 Does it appear to be well-
accepted by patients (any data on 
problems)? 
 There is some evidence of good 
acceptance, i.e. no problems with 
completing the WORC (Huber et al. 2005, 
Kirkley et al. 2003a). 
8 Is it available free of charge?   
9 Is it sufficiently easy and quick to 
analyse? 
 Analysis requires a bit more effort due to 
the use of VAS scales, but appears 
acceptable.  
= satisfactorily fulfilled;  = not satisfactorily fulfilled 
  
CHAPTER 5 97 
 
 
 
The WORC (see Appendix 5.5) consists of 21 questions (items), which are subdivided 
into five domains: “physical symptoms” (items 1-6), “sports/recreation” (items 7-10 
items), “work” (items 11-14), “lifestyle” (items 15-18) and “emotions” (items 19-21). 
Each question is answered by putting a mark on a 100 mm visual analogue (VAS) 
scales (with the right end indicating the highest extent of symptoms or disability), which 
leads to a score between 0 (no symptoms no disability) and 2100 (greatest extent of 
symptoms and disability). The score can alternatively be presented as percentage of 
normal by applying the following formula: (2100 – total score) / 2100 x 100 (Kirkley et 
al. 2003a p. 87). 
5.5.2.2 Pain 
Baseline pain intensity was assessed with a VAS. VAS are widely used to measure 
pain intensity in clinical populations and are quick and easy to administer (Hawker et 
al. 2011, Kamper 2012). VAS scales are considered a reliable and responsive 
measurement showing a high correlation with numerical rating scales (NRS) and other 
measures of pain (Hawker et al. 2011). VAS have been claimed to show some 
disadvantages compared to NRS, which include that they may be more difficult to 
understand, especially for older people (Hjermstad et al. 2011, Schomacher 2008), and 
that patients appear to prefer NRS over VAS (Hjermstad et al. 2011). The key reason 
for choosing a VAS for use in the study was that the WORC items (some of which 
relate to pain) are similarly rated using VAS scales. This minimised the number of 
different concepts of measurement in the questionnaires that the patients needed to 
become familiar with, thereby potentially reducing patient confusion. 
The anchor for the assessment of the baseline pain intensity (“What is the worst 
amount of pain that you have experienced within the past week?”) was chosen based 
on my clinical experience of the varying intensity of pain, i.e. its dependency of pain to 
shoulder movements. A 100 mm long VAS was chosen, with the verbal descriptor “no 
pain” at the left end and “worst imaginable pain” at the right end. These are reportedly 
the most widely used descriptors used in research on VAS (Hjermstad et al. 2011).  
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5.5.3 FACTORS RELATED TO HISTORY OF SYMPTOMS/SHOULDER 
PAIN 
5.5.3.1 History of shoulder pain 
Linking the patients’ history of shoulder pain to the consultation of a healthcare 
professional (doctor ot therapist) enabled the assessment of both previous episodes of 
and previous treatment (by any healthcare professional) for pain in the affected 
shoulder. Considering only episodes that led to the consultation of a healthcare 
professional further introduced a threshold of severity. This question was pre-tested in 
clinical practice on a small sample of patients by Dr Betthäuser to ensure that it was 
sufficiently comprehensible. No problems were encountered. 
5.5.4 FACTORS RELATED TO COMORBIDITIES AND (SELF-REPORTED) 
HEALTH STATUS 
5.5.4.1 Diabetes 
I decided on a simple binary measure (“yes” or “no”) for diabetes. This appeared 
reasonable given the lack of direct evidence on the role of diabetes in painful rotator 
cuff disorders and prevalence data. Since the estimated prevalence of (diagnosed) 
diabetes in the German population was approximately 7% at the time when the 
prognostic study was planned (Diabetes Deutschland 2012), any further categorisation 
of diabetes (such as by type of diabetes or treatment) would have introduced a threat 
to obtaining appropriate numbers of cases for the statistical analysis. 
5.5.4.2 Smoking 
The consideration of a threshold of dose for smoking, although arbitrarily chosen, was 
included to reflect the accumulating evidence on the increasing prevalence and health 
risks of light or intermittent smoking (Schane et al. 2010). As light smokers may not 
consider themselves as smokers, it has been suggested to use more focused 
questions to also detect light smokers rather than just asking “Are you a smoker?” 
(Schane et al. 2009). In view of the limited knowledge on the role of smoking in rotator 
cuff disorders, it seemed reasonable to keep the question broad. The estimated overall 
prevalence of smokers in the German population (including both daily and intermittent 
smokers) was around 30% in 2011 (Statista.com_Rauchen no date). Thus, similar as 
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with diabetes, any further categorisation would have introduced a threat to obtaining 
appropriate numbers of cases for the statistical analyses.  
5.5.5 PSYCHOLOGICAL/PSYCHOSOCIAL FACTORS 
5.5.5.1 Pain catastrophizing 
Pain catastrophizing has been defined as “an exaggerated negative ‘mental set’ 
brought to bear during actual or anticipated painful experience” (Sullivan et al. 2001 p. 
53). It refers to the interpretation of pain as being “extremely threatening” (Leeuw et al. 
2007 p. 79).  
An investigation of the literature for available measures of pain catastrophizing yielded 
the Pain Catastrophizing Scale (PCS) (Sullivan et al. 1995). This validated, generic 13-
item patient-reported instrument designed for both clinical and non-clinical populations 
appeared to be the only available PROM explicitly designed to assess pain 
catastrophizing. I checked it for suitability for its use in my prognostic study and also 
against the same criteria as the WORC (Table 5.5). The results presented in Table 5.6 
show that the PCS appeared well suited for use in the prognostic study. 
The PCS instrument can be viewed in Appendix 5.6. The PCS consists of 13 items 
which represent statements describing different thoughts and emotions that may be 
associated with pain. Patients are asked to rate the degree to which they have each of 
these thoughts and emotions when they are experiencing pain by a five-point scale 
ranging from 0 (“not at all”) to 4 (“all the time”). The total PCS score can thus range 
from 0 to 52, with 0 representing no pain catastrophizing and 52 representing the 
highest possible degree of pain catastrophizing. Sullivan (2009) has proposed a PCS 
score of 30 as the “cut-off score for clinically relevant levels of catastrophizing” (p.7).  
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Table 5.6: Assessing the suitability of the PCS  
No Criteria /   Details 
1 Is the PROM rotator cuff specific, 
or, if not, does it appear suitable 
for use in the study population? 
 The PCS is a generic measure that has 
been developed for use in various clinical 
and non-clinical populations. As such, it 
was appropriate for use in the prognostic 
study population. 
2 Does it assess pain 
catastrophizing? 
 It was explicitly designed to assess pain 
catastrophizing (Sullivan et al. 1995). 
3 Does it have satisfactory 
psychometric properties? 
 The PCS has been shown to be a 
sufficiently valid and reliable instrument 
(Meyer et al. 2008; Osman et al. 2000; 
Osman et al. 1997; Sullivan et al. 1995). 
4 Is a validated German version 
available? 
 Meyer et al. (2008) 
5 Is the PROM easy for patients to 
understand and complete 
(availability and quality of 
instructions)? 
 Appears to be; the introductory 
instructions on how to complete the PCS 
appear easy to understand. 
6 Is it sufficiently quick to 
complete? 
 < 5 minutes (Sullivan 2009) 
7 Does it appear to be well-
accepted by patients (any data on 
problems)? 
 There is some evidence of good 
acceptance, i.e. no relevant problems 
with completing the PCS (Meyer et al. 
2008). 
8 Is it available free of charge? 
 
 Available via: http://sullivan-
painresearch.mcgill.ca/pcs.php [last 
accessed 11 June 2016] 
9 Is it sufficiently easy and quick to 
analyse? 
 Very easy and quick to analyse by 
summing up the scores for all items 
(Sullivan et al. 1995) 
= yes;  = no 
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5.6 SUMMARY 
The three-stage process for selecting the 10 candidate factors for the prognostic model 
study comprised a systematic literature review to identify prognostic factors reported in 
clinical studies and other sources; a screening process to select factors which were 
relevant to the study, had suitable measurement properties, and were applicable and 
practical in clinical practice; and a consensus process which included an appraisal of 
the evidence base for each factor. Overall 36 factors were identified, most of which 
were evidenced from single studies. After screening, 19 factors were excluded. From 
the remaining 17 factors, 10 were chosen for inclusion in the study through a 
consensus process. Careful consideration was given to the selection of the specific 
measures and/or measurement systems for each factor for their use in the prognostic 
model study. 
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CHAPTER 6 
Predicting the outcome of physiotherapy in adults  
with painful partial-thickness rotator cuff tears (PPTs) –  
a prognostic model study 
6.1 INTRODUCTION 
The background literature review for this programme of research (see Chapter 2) and 
the systematic review of prognostic models (see Chapter 3) showed considerable 
uncertainty regarding indications for any treatment of people with painful PTTs, but 
especially conservative treatment. Conservative treatment is the first line for patients 
with PTTs and commonly includes physiotherapy, with possible adjuncts such as oral 
pain medication or subacromial corticosteroid injections. Despite this, no valid and 
usable prognostic model was available for the outcome of conservative treatment with 
physiotherapy for any type of rotator cuff disease, and no prospective prognostic model 
study had specifically addressed a population with painful PTTs. These findings 
highlighted the need for well-designed prognostic modelling research into the outcome 
of conservative treatment with physiotherapy in patients with painful PTTs. The present 
chapter reports on such a prognostic model study, which I designed and conducted as 
a key element of my PhD programme. The originality of this work is evidenced by the 
findings from the prognosis systematic review, which showed that at the time my study 
was planned, and indeed to date (June 2016)5, there were no completed or registered 
on-going prospective prognostic model studies addressing the same research 
question. 
6.2 STUDY AIMS AND PRIMARY RESEARCH QUESTION 
The primary aim was to develop a prognostic model for the outcome of a phase of 
conservative treatment with physiotherapy in adults with painful PTTs. The primary 
research question was thus: what combination of factors can best predict the outcome 
of a period of conservative treatment with physiotherapy (with or without adjunctive 
medical treatment) in adults with shoulder pain and ultrasonographically diagnosed, 
atraumatic PTTs?  
                                            
5
 Last update of database searches (systematic review strategy): 14 June 2016 
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Secondary aims were to determine the incidence of PTT progression and to establish 
participants’ perceived global change in their shoulder complaints over the observation 
period. The latter was to enable an estimate of the MID of the WORC, the primary 
outcome of this study. The MID analysis, in itself a novel contribution to knowledge, is 
reported in Chapter 7. 
6.3 ETHICS AND GOVERNANCE COMMITTEE APPROVALS  
Approval for this study and the MID analysis was required from two ethics committees: 
the Teesside University School of Health and Social Care (SHSC) Research 
Governance & Ethics Committee (RGEC), and the Ethics Commission of the Hamburg 
Medical Council (the responsible German local commission). SHSC RGEC approval 
was obtained on 23 May 2012 (Appendix 6.1). This conferred cover under the 
University’s Public Liability and Professional Indemnity scheme on the condition that all 
collaborating physiotherapy practices would provide written evidence of indemnity. 
Approval by the Ethics Commission of the Hamburg Medical Council was obtained on 
09 November 2012 6  (Appendix 6.2). The ethics approvals applied to both the 
prognostic study and the MID analysis. 
6.4 STUDY PROTOCOL AND REGISTRATION 
The study was developed from an a priori protocol (Appendix 6.3), which, in turn, was 
based on the information required by the ethics applications. It was retrospectively 
registered in the German Clinical Trials Register (Deutsches Register Klinischer 
Studien, DRKS7), which feeds into ICTRP, the International Clinical Trials Registry 
Platform of the WHO8, on 08 April 2014. The registration number is DRKS00004462. 
For deviations from the protocol see Appendix 6.4. 
6.5 COMPLIANCE WITH REPORTING STANDARDS  
The methods, results and discussion collectively report all items required by the 
TRIPOD (Transparent Reporting of a multivariable prediction model for Individual 
Prognosis or Diagnosis) statement (Collins et al. 2015, Moons et al. 2015). The 
                                            
6
 This appendix includes the German letter and an English translation of its content. 
7
 Link: https://drks-neu.uniklinik-freiburg.de/drks_web/ [last accessed 13 May 2016] 
8
 Link: http://apps.who.int/trialsearch [last accessed 13 May 2016] 
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completed (prediction model development) checklist for the study can be viewed in 
Appendix 6.5. 
6.6 STUDY METHODS 
The relevant general methodological concepts were introduced in Chapter 2. The 
design of the study was, as far as possible, based on the most recent methodological 
guidance and publications on prognosis research as outlined in Chapter 2 (see section 
2.11). 
6.6.1 OVERWIEW OF STUDY DESIGN 
This was a prospective, single-group cohort study (Moons et al. 2009; Royston et al. 
2009). Figure 6.1 illustrates the study design in terms of the key elements of prognosis 
research (as introduced in Chapter 2 Figure 2.3). The phase of prognostic model 
research was development.  
 
Figure 6.1: Outline of study design  
6.6.2 GENERAL SETTING 
The study was conducted in Hamburg, Germany.  
ACTION 
 
Observation of 
three months of  
conservative treatment 
with physiotherapy 
(with or without  
adjunctive modalities) 
ENDPOINT 
 
Follow-up; 
outcome  
assessment 
 
Time 
Prognostic factors 
from initial  
presentation 
STARTPOINT 
 
Adults with a painful 
PTT as diagnosed by 
an orthopaedic  
shoulder specialist in 
Hamburg, Germany 
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6.6.3 STUDY PERSONNEL IN CONTEXT 
The study involved collaboration with a shoulder surgeon and physiotherapists in 
clinics across the Hamburg area. 
6.6.3.1 Shoulder surgeon  
The shoulder surgeon, Dr Andreas Betthäuser, is a certified instructor in 
ultrasonographic shoulder diagnosis (Deutsche Gesellschaft für Ultraschall in der 
Medizin (German Society for Ultrasonography in Medicine), DEGUM). He conducts 
approximately 4,000 shoulder scans annually in his single-handed secondary care 
clinic (Schulter-Zentrum Hamburg; www.schulter-zentrum.com). Dr Betthäuser 
conducted all recruitment into the study, performed and interpreted all initial and follow-
up assessments, including ultrasound scans, and, in keeping with his role as the 
“responsible treating doctor” (as required by German ethics regulations), monitored the 
treatment phase. 
6.6.3.2 Physiotherapists  
The physiotherapy took place in collaborating physiotherapy practices whose staff also 
undertook some patient-specific administrative tasks, namely collection of the signed 
informed consent forms and completion of physiotherapy report forms. The practices 
did not have to fulfill any specific requirements in terms of facilities, equipment or 
specialist training of staff, but their leads were expected to ensure that all staff involved 
would have sufficient experience and expertise in the physiotherapeutic treatment of 
patients with PTTs and impingement-related shoulder complaints to comply with the 
protocol, and to provide written evidence of their staffs’ indemnity as required by 
Teesside University’s indemnity policy.  
As outlined in Chapter 4 (section 4.8), eleven potentially eligible practices were initially 
selected based on my own knowledge, recommendations by Dr Betthäuser and other 
colleagues, and complementary web searches. I telephoned the practice leads to 
gauge their interest and evaluate their practices’ eligibility. Nine were willing to 
collaborate (two lacked the time), and seven practices (comprising nine locations) were 
eligible. (The other two focused on osteopathic rather than physiotherapeutic care.) As 
previously indicated (Chapter 4), the leads of these seven practices confirmed that the 
protocol, as outlined, complied well with their usual approach to the treatment of 
patients with impingement-related shoulder pain. Staff in the seven practices were 
subsequently sent written information (in German, and therefore not appended to this 
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thesis, and materials including: blank copies of the consent and physiotherapy report 
forms, prepared reply envelopes, contact details for Dr Betthäuser and me, and a 
sample “study pack” (see further)). A face-to-face meeting was then arranged at each 
site (between May and July 2012) to provide opportunities for discussion. Following the 
respective meetings, the practice leads each signed a statement (see Appendix 6.6) 
confirming that they had been informed about the study and had agreed to collaborate, 
and that their staff were appropriately indemnified.  
Patients were free to choose which physiotherapy practice they would attend. The list 
of the seven collaborating practices was provided, but for various reasons, often 
logistical, patients sometimes expressed a preference to be treated elsewhere. To 
accommodate this, and optimise recruitment, these additional practices (numbering 24) 
were contacted and incorporated ad hoc, but following the same processes detailed 
above9.  
Throughout the study I maintained regular contact with the practice leads and their 
clinical staff, mainly by telephone or email.  
6.6.4 STUDY POPULATION 
The population of interest was adults ( 18 years) with painful, ultrasonographically 
diagnosed PTTs presenting to Dr Betthäuser. The eligibility criteria were developed to 
restrict inclusion to patients whose shoulder pain could reasonably be linked to the 
presence of a PTT, while avoiding over-exclusivity. The eligibility criteria are presented 
in Textbox 6.1.  
                                            
9
 The incorporation of further physiotherapy practices reflects a deviation from protocol (see 
Appendix 6.4). 
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Textbox 6.1: Study eligibility criteria 
Inclusion: 
 Patients with (local) shoulder pain in the presence of an atraumatic (ultrasonographically 
detected) PTT 
 Clinical signs of shoulder impingement (e.g. painful arc, positive impingement tests) 
 Adults ( 18 years) 
 No restrictions on sex 
 Agreement on conservative treatment 
 Ability to speak and comprehend the German language  
 Agreement to participate (signed informed consent) 
 Anticipated availability for follow-up (living in area of Hamburg) 
 Agreement to physiotherapy in a collaborating practice 
Exclusion:  
 Presence of an FTT at the affected shoulder 
 Previous substantial shoulder trauma (e.g. shoulder dislocation, fractures) 
 Previous surgery for the affected shoulder 
 Previous surgery in the shoulder area that may be causal of or contributory to the current 
problem (e.g. surgery for breast cancer) 
 Clinically relevant glenohumeral degeneration or disease (e.g. frozen shoulder) 
 Current glenohumeral septic arthritis  
 Clinically relevant acromioclavicular arthritis (e.g. local tenderness, positive provocation 
tests) 
 Clinically relevant calcific tendinitis 
 Ultrasonographic evidence of LHB tendon subluxation/ dislocation 
 Referred pain from the cervical spine region  
 Multisite musculoskeletal pain  
 Systemic disorders, diseases or comorbidities as potential sources of (the current) 
shoulder pain (e.g. breast cancer, rheumatoid disease, inherited disorders (e.g. Marfan 
syndrome, Ehlers-Danlos syndrome)), or as impairing treatment (e.g. cancer, cardiac 
insufficiencies)  
 Neurological disorders or deficits as potential sources of (the current) shoulder pain or 
impairing assessment and treatment (e.g. hemiplegic shoulder) 
 Worker’s compensation claims 
 Unwillingness or inability to give informed consent (e.g. cognitive or intellectual 
impairments) 
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6.6.5 ASSESSING ELIGIBILITY 
The assessments conducted were standard for Dr Betthäuser’s practice. 
6.6.5.1 Physical assessment 
Dr Betthäuser conducted the physical assessment based on recommendations by the 
German Society for Shoulder and Elbow Surgery (Deutsche Vereinigung für Schulter- 
und Ellbogenchirurgie, DVSE) (DVSE 2012). In Appendix 6.7, an overview is provided 
of the recommended components and selection of tests. Dr Betthäuser chose the tests 
based on the individual patients’ presentations. All tests were carried out on both 
shoulders. Further aspects of the assessments are provided with the study procedures.  
6.6.5.2 Ultrasonographic assessment 
Dr Betthäuser determined the presence of each PTT ultrasonographically using an 
ultrasound unit in appliance class 3 (the highest classification) according to DEGUM 
(http://www.degum.de/service/geraetelisten.html) and a linear transducer with a 
resolution of  10 MHz and a width of  40 mm.  
The assessment was based on the standards by DEGUM and the German Society for 
Orthopaedics and Trauma (Deutsche Gesellschaft für Orthopädie und Unfallchirurgie, 
DGOU) (Konermann & Gruber 2007). As the minimum standard, the ventral, dorsal, 
superior and lateral shoulder regions were assessed both in the transveral and 
longitudinal plane. The assessment was tailored to the individual patient and could thus 
involve further planes. The assessment always included both a static and a dynamic 
evaluation.  
Diagnosis of a PTT was based on the criteria by Hedtmann & Fett (1995, 2002). The 
key criteria for the presence of a rotator cuff defect were alterations of structure 
(echogeneity) and form (diameter, reversal of contour). In distinction to a PTT, an FTT 
was marked by the absence of the depiction of the rotator cuff (discontinuity of the 
rotator cuff). Figure 6.2 shows three examples of rotator cuff ultrasound scans: an 
intact cuff, a supraspinatus PTT and a supraspinatus FTT. (All scans show a right 
shoulder. All three patients were male and between 59 and 62 years old). 
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Figure 6.2: Example US scans of the rotator cuff 
  (US scans and picture provided by Dr Betthäuser) 
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6.6.6 TREATMENT 
All study participants were followed over approximately three months of standard care 
with physiotherapy at one of the collaborating physiotherapy practices, with or without 
adjunctive treatment such as oral medication or local steroid injections as deemed 
clinically appropriate.  
The physiotherapy treatment followed the broad protocol as described in Chapter 4. 
Beyond that, and in keeping with the ethos of an observational study, the type, content 
and amount of treatment were unregulated. Participants were advised on the amount 
and content of physiotherapy on an individual basis by their treating therapist and in 
agreement with Dr Betthäuser. All treatments were delivered in compliance with 
German national healthcare regulations (see Chapter 2 section 2.10.4). Details were 
documented. 
Dr Betthäuser implemented, monitored and documented any adjunctive medical 
treatment and any modifications of the treatment regime that were considered 
necessary. Participants were free to consult Dr Betthäuser during the treatment phase 
if they felt in need of further advice or adjunctive medical treatment, which was in line 
with usual practice.  
6.6.7 PROGNOSTIC FACTORS 
The 10 candidate prognostic factors for this study (fully described and defined in 
Chapter 5) were: age, sex, physical demands, disability, pain, history of shoulder pain, 
symptom duration, diabetes, smoking and pain catastrophizing. All were assessed 
during the baseline assessment, some by patient-completed questionnaires that 
formed part of a paper-based initial questionnaires package (Appendices 6.8, 5.5 
(WORC) and 5.6 (PCS)), and others by Dr Betthäuser’s standard clinical history 
interview.  
6.6.8 ADDITIONAL BASELINE CHARACTERISTICS  
Additional baseline characteristics, collected not for modelling purposes but to enhance 
characterisation of the study sample, were: “affected tendon” (supraspinatus, 
infraspinatus, supraspinatus and infraspinatus, or any other), “involvement of dominant 
arm” (yes or no) and “work status” (full-time, part-time, sick leave, retired, or not 
working (any other reason)). As with the candidate prognostic factors, some of these 
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data were derived from a patient-completed questionnaire (Appendix 6.8) and others 
from Dr Betthäuser’s standard clinical history. 
6.6.9 OUTCOME MEASURES AND MEASUREMENT 
6.6.9.1 Primary outcome measure  
The primary outcome measure was the change in the WORC score (WORC_change) 
between baseline (WORC_1) and follow-up (WORC_2). The WORC is described in 
Chapter 5 (section 5.5.2.1), because it was also used as a prognostic factor. 
Participants completed the WORC_2 as part of a paper-based “follow-up 
questionnaires” package which included the WORC (Appendix 5.5) and the Global 
Perceived Change (GPC) scale (see further). Completion of the WORC_2 was 
standard at follow-up assessments in Dr. Betthäuser’s practice, but for the purposes of 
the study, alternative provision was also made for postal completion, as required (see 
timing of outcome assessment, below).  
6.6.9.2 Secondary outcome measures 
Global Perceived Change (GPC) 
The participant-perceived overall change of the shoulder problem was assessed by a 
GPC scale (Kamper et al. 2009) (see Appendix 6.9). GPC scales are widely used as 
an overall measure of patients’ perceptions of how their health status has improved 
over a period of treatment or time. While GPC scales may vary in their design, they 
generally ask patients to rate the perceived change in their health status by comparing 
its current state to that at a defined, previous point in time. There are some criticisms of 
GPC scales, specifically that they may be prone to recall bias and that current status 
may influence ratings more than change (Kamper et al. 2010). However, their face 
validity is high, the limited evidence available on their measurement properties 
suggests that they are adequately reproducible and sensitive to change, and they are 
strongly correlated with various other PROMs such as the Roland Morris Disability and 
the Oswestry Low Back Pain Disability Questionnaire (Kamper et al. 2009). GPC 
scales are a recommended core outcome measure for use in chronic pain trials 
(Dworkin et al. 2005, Kamper et al. 2009) and are the most widely used patient-based 
anchor in studies determining the MID of outcome measures (Brozek et al. 2006, 
Jevsevar et al. 2015, Revicki et al. 2008, Turner et al. 2010, Wright et al. 2012). 
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Consequently, a GPC scale was also used in the MID analysis of the WORC (see 
Chapter 7).  
Based on an investigation of different numbers of response options in rating scales by 
Preston & Colman (2000), Kamper et al. (2009) postulated that “scales with 7 to 11 
points appear to offer the best compromise between patient preference, adequate 
discriminative ability, and test-retest reliability” (p. 168). The scale was therefore 
constructed around a central (“unchanged”) point, with equal numbers of response 
points (-3 to +3) on both sides (Kamper et al. 2009 p. 168). In addition to the numbers, 
written descriptors were assigned to each response point. The phrasing of the question 
(i.e. the anchor statement) is critically important if the scale is to measure what it is 
intended to measure (Kamper et al. 2009). To this end, there was explicit mention of 
the health condition [shoulder problem], the construct of interest [overall change] and 
the reference time point for the assessment of change [“since your first assessment 
with Dr Betthäuser”] (Kamper et al. 2009).  
As with the WORC_2, GPC rating was done as part of the follow-up assessment but 
could alternatively be done postally.  
Tear progression 
Tear progression was defined as progression from a PTT to an FTT (yes or no) and 
was measured ultrasonographically by Dr Betthäuser. Presence of an FTT was based 
on the ultrasonographic criteria described above (section 6.6.5.2).  
Tear progression was primarily assessed as a means of determining the safety of a 
three-month phase of conservative treatment with physiotherapy in patients with PTTs. 
I had initially intended to measure progression on a continuous scale (in mm or % 
change in depth), but a preliminary review of the literature cast doubt on the validity 
and reliability of ultrasonographic cuff tear measurement in terms of either tear depth or 
area (Bryant et al. 2002, Iannotti et al. 2005, Kim et al. 2011, Teefey et al. 2004).  
Adverse events 
The treating physiotherapists were asked to document any adverse events that they 
considered as related to the physiotherapy treatment. This was done by an open 
question on the physiotherapy report form (Appendix 4.2): “Did your patient report any 
problems such as exacerbations of symptoms or side effects?” and a blank space. The 
question was deliberately kept broad to allow for any experienced adverse events. 
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6.6.9.3 Blinding of outcome assessment 
In strict terms, assessment of the primary outcome (WORC_change) could not be 
blinded to knowledge about the prognostic factors, because both the outcome and all 
prognostic factors were patient-reported. In practice however, patients were not aware 
which of the many parameters evinced at baseline were candidate prognostic factors. 
The forms were completed in a separate room, i.e. not in the presence of 
Dr Betthäuser. 
6.6.9.4 Timing of outcome assessment 
Follow-up assessments were conducted as close as possible to three months after the 
baseline assessment. This complies with Dr Betthäuser’s usual practice. Some 
flexibility was allowed, but four months was considered the longest acceptable interval. 
For patients who would be unable to attend within this timeframe, follow-up 
questionnaires were sent by post instead, aiming for return (in a postage-paid 
envelope) at around three months after the baseline assessment. 
6.6.10 PATIENT INFORMATION AND INFORMED CONSENT 
All potential participants were verbally informed about the study by Dr Betthäuser. 
Those who expressed potential interest were given a fuller explanation, supplemented 
by a written patient information sheet (PIS, Appendix 6.10) and an informed consent 
form (Appendix 6.11). The sheet and form were developed following guidance from 
various sources (e.g. Teesside University 2011, Health Research Authority 2011) and 
the requirements of the ethics commission of the Hamburg Medical Council. 
In order to give sufficient time to consider participation, all eligible participants were 
asked to take the form with them and sign it, if they still wished to do so, during their 
first physiotherapy session.  
6.6.11 POTENTIAL RISKS TO THE INTERESTS OF PARTICIPANTS 
The risks to the interests of participants were considered minimal as there was no 
deviation from standard clinical practice. As part of his usual practice, Dr Betthäuser 
informed all participants of any potential risks or harms related to any treatment he 
initiated or provided. Regarding the physiotherapy treatment of patients with PTTs, 
there are no known serious risks or harms. Participants were routinely informed that 
temporary increases in symptoms could occur as a reaction to the physiotherapy 
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treatment, and that in case of any such reaction, the treating therapist would be the 
primary person to manage this. Participants were further informed that they could at 
any time contact Dr Betthäuser, who, as routine, monitored the whole treatment phase. 
Dr Betthäuser also initiated, monitored and documented provision of any adjunctive 
medical treatment (e.g. oral pain medication, local steroid injections to the shoulder), or 
any modifications of the treatment regime if considered necessary.  
6.6.12 STUDY PROCEDURES 
In the following section, the study procedures are described. Figure 6.3 provides an 
outline of the procedures from the baseline (initial) assessment (the study’s startpoint) 
to the follow-up assessment (the study’s endpoint). 
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Figure 6.3: Overview of study procedures 
  
Initial presentation to Dr Betthäuser  
 Initial assessment 
   Diagnosis, check for eligibility 
Patient eligible   
 Patient was invited to 
participate in study. 
 Patient was offered informa-
tion on study (study pack). 
 Physiotherapy treatment was 
initiated. 
 Where considered 
appropriate, adjunctive 
medical treatment was 
initiated or provided. 
Patient non-eligible   
No further consideration for 
study; patient received care 
as needed. 
Physiotherapy treatment started  
 
 
Patient did not consent  
  non-participant; patient 
received care and further 
assessment as planned and 
considered appropriate. 
Patient signed informed consent 
  Patient became actual study 
participant; received treatment 
as planned and further needed 
(including additional visits to 
Dr Betthäuser if needed). 
 
 
Follow-up presentation to 
Dr Betthäuser 
 Outcome assessment 
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6.6.12.1 Baseline assessment and diagnosis (startpoint) 
At baseline, Dr Betthäuser assessed and diagnosed all patients (as described in 
section 6.6.5). The assessment included:  
 a subjective assessment of the patient’s history and current complaints, comprising 
a one-to-one interview and the completion of participant-completed questionnaires 
(see sections 6.6.7 and 6.6.8). Evaluation of the candidate prognostic factors was 
part of this assessment. 
 a physical assessment 
 an ultrasonographic assessment 
6.6.12.2 Recruitment 
Throughout the recruitment period, consecutive patients were screened for eligibility. 
Eligible patients were informed about the study and invited to consider participating. 
Those who were interested were given a study pack in an envelope labelled with a 
unique study ID. The study pack included: 
 a PIS labelled with a unique study ID (Appendix 6.10)  
 an informed consent form without the study ID (Appendix 6.11) 
 a list with the names and contact details of the primary collaborating physiotherapy 
practices (not included in appendices for reasons of confidentiality) 
 a physiotherapy report form labelled with the study ID (Appendix 4.2)  
Dr Betthäuser documented the unique study ID and asked the patient to arrange a 
follow-up assessment at three months after the initial presentation (as is his standard 
practice). He also initiated or provided further medical treatment (e.g. oral medication, 
corticosteroid injections), if appropriate, and provided the patient with a prescription for 
physiotherapy. 
Thus, all eligible patients who were interested in the study left Dr Betthäuser’s practice 
with a study pack and a physiotherapy prescription. They were invited to read the 
information and were informed that they could contact Dr Betthäuser or me in case of 
any further questions about the study. They were asked to keep the study pack 
together with their prescription, and to take it with them when they saw their 
physiotherapist.  
Patients wishing to participate were asked to choose one of the collaborating 
physiotherapy practices for their treatment. If they indicated that they would prefer a 
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different practice, they were asked to do the same but where additionally asked to 
either contact me or ask the treating therapist to contact me for the relevant information 
about the study and to implement collaborator status (see section 6.6.3.2).  
6.6.12.3 Treatment 
During the first physiotherapy treatment session, the treating physiotherapists asked 
the patient if he or she had decided to participate in the study. If so, the consent form 
was completed and returned, by the physiotherapist, to Dr Betthäuser, who informed 
me. If a patient had forgotten to bring the study pack, but wished to participate, the 
physiotherapist provided a spare blank form, and contacted me for the study ID. The 
physiotherapist added a note to the patient documentation when a patient had given 
consent, and attached the report form containing the study ID to the patient 
documentation, ready for completion at the end of the study observation period.  
Upon receipt of the signed consent form, I confirmed eligibility according to the data 
documented by Dr Betthäuser. Any uncertainties were resolved through discussion 
with Dr Betthäuser. Receipt of a signed consent form and confirmation of eligibility by 
me marked a patient’s entry into the study. Participants then received treatment as 
described (see section 6.6.6 and Chapter 4 section 4.6). On completion of their original 
physiotherapy prescription, participants were individually advised on the number and 
type of follow-up prescriptions by the treating physiotherapist in agreement with 
Dr Betthäuser. 
6.6.12.4 Follow-up assessment (endpoint) 
When the physiotherapy treatment phase ended, the physiotherapists reminded their 
patients of the follow-up assessment with Dr Betthäuser, completed the physiotherapy 
report forms and sent them to Dr Betthäuser. The follow-up assessment by 
Dr Betthäuser included: 
 a subjective follow-up assessment of the patient’s complaints comprising the 
completion of the WORC_2 and the GPC scale (see sections 6.6.9.1 and 6.6.9.2) 
 a clinical re-examination and 
 an ultrasonographic re-examination 
The follow-up assessment marked the end of the observation and involvement of the 
patient in the study. Follow-up was considered completed if as a minimum the primary 
outcome measure, i.e. the WORC_2, was completed. 
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6.6.13 DATA COLLECTION AND MANAGEMENT 
6.6.13.1 Questionnaire data 
Participants were asked to carefully read the instructions provided in the 
questionnaires, to complete them in full, and to ask for clarification if they had any 
questions. Standard ballpoint pens were provided for the completion of the 
questionnaires in Dr Betthäuser’s practice. I printed all questionnaire paper copies 
myself to ensure that the length of all VAS scales (WORC and pain) were exactly 100 
mm long, as printing or copying of VAS scales can lead to a distortion of the length of 
the scales (Schomacher 2008).  
6.6.13.2 Evaluation of questionnaire data 
Specific attention was given to the evaluation of the data that were measured by VAS, 
i.e. WORC and baseline pain. All measurements were done with the same standard 
ruler. The length of all VAS scales was double-checked. The distance between the left 
end of the line and the participant’s mark on the line was measured to establish the 
score. Measurement was in mm, and to the nearest mm, or, where this was unclear, to 
the higher mm. All measurements were done twice to minimise the risk of error. When 
a rating was difficult to read, it was independently assessed by a second person (either 
Dr Betthäuser or Dr Hanchard) to reach consensus where possible. Otherwise, the 
rating was considered missing. 
6.6.13.3 Interview data 
As described in the sections on the prognostic factors, additional baseline data and 
outcome measures (sections 6.6.7 to 6.6.9), some of the data were collected verbally 
as part of Dr Betthäuser’s standard interviews. Dr Betthäuser documented all his 
assessments in his patient database (see further).  
6.6.13.4 Data storage 
All paper-based patient documents were stored securely in Dr Betthäuser’s practice, in 
view of his responsibility as the treating doctor. Study IDs were removed from postal 
questionnaires and physiotherapy report forms, thus removing any link between named 
patient data and study data. The standard documentation maintained by the 
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collaborating physiotherapy practices was outside the scope of governance for this 
study.  
6.6.14 SAMPLE SIZE CONSIDERATIONS 
Due to the multivariable nature of prognostic development studies, it is difficult to 
estimate the required sample size (Moons et al. 2009). Indeed, there are no formal 
methods (based on either power calculations or adequate precision of estimation of 
effects) to determine the effective sample size. A commonly used rule of thumb is that 
there should be at least 10 outcome events (for binary or time to event outcomes) or 
individuals (for continuous outcomes) per prognostic factor (Peduzzi et al. 1996), with 
the number of outcome events relating to the smallest group when the outcome is 
categorical (Bouwmeester et al. 2012). However, more recently it has been proposed 
that this guideline might be too conservative and fewer than 10 events per prognostic 
factor might provide adequate accuracy and precision of estimation of effects. In a 
comprehensive and rigorous simulation study Vittinghoff and McCulloch (Vittinghoff & 
McCulloch 2007) reported that CI coverage, Type 1 error rate, and relative bias were 
comparable in scenarios with 5-9 events per prognostic factor versus those with 10-16 
events per factor. Following this work, and in order to analyse the WORC on a 
continuous scale10, I based the minimum sample size of my study on a requirement for 
5-9 individuals per prognostic factor. With 10 prognostic factors, which was considered 
achievable, this required (5 to 9)*10 = 50 to 90 participants which, inflated by 20% to 
allow for losses to follow up, resulted in a target of 60 to 108 participants.  
6.6.15 MISSING DATA 
Missing data were documented for all prognostic factors and outcomes. Missing values 
for the two multi-item PROM questionnaires, the WORC and the PCS, were replaced. 
As no standard missing rules were available for the WORC from the literature, I 
decided to replace missing values by the mean of the domain to which the missing 
value belonged. In case of missing data for the PCS, I followed the approach 
suggested by the primary originator of the PCS, Prof Peter Sullivan, whom I contacted 
in June 2014. He responded: “If there are one or two items missing, we compute the 
mean of items that were completed and substitute the mean for the missing 
values. The internal consistency of the measure is sufficiently high to make this 
approach acceptable.” (Personal communication 02/06/2014). I did not replace missing 
                                            
10
 The analysis of the WORC on a continuous scale reflects a deviation from protocol; see 
Appendix 6.4 
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data for the WORC and PCS in cases where the complete questionnaire data were 
missing.  
No further missing values were replaced. The decision about which method to apply for 
dealing with any further missing data, i.e. whether to conduct a complete-case analysis 
or to impute missing data, was made after the inspection of the data, but prior to 
conducting the analysis. I intended to consider in particular the amount of, but also 
potential reasons for, missing values. The chosen approach to the model selection 
(AIC approach, see further) required identical samples (see further). The analysis was 
eventually conducted on a complete-case basis, which is further addressed with the 
results.  
6.6.16 DATA CHECKS 
The study data were kept on a Microsoft Office 2011 (for Mac) Excel database. Prior to 
the statistical analyses, data were scrutinised for completeness and possible data 
abstraction errors. Comprehensive double checks were conducted to ensure that all 
data had been abstracted correctly. Any identified mistakes were corrected.  
6.6.17 STATISTICAL ANALYSIS  
6.6.17.1 Handling of candidate prognostic factors in the analyses 
The process of selecting candidate prognostic factors for inclusion in the study is 
described in detail in Chapter 5. All initially considered factors were included in the 
multivariable analysis, i.e. there was no further selection prior to the multivariable 
modelling. All continuous factors were analysed on their continuous scale, i.e. none 
were categorised for the multivariable modelling. The PCS and WORC scores were 
treated as continuous measurements. All non-continuous factors were binary variables. 
Their numerical coding is presented with the results. All continuous factors were 
modelled as linear (see further for checks of assumptions).  
6.6.17.2 Handling of the outcome in the analyses 
As previously described, the outcome (WORC_change) was also analysed on a 
continuous scale. The data was analysed as linear (see further for checks of 
assumptions). 
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6.6.17.3 Statistical analysis methods 
The primary approach to the multivariable modelling of the candidate prognostic factors 
(as independent variables) in relation to the outcome (i.e. WORC_change as 
dependent variable) was a linear regression analysis (Burnham & Anderson 2002, 
Miles & Shevlin 2001, Royston et al. 2009).  
6.6.17.4 Checking assumptions of linear regression 
Satisfaction of the assumptions of linear regression, i.e. normality, homoscedasticity, 
linearity and independence was checked for each model by inspecting the scatterplot 
of the standardized residuals against the standardized predicted values (residual plot) 
(Miles & Shevlin 2001 pp. 84–112). 
6.6.17.5 Approach to model selection: Akaike’s Information Criterion (AIC) 
approach 
The general aim of multivariable modelling analysis is to find a parsimonious model, 
i.e. “one that explains the most variance in the dependent variable containing the 
fewest number of independent variables.” (Miles & Shevlin 2001 p. 38). This can be 
achieved through a variety of techniques, many of which, though, such as forward, 
backward and stepwise regression rely entirely on statistical criteria with arbitrary cut-
offs for “significance” (p values) (Miles & Shevlin 2001 p. 38). As stated in the 
prognostic systematic review report (Chapter 3), these automated, “p-value-based” 
approaches, but in particular stepwise regression, have consistently been linked to 
biased predictions (Flom & Cassell 2007, Harrell 2001 pp. 56–8, Miles & Shevlin 2001 
pp. 38–9, Sainani 2013). As Miles & Shevlin (2001 p. 38) state, “The basic problem [of 
stepwise regression techniques] is that we are asking the computer to make a decision 
regarding which variables are important, when the computer has no idea about the 
theory that may determine which variables are important.” (p. 38). I avoided these 
issues by using Akaike’s Information Criterion (AIC), an information-theoretic approach 
which was developed by Hirotogu Akaike in the 1970s (Anderson 2008 p. 55, Burnham 
et al. 2011).  
Information-theoretic approaches to model selection differ from the automated 
selection methods such as forward, backward or stepwise regression in important 
ways. One is that selection is based on the comparison of multiple (candidate) models 
representing alternative hypotheses rather than on a single global cluster of prognostic 
factors (Burnham 2004, Burnham et al. 2011). A second principle is that the selection 
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is based on an information-theoretic criterion (such as the AIC, see further), which 
provides “numerical values that represent the scientific evidence” for each model 
(Anderson 2008 p. 64), but which does not provide any test statistics such as p values 
and does not involve any arbitrary decisions based on statistical significance 
(Anderson 2008 p. 64).  
The AIC approach is based on Kullback-Leibler (KL) information (Burnham 2004, 
Burnham et al. 2011). Reflecting the perspective that models never reflect “full reality”, 
i.e. that they are approximations (Anderson 2008 p. 27), KL information “represents the 
information lost when model gi [a model] is used to approximate full reality.” (Burnham 
et al. 2011 p. 24) or, equivalently, the “distance” between the approximating model and 
full reality (Anderson 2008 p. 53). Figure 6.4 (see left side) illustrates KL information 
(dX), with f representing full reality and gX representing a set of models (Anderson 2008 
p. 24, Burnham et al. 2011 fig. 1). The full reality is inherently unknown and cannot be 
estimated, but is the same for all models, and can thus be removed (Burnham et al. 
2011). The AIC approach uses a criterion (the AIC) to identify the model within a set of 
candidate models that is “closest to full reality” (Burnham et al. 2011 p. 24). This is then 
termed the “best” model and used as the reference model to which the other candidate 
models are compared. The AIC value provides an estimate of the KL information, with 
smaller AIC values representing a smaller loss of information, i.e. a closer 
approximation to full reality. Thus, the model with the smallest AIC value (AICMIN) is 
considered the one that is „closest to full reality“ (Burnham et al. 2011 p. 24).  
 
Figure 6.4: KL information and AIC differences 
  (modified from Burnham et al. 2011 fig. 1) 
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The candidate models should be defined a priori; they represent different “working 
hypotheses” and should ideally be derived by sound theoretical reasoning, i.e. by 
consideration of “the science of the matter, experience and expertise” (Burnham & 
Anderson 2002 p. 96). Their number may vary, though it is recommended that it should 
usually be limited to a few, and should, as a general rule, not exceed the size of the 
study sample (Anderson 2008 p.62). As AIC values are functions of sample size, the 
models must be based on identical datasets to allow for their unbiased comparison 
(Anderson 2008 p. 63).  
Comparison of the other candidate models to the best model is done by calculating 
their distance to the best model, i.e. by calculating AIC differences (AIC = AIC – 
AICMIN), which allows for a ranking of the models according to the amount of their 
distance to the best model. Smaller AIC values represent a closer approximation to 
the best model, thus providing an indication of a better relative fit. Thus, whereas the 
AIC provides an estimate of the distance between each model and full reality, the AIC 
is the difference between each model and the best (Anderson 2008 p. 84). Figure 6.4 
(see right side) illustrates the basic approach to AIC model selection (Burnham et al. 
2011 p. 25). 
AIC accounts for the number of prognostic factors by “penalising” models with larger 
numbers of prognostic factors, thereby favouring parsimony (Anderson 2008 pp. 58–9). 
A version of AIC for small samples (second-order bias-correction), termed AICC, is 
available and strongly recommended for use in cases where the sample size (n) in 
relation to the number of prognostic factors (K) is small (suggested ratio n/K < 40) 
(Anderson 2008 pp. 60–1). AICC was thus used for the analysis of the models in this 
study. 
It is important to consider that AICC (and AIC) values are relative rather than absolute, 
and “on the scale of information” (Anderson 2008 p. 84). This means that the values 
themselves are uninterpretable (Burnham 2004). Rather, their use is limited to 
comparing models within a defined set of models (Burnham & Anderson 2002 p. 71). 
Moreover, though AIC will always select a best model among a set of models, this 
does not mean that it is necessarily a good model (Burnham & Anderson 2002 p. 62). 
Consequently, it has been suggested that the worth of the best or the global (full) 
model be assessed by e.g. a goodness-of-fit test, analysis of residuals or the adjusted 
R2 (Anderson 2008 pp. 67–8). 
For the interpretation of the AIC of any model in relation to the best model, Burnham 
et al. (2011) have proposed considering models with AIC values < 4-7 as “plausible” 
alternatives to the best model, models with AIC values of 9-11 as having “relatively 
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little support”, models with AIC values > about 14 as “implausible” alternatives to the 
best model (p. 25), and models with AIC values > 20 as having “essentially no 
empirical support” (p. 25). 
Further methods have been proposed for the scaling and comparison of each model 
within a set of candidate models (see e.g. Burnham & Anderson 2002 pp. 74–9). The 
analysis of the models in my study, though, was limited to the identification of the best 
model and the ranking of the other models in relation to it. 
6.6.17.6 Candidate models 
Prior to the analysis, I developed a set of candidate models. The choice of the models 
was based on clinical and theoretical considerations, which I discussed with 
Dr Betthäuser and Dr Hanchard. The intention was not to assess any possible 
combination of factors, but to select a limited number with a justification for why each 
might be of interest. In Table 6.1, the models are presented together with a brief 
rationale for each. The first model included all ten candidate prognostic factors (thus 
representing the “full” model), whereas the further models, all nested models (i.e. all 
factors were part of the full model), included between two and eight factors. As outlined 
in the table, selection considered various aspects such as the “potential for 
modification” or “effort of assessment”. Thus, while I aimed to find a parsimonious 
model, I was also interested in considering aspects such as the effort (time) required to 
assess the prognostic factors, which would be highly relevant to clinical practitioners. 
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Table 6.1: Candidate prognostic models  
No Candidate model N Rationale 
1 Age + sex + physical demands + 
disability (WORC) + pain + history of 
shoulder pain + symptom duration + 
Diabetes + smoking + pain 
catastrophizing (PCS)  
10 Full model (all factors) 
2 Diabetes + smoking + pain 
catastrophizing (PCS)  
3 Potential for modification (could be 
modified (addressed) by some action 
(e.g. treatment) 
3 Age + sex 2 Factors that cannot be modified 
4 Age + sex + physical demands + pain 
+ history of shoulder pain + symptom 
duration + diabetes + smoking 
8 Type of assessment: “no 
questionnaires” 
5 Disability (WORC) + pain 
catastrophizing (PCS) 
2 Type of assessment: “questionnaires” 
6 Diabetes + smoking 2 Type of factor: “bio(logical) factors” 
7 History of shoulder pain + symptom 
duration  
2 Background (patient history) 
8 Pain + history of shoulder pain + 
symptom duration 
3 Further models: pain-related factors 
(excluding pain catastrophizing) 
9 Pain + pain catastrophizing (PCS) 2 Further models: pain and attitude 
towards pain 
 
6.6.17.7 Model selection 
I intended to compare and rank the models by the AICC approach as described above. I 
intended to select the best model identified, but to select more than one “final” model if 
there were plausible alternatives to the best model. 
6.6.17.8 Adjusting for regression to the mean 
Regression to the mean (RTM) describes the statistical phenomenon of a “tendency for 
subjects who score below average on a test to do better next time, and for those who 
score above average to do worse” (Hopkins 2002, no pagination). This was potentially 
relevant because the WORC was used both as a prognostic factor (WORC_1, 
measured at baseline) and as the primary outcome (change_WORC). Thus, the 
WORC_1 values were adjusted for RTM (WORC_1ADJ) prior to the prognostic 
modelling analysis, and the WORC_change scores were then corrected accordingly 
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(WORC_changeADJ). The adjustment was done using the following equation: xADJ = x  + 
p (x – x ) , where x  denotes the mean of the cohort, p the pre-post correlation for the 
cohort, and x the individual participant’s pre-test value (Linden 2013, “Controlling for 
RTM through data analysis” para. 2).  
6.6.17.9 Model validation and further analyses 
I did not pre-specify any method of validation or any further evaluations of model 
performance (e.g. calibration or discrimination) or other analyses (e.g. accounting for 
complexities in the data), but planned to decide on them based on the results. I 
intended to compare the SEE of the best model(s) with the MID estimate of the WORC 
derived from the sample data, and to internally validate any model with an SEE that is 
substantially lower than the MID. The determination of the MID estimate is presented 
separately in Chapter 7. Bootstrapping is recommended as the preferable approach for 
the internal validation of multivariable prognostic models (Steyerberg & Harrell 2016).  
I intended to conduct the following exploratory subgroup analyses to account for the 
anticipated variability of some aspects related to the treatment: amount of 
physiotherapy treatment (number of treatment sessions), provision of injection (yes or 
no) and length of follow-up.  
6.6.17.10 Period of analysis and software 
The statistical analyses were conducted between June and November 2015 using IBM 
SPSS software (version 22). Both the “Regression” and “Generalized Linear Models” 
analysis options were used to obtain all relevant statistics including AICC values. 
6.6.18 Presentation of statistical parameters  
Baseline, candidate prognostic factor and outcome data, where available, were 
presented for all participants who completed the study. As a standard, these included 
means, standard deviations and ranges for continuous data; and numbers and 
proportions for binary data.  
I intended to present the following statistical parameters: 
 Model summary (for each model): AICC, standard error of the estimate (SEE) and 
adjusted coefficient of (multiple) determination (R2ADJ). The SEE was the primary 
parameter for the assessment of the models’ precision. The R2ADJ was reported for 
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the purpose of providing a complementary measure of the models’ performance 
only, but not for ranking the models. 
 Model coefficient statistics (for each model): the regression constant (Constant) 
and the unstandardized regression coefficients (B) of all prognostic factors with 
their (95%) CIs.  
 Model comparison: AICC, AICC and SEE values 
Because this research was in the developmental phase, the models were not intended 
to be used in practice, and therefore full equations were not reported.  
All relevant data as well as the results of the statistical analyses were presented in text 
and tables.  
6.7 RESULTS 
6.7.1 Recruitment, flow of participants and sample size 
Recruitment took place over the 22 months from December 2012 September 2014 
inclusive. The last follow-up was completed in January 2015. Figure 6.5 outlines the 
flow of participants through the study.  
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Fi g ur e 6. 5: Fl o w of p arti ci p a nt s 
B y t h e e n d of S e pt e m b er 2 0 1 4, 8 2 p ati e nt s h a d b e e n i n vit e d t o t a k e p art. F or 1 2 of 
t h e s e, n o c o n s e nt f or m w a s r e c ei v e d: t hr e e di d n ot w a nt t o p arti ci p at e; f o ur di d n ot 
u n d er g o a n y p h y si ot h er a p y; fi v e m a d e n o f urt h er c o nt a ct wit h Dr B ett h ä u s er or m e. 
T h u s, at t h at st a g e 7 0 p arti ci p a nt s h a d b e e n r e cr uit e d. B a s e d o n t h e r at e of 
r e cr uit m e nt, it s e e m e d t h at r e cr uiti n g f or a n ot h er y e ar ( wit h t h e o pti o n of p o s si bl y 
i n cl u di n g a n ot h er 3 0- 3 5 p arti ci p a nt s) w o ul d h a v e n o s u b st a nti al i nfl u e n c e o n t h e 
pr e ci si o n of t h e pr o g n o sti c m o d el s. I n a gr e e m e nt wit h m y s u p er vi s or y t e a m, it w a s t h u s 
d e ci d e d t o st o p r e cr uit m e nt.  
Of t h e 7 0 p arti ci p a nt s ( 7 0 s h o ul d er s) i n t h e c o h ort, 6 5 ( 9 3 %)  c o m pl et e d t h e f oll o w- u p 
a n d  5 ( 7 %) di d n ot. I n t hr e e c a s e s t hi s w a s d u e t o n e wl y ari si n g m e di c al r e a s o n s: o n e 
Eli gi bl e p ati e nt s: 
n  = 8 2  
 
P arti ci p a nt s i n cl u d e d i n t h e st u d y: 
n  = 7 0 
 
P arti ci p a nt s c o m pl eti n g f oll o w- u p: 
n  = 6 5  
 
P arti ci p a nt s (i n di vi d u al s) a n al y s e d b y 
m u lti v ari a bl e m o d elli n g: 
n = 6 1  
E x cl u d e d p ati e nt s ( n o i nf or m e d 
c o n s e nt): n = 1 2  
• U n willi n g t o p arti ci p at e: n = 3 
• N o p h y si ot h er a p y: n = 4 
• L a c k of f urt h er c o nt a ct: n = 5 
S e e t e xt f or d et ail s. 
E x cl u d e d p ati e nt s: n = 5  
• M e di c al r e a s o n s: n = 4 
• Mi s si n g d o c u m e nt s: n = 1 
S e e t e xt f or d et ail s. 
E x cl u d e d p ati e nt s: n = 4  
• M is si n g pr o g n o sti c f a ct or d at a:    
n = 4 
S e e t e xt f or d et ail s. 
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participant injured himself in an accident shortly after inclusion in the study; one 
developed symptoms of a frozen shoulder; and another developed neurological 
symptoms. One further participant was retrospectively excluded because of a previous 
operation on the affected shoulder which was initially not documented. The follow-up 
questionnaires of one further participant were missing for unknown reasons and could 
not be obtained, necessitating exclusion.  
Of the 65 participants who completed the follow-up, four were excluded from the 
analysis due to missing prognostic factor data. Thus, 61 (i.e. 87% of the enrolled 
participants and 94% of those who completed the study) were analysed by the 
multivariable modelling. This is further explained in the context of how I dealt with 
missing data (section 6.7.1.5). There were no complexities (e.g. unit of analysis issues) 
in the data. 
6.7.2 Missing data 
A small number of data items were missing for both some candidate prognostic factors 
and the outcomes for some of the 65 participants who completed the study.  
6.7.2.1 Missing prognostic factor data 
The missing data are presented separately for those factors that were assessed by a 
single-item measure (i.e. sex, age, duration of symptoms, pain, physical demands, 
history of shoulder pain, Diabetes and smoking) and those that were assessed by a 
multi-item measure (disability (WORC_1) and pain catastrophizing (PCS)).  
Table 6.2 shows the amount of missing values for the eight candidate prognostic 
factors that were assessed by single-item measures. The six missing values related to 
two (3%) of the 65 participants; one of them had five missing values, the other one had 
one.  
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Table 6.2: Missing prognostic factor data: factors assessed by single-item 
measures  
  (n = 65) 
Factor  Missing values 
N % 
Age, yr 0 0 
Sex, female/male 0 0 
Physical demands, yes/no 1 2 
Duration of symptoms, wk 2 3 
Pain, mm VAS 1 2 
History of shoulder pain, yes/no  1 2 
Diabetes, yes/no 0 0 
Smoking, yes/no 1 2 
 
Table 6.3 shows the amount and key characteristics of missing values for the two 
candidate prognostic factors that were assessed by multiple-item measures, i.e. of 
missing values within the WORC_1 and PCS questionnaires. As the PCS was missing 
completely for three participants, the details in the table relate to the 62 participants for 
whom some values within the PCS were missing. The six missing values within 
WORC_1 were distributed as follows: one participant had two missing values, and four 
had one.  
Table 6.3: Missing prognostic factor data: factors assessed by multiple-item 
measures  
Factor (n) Overall missing 
values, n (%) 
of all values*† 
Items with missing 
values, list 
Participants with 
missing values, 
n (%) 
Disability (WORC_1)*  
(65) 6 (0.4) 3, 9, 13, 14, 16, 21 5 (8) 
Pain catastrophizing 
(PCS)† (62) 1 (0.1) 13 1 (2) 
*WORC: WORC: 21 items  65 x 21 values = 1365; †PCS: 13 items  62 x 13 values = 806 
values 
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6.7.2.2 Missing outcome data 
Table 6.4 shows the amount and key characteristics of missing outcome data. The 11 
missing WORC_2 values were distributed as follows: one participant had three missing 
values, one had two, and six had one. For 14 patients, who did not have a documented 
ultrasound scan within the follow-up period of the study, there were no tear progression 
data.  
Table 6.4: Missing outcome data 
Outcome (n = 65) Overall missing 
values, n (%) 
of all values* 
Items with missing 
values, list 
Participants with 
missing values, 
n (%) 
Disability (WORC_2)*  11 (1) 4, 7, 8, 9, 13, 16, 21 8 (12) 
GPC 1 (2) n/a 1 (2) 
Tear progression 13 (20) n/a 13 (20) 
*WORC: 21 items  65 x 21 values = 1,365; n/a = not applicable 
6.7.2.3 Approach to dealing with the missing data 
As shown in Tables 6.2 to 6.4, the amount of missing data was small. For 61 (94%) of 
the participants, values were available for all prognostic factors. Regarding the primary 
outcome, 57 (88%) of the participants had no missing values for the WORC_2. I 
replaced all missing values for the WORC and PCS by applying the pre-specified rules 
(see section 6.6.15).  
Following the replacement of the missing WORC and PCS values, four participants 
(6%) still had missing data for one or more of the prognostic factors. I decided not to 
replace any further missing values but to exclude these four cases from the analysis 
and to conduct the multivariable modelling analysis on a complete-case basis. As 
previously stated (see section 6.6.17.5), the AIC approach requires candidate models 
to be based on identical datasets. Excluding the four cases appeared legitimate as the 
impact on precision would be minimal. The missing data were too few to permit testing 
for differences between patients with and without them. However, since five out of the 
six missing values were only missing once, the reasons for missingness did not seem 
systematic. Thus, I considered the data from the complete cases as representative of 
the complete sample.  
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6.7.3 Baseline participant characteristics including prognostic factors 
All of the participants had presented to Dr Betthäuser because of shoulder pain; all had 
been diagnosed with a painful PTT; and all fulfilled the predefined study eligibility 
criteria. The summary participant characteristics are presented in Table 6.5. These 
include the prognostic factors, all of which were assessed at baseline. Details on the 
prognostic factors, their definitions and measurements are provided in Chapter 5.  
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Table 6.5: Baseline participant characteristics - prognostic factors and 
additional characteristics  
  Prognostic factors are listed by type of measurement (continuous/ 
categorical). 
Characteristic (n) Measurement Values 
Continuous prognostic factors  x

 SD Range 
Age (65) yr 50 12 24-76 
Disability (65)* WORC_1 score 897 380 130-1660 
Pain (64) mm VAS 63 26 7-100 
Symptom duration (63) wk 36 49 1-250 
Pain catastrophizing (62)*†  PCS score 15 9 1-37 
Categorical prognostic factors N %  
Sex (65) female 25 38  
male 40 62  
Physical demands (64) yes 41 64  
no 23 36  
History of shoulder pain (64) yes 35 55  
no 29 45  
Diabetes (65) yes 4 6  
no 61 94  
Smoking (64) yes 10 16  
no 54 84  
Additional characteristics N %  
Affected tendon (65)  
 
1. supraspinatus  63 97  
2. infraspinatus 1 2  
3. supraspinatus + 
infraspinatus  1 2 
 
4. any other 0 0  
Dominant arm affected (65) yes 46 71  
no 19 29  
Work status (64) 
 
1. full-time  41 64  
2. part-time 11 17  
3. sick leave  0 0  
4. retired 10 16  
5. not working (other 
reason) 2 3 
 
*Includes replaced values for missing data (see section 6.6.15); †PCS data were completely 
missing for three cases 
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6.7.4 Treatment characteristics 
6.7.4.1 Physiotherapy 
Table 6.6 presents the key summary data related to the amount and duration of the 
physiotherapy treatment sessions. Only three participants (5%) had fewer than six 
sessions (one, two and three sessions, respectively), and 62 (95%) had six or more 
sessions.  
Table 6.6: Physiotherapy – amount and duration  
Aspect (n = 65) x

 SD Range 
Number of sessions 12 6 1-25 
Duration of sessions (min) 28 13 20-80 
 
Table 6.7 presents the summary data of the key components of the physiotherapy 
treatment, as documented by the treating physiotherapist in the physiotherapy report 
for each participant (see Appendix 4.2 for the report form). For reasons of clarity, the 
domains are grouped into several categories such as “types of exercises”, “types of 
manual techniques” or “supplementary modalities”.  
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Table 6.7: Breakdown of physiotherapy interventions  
  Interventions are listed by general category and specific domain; 
domains are in descending order of use. 
Category Domain (n = 65) N % 
Types of exercises Strengthening exercises focused at rotator cuff 
muscles 52 80 
Scapula positioning exercises 47 72 
Stabilisation exercises 41 63 
Stretching techniques or exercises 
(shoulder/shoulder girdle) 36 55 
Strengthening exercises focused at shoulder 
girdle muscles 34 52 
Humeral head ‘positioning’ exercises  33 51 
Coordination exercises 25 38 
Inclusion of high load exercises (> 80% RPM) 5 8 
Correction of thoracic spine posture*  2 3 
Proprioceptive Neuromuscular Facilitation 
(PNF)* 1 2 
Types of exercise 
equipment 
Use of small equipment (e.g. elastic bands)  45 69 
Use of training machines (e.g. pulley, pull-
down) 27 42 
Setting of exercise 
treatment 
Provision and supervision of supplementary 
home exercises 42 65 
Types of manual 
techniques 
Soft tissue techniques (shoulder or shoulder 
girdle) 56 86 
Manual mobilisation techniques (shoulder) 51 78 
Manual mobilisation of thoracic spine*  9 14 
Manual mobilisation of ribs*  2 3 
Manual mobilisation of cervical spine*  2 3 
Supplementary 
modalities 
Heat or cold applications 14 22 
Therapeutic ultrasound*  1 2 
*Recorded in “anything else?” category (physiotherapy report form) 
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6.7.4.2 Medical treatment 
Table 6.8 presents the summary data of supplementary medical treatment. Of the 28 
participants who had additional appointments with Dr Betthäuser during the 
observation period, i.e. in between the initial presentation and the follow-up, 27 had 
one appointment, and two had two. The most frequently provided medical treatment 
was a subacromial corticosteroid injection (25 participants received one injection and 
three received two); the second most frequent was the application of an elastic tape to 
the shoulder (11 participants received one application and one received two). One 
participant was provided with a prescription of oral pain medication. Seven participants 
received more than one treatment, i.e. both a corticosteroid injection and a tape 
application.  
Table 6.8: Supplementary medical treatment  
Medical treatment (n = 65) N % 
Additional appointments with Dr Betthäuser 28 43 
Any medical treatment 37 57 
Subacromial corticosteroid (Triamcinolone) injections 27 42 
Elastic tape (shoulder) 12 18 
Oral pain medication prescription (Metamizole) 1 2 
Sick leave 0 0 
 
6.7.5 Follow-up assessment 
The mean (SD) interval between the initial assessment and the completion of the 
follow-up questionnaires (n = 65) was 97 (17) days, the range 77 to 121 days. 34 
participants (52%) completed the follow-up questionnaires at Dr Betthäuser’s practice, 
whereas 31 (48%) completed them at home. The mean (SD) interval between the initial 
assessment and the follow-up ultrasound scan (n = 52) was 100 (13) days, the range 
77-121 days.  
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6.7.6 Outcomes 
6.7.6.1 WORC, GPC and tear progression 
The results of the assessment of the primary (WORC_2, WORC_change and 
WORC_changeADJ) and secondary (GPC, tear progression) study outcomes are 
presented in Table 6.9.  
Table 6.9: Summary outcome statistics 
  Outcomes are listed by type of measurement (continuous/categorical). 
Outcome (n) Measurement Values 
Continuous outcomes 
 
x

 SD Range 
Disability (65) WORC_2 score* 533 427 7-1560 
Disability _change (65) 
WORC2 – WORC1 
score, unadjusted -363 361 -1248-372 
WORC2 – WORC1 
score, RTM-adjusted -363 341 -1102-387 
Categorical outcomes 
 
N % 
 
Perceived Change, GPC (64) 
+3 5 8  
+2 32 50  
+1 18 28  
±0 5 8  
-1 3 5  
-2 1 2  
-3 0 0  
Tear progression (PTT  FTT) 
(52) 
Yes 2 4  
No 50 96  
*Includes replaced missing data (see section 6.6.15) 
6.7.6.2 Adverse events 
Adverse events were documented by the treating physiotherapists for six participants 
(9%). All related to temporary exacerbations of the shoulder symptoms, but only one 
was explicitly linked to the physiotherapy treatment. 
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6.7.7 Prognostic modelling  
6.7.7.1 Ratio of individuals in relation to the number of prognostic factors 
As described with the methods, I had planned to include all 10 candidate prognostic 
factors in the multivariable modelling, and to run one full model with all factors. In fact, I 
excluded one factor, diabetes, on the grounds of its very low prevalence (n = 4; 6%) in 
the study population (see Table 6.5). In consequence, the analyses were run with a 
maximum of nine factors. One model (model 6), which was a two-factor model 
including diabetes and smoking (see Table 6.1 for the candidate models), was 
removed from the set of candidate models as, without diabetes, it was no longer a 
multivariable model. Thus, eight candidate models were analysed. In relation to the full 
model, the ratio of individuals in relation to the number of prognostic factors was thus 
approximately 7 (61/9).  
6.7.7.2 Analysing the candidate models 
All analysed models relate to the 61 complete cases, and their key statistics are 
presented in Tables 6.11 (a & b) to 6.18 (a & b). The residual plots showed no strong 
evidence of any violation of assumptions (see Appendix 6.12). Table 6.10 shows how 
the categorical variables were coded. 
Table 6.10: Coding of categorical candidate prognostic factors 
Factor Categories Code 
Sex 
Female 1 
Male 0 
Physical demands 
Yes 1 
No 0 
History of shoulder pain 
Yes 1 
No 0 
Diabetes 
Yes 1 
No 0 
Smoking 
Yes 1 
No 0 
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Model 1 
Table 6.11a: Model 1 summary 
Candidate model N AICC SEE R2ADJ 
Age + sex + physical demands + disability 
(WORC_1ADJ) + pain + history of shoulder pain 
+ symptom duration + smoking + pain 
catastrophizing (PCS) 
9 891 313 0.12 
Table 6.11b: Model 1 coefficient statistics 
Constant and factors Unstandardized 
coefficient B 
95% CI 
Lower limit Upper limit 
Constant -729 -1315 -144 
Age (yr) 5 -3 12 
Sex (female or male) 47 -130 224 
Physical demands (yes or no) 75 -108 258 
Disability (WORC_1ADJ score) -0.5 -1 0.03 
Pain (mm VAS) 2 -2 6 
History of shoulder pain (yes or no) 50 -123 223 
Symptom duration (wk) -0.4 -2 1 
Smoking (yes or no) 194 -42 430 
Pain catastrophizing (PCS score) 20 9 32 
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Model 2 
Table 6.12a: Model 2 summary 
Candidate model N AICC SEE R2ADJ 
Smoking + pain catastrophizing (PCS) 2 880 314 0.11 
Table 6.12b: Model 2 coefficient statistics 
Constant and factors Unstandardized 
coefficient B 
95% CI 
Lower limit Upper limit 
Constant -599 -766 -433 
Smoking (yes, no) 132 -91 355 
Pain catastrophizing (PCS score) 14 5 23 
 
Model 3 
Table 6.13a: Model 3 summary 
Candidate model N AICC SEE R2ADJ 
Age + sex 2 889 336 -0.02 
Table 6.13b: Model 3 coefficient statistics 
Constant and factors Unstandardized 
coefficient B 
95% CI 
Lower limit Upper limit 
Constant -542 -908 -175 
Age (yr) 3 -4 10 
Sex (female or male) 37 -143 216 
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Model 4 
Table 6.14a: Model 4 summary 
Candidate model N AICC SEE R2ADJ 
Age + sex + physical demands + pain + history 
of shoulder pain + symptom duration + 
smoking 
7 899 344 -0.06 
Table 6.14b: Model 4 coefficient statistics 
Constant and factors Unstandardized 
coefficient B 
95% CI 
Lower limit Upper limit 
Constant -727 -1304 -150 
Age (yr) 3 -5 12 
Sex (female or male) 15 -177 207 
Physical demands (yes or no) 40 -160 239 
Pain (mm VAS) 2 -1 6 
History of shoulder pain (yes or no) 45 -144 234 
Symptom duration (wk) -0.3 -2 2 
Smoking (yes or no) 90 -160 341 
 
Model 5 
Table 6.15a: Model 5 summary 
Candidate model N AICC SEE R2ADJ 
Disability (WORC_1ADJ) + pain catastrophizing 
(PCS) 2 880 314 0.11 
Table 6.15b: Model 5 coefficient statistics 
Constant and factors Unstandardized 
coefficient B 
95% CI 
Lower limit Upper limit 
Constant -388 -713 -63 
Disability (WORC_1ADJ score) -0.3 -1 0.2 
Pain catastrophizing (PCS score) 16 6 27 
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Model 7  
(Model 6 was not analysed, see section 6.7.7.1) 
Table 6.16a: Model 7 summary 
Candidate model N AICC SEE R2ADJ 
History of shoulder pain + symptom duration 2 889 336 -0.02 
Table 6.16b: Model 7 coefficient statistics 
Constant and factors Unstandardized 
coefficient B 
95% CI 
Lower limit Upper limit 
Constant -380 -519 -241 
History of shoulder pain (yes or no) 61 -115 236 
Symptom duration (wk) -1 -3 1 
 
Model 8 
Table 6.17a: Model 8 summary 
Candidate model N AICC SEE R2ADJ 
Pain + history of shoulder pain + symptom 
duration 3 889 335 -0.01 
Table 6.17b: Model 8 coefficient statistics 
Constant and factors Unstandardized 
coefficient B 
95% CI 
Lower limit Upper limit 
Constant -513 -776 -249 
Pain (mm VAS) 2 -1 5 
History of shoulder pain (yes or no) 60 -115 235 
Symptom duration (wk) -1 -2 1 
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Model 9 
Table 6.18a: Model 9 summary 
Candidate model N AICC SEE R2ADJ 
Pain + pain catastrophizing (PCS) 2 882 318 0.09 
Table 6.18b: Model 9 coefficient statistics 
Constant and factors Unstandardized 
coefficient B 
95% CI 
Lower limit Upper limit 
Constant -596 -822 -371 
Pain (mm VAS) 1 -3 4 
Pain catastrophizing (PCS score) 12 2 22 
 
6.7.7.3 Model comparison  
Table 6.19 summarises the key statistics by which the analysed models were 
compared and ranked (see section 6.6.17.5). The models are ordered by size of their 
AICC values (from the lowest to the highest). Where AICC values are the same, they are 
further ordered by magnitude of the SEE. An AICC of 0 denotes the model(s) with the 
lowest AICC value representing the best model(s) among all candidate models. The 
AICC values of the other models thus represent their distance to the best model(s). 
Table 6.19: Model comparison based on AICC differences 
Model N factors AICC AICC SEE 
2 2 880 0 314 
5 2 880 0 314 
9 2 882 2 318 
8 3 889 9 335 
3 2 889 9 336 
7 2 889 9 336 
1 9 891 11 313 
4 7 899 19 344 
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As can be seen in Table 6.19, models 2 and 5 had the smallest AICC value (AICMIN) 
and thus represented the best models. These models were consequently taken as the 
reference models against which the other models were ranked. The AICC of model 9 
came third. Its AICC was within the range of plausible alternatives to the best models 
(see section 6.6.17.5). All other models had AICC values outside this range, thus 
lacking support. The SEE of model 1 was almost identical to that of the two best 
models, whereas the other models had larger SEEs. The full model had the highest 
R2ADJ (see Table 6.11a). The models could at the maximum explain approximately 12% 
of the variation in the WORC_change.  
6.7.7.4 Supplementary analysis: PCS 
The aim of the multivariable analysis of the candidate models was to identify at least 
one promising multivariable model. I decided to supplement the multivariable analysis 
by a univariable linear regression analysis of pain catastrophizing to explore the 
contribution of this factor alone in predicting the WORC_change11. The reason was that 
the closer inspection of the candidate prognostic factors included in the three models 
with the lowest AICC and AICC values (models 2, 5, 9) revealed a noticeable 
commonality between these models, namely pain catastrophizing (PCS). The summary 
and coefficient statistics of this univariable model are shown in Table 6.20 (a & b). The 
residual plot can be viewed in Appendix 6.12. The residuals were well-behaved. 
The analysis was then re-run with the PCS score expressed as 2SD (PCS), to estimate 
the effect of the difference between a typically high (top third) and typically low (lowest 
third) PCS value on the WORC_changeADJ. The resulting coefficient statistics are 
included in Table 6.20 (a & b). 
  
                                            
11
 The univariable analysis of pain catastrophizing reflects a deviation from protocol; see 
Appendix 6.4. 
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PCS model 
Table 6.20a: PCS model summary 
Model N SEE R2ADJ 
Pain catastrophizing (PCS) 1 315 0.11 
Table 6.20b: PCS and PCS_2SD coefficient statistics 
Constant and factors Unstandardized 
coefficient B 
95% CI 
Lower limit Upper limit 
Constant -561 -715 -407 
PCS score 13 4 22 
PCS_2SD score 232 69 395 
 
6.7.8 Model validation and further analyses 
The performance and precision of the analysed candidate models did not justify 
internal validation. Regarding precision, the models’ SEE of between 313 and 344 was 
higher rather than substantially lower than the MID of 300 derived from the sample 
data (see Chapter 7). The sample size, which was towards the lower end of the target 
range, precluded useful subgroup analysis. 
6.8 DISCUSSION 
6.8.1 SUMMARY OF THE STUDY  
The prognostic study was designed to develop a prognostic model for the outcome of a 
phase of conservative treatment with physiotherapy in adults with painful PTTs. 
Seventy patients were enrolled in a prospective single-group cohort study, which was 
conducted within a secondary care setting in Hamburg, Germany, between December 
2012 and January 2015. Sixty-five participants completed the study. All participants 
were recruited from an orthopaedic specialist practice. The startpoint was the diagnosis 
of a painful PTT. All participants underwent conservative treatment including 
physiotherapy, with or without supplementary medical treatment, over a period of 
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approximately three months. Ten candidate prognostic factors were assessed at the 
baseline assessment. The primary outcome measure was the WORC, i.e. the 
WORC_change from baseline to the follow-up after three to four months, the study’s 
endpoint. Secondary outcome measures were ratings of the perceived change of the 
shoulder problem on a GPC scale, the incidence of tear progression (PTT to FTT) and 
the occurrence of physiotherapy-related adverse events. The data of 61 participants 
were analysed by a multivariable modelling analysis based on the AICC approach. 
Eight predefined candidate models were analysed and compared. In a post-hoc 
exploratory analysis, one additional univariable model, which included only pain 
catastrophizing, was explored. 
6.8.2 STRUCTURE OF DISCUSSION 
The present discussion focuses on the prognostic modelling. (WORC_change, GPC, 
tear progression and adverse events are discussed in Chapter 7). The discussion 
considers both strengths and limitations of the study. Textbox 6.2 shows the general 
structure of this section.  
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Textbox 6.2: Structure of discussion 
  Section numbers are provided in brackets. 
 Summary of main findings (6.8.3) 
 PROBAST self-assessment (risk of bias, applicability and usability) (6.8.4) 
 Risk of bias (6.8.5) 
o Participant selection (6.8.5.1) 
o Predictors (i.e. prognostic factors) (6.8.5.2) 
o Outcome (6.8.5.3) 
o Treatment (6.8.5.4) 
o Sample size and participant flow (6.8.5.5) 
o Analysis (6.8.5.6) 
 Applicability (6.8.6) 
o Participant selection (6.8.6.1) 
o Predictors (i.e. prognostic factors) (6.8.6.2) 
o Outcome (6.8.6.3) 
o Treatment (6.8.6.4) 
 Usability (6.8.7) 
 Discussing the findings (6.8.8) 
o Model performance (6.8.8.1) 
o Precision of predictions (6.8.8.2) 
o Prognostic factors (6.8.8.3) 
 Comparison with other prognostic model studies (6.8.9) 
 Conclusions (6.8.10) 
o Implications for clinical practice (6.8.10.1) 
o Implications for research (6.8.10.2) 
 
6.8.3 SUMMARY OF MAIN FINDINGS 
As determined through the AICC approach, two out of the eight analysed candidate 
models, pain catastrophizing and smoking, and pain catastrophizing and disability, 
were selected as the best models, to which the other models were compared. Only one 
model, pain catastrophizing and pain, was considered as having substantial support for 
approximating the best models, i.e. for constituting a plausible alternative to them. The 
full model had the largest adjusted R2, which was 0.12. The SEE of the nine candidate 
models ranged between 313 and 344. A noticeable commonality of the two best 
models and the model with substantial support for approximating them was that all 
three included pain catastrophizing. To explore the common factor further, I conducted 
a complementary univariable regression analysis. The R2ADJ of this model was 0.11, the 
SEE 315. 
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6.8.4 PROBAST ASSESSMENT (RISK OF BIAS, APPLICABILITY AND 
USABILITY)  
I assessed my study with the most recent PROBAST version (20/07/2015, Appendix 
6.13) that was available at the time of writing of this chapter (January 2016; personal 
communication with Dr Wolff, 07/01/2016)12. Differences between this version and the 
one I used in the prognostic systematic review (Chapter 3) were that two questions 
(relating to domains 2 and 3) had been removed, and that the wording and layout of 
the tool had been refined. The coding manual which I had developed for use in the 
prognostic systematic review (see Appendix 3.8) was still applicable. At the time of 
writing of this chapter there was still no official PROBAST guidance document available 
(personal communication with Robert Wolff, 11 January 2016).  
The PROBAST assessment was based on the full (nine-factor) model. The 
assessment was independently performed by me and a second rater (Dr Hanchard), 
and then discussed and agreed. Table 6.21 shows the summary results of the 
assessment. A more detailed table, which includes the ratings for all signalling 
questions, can be viewed in Appendix 6.14. 
Table 6.21: Summary of PROBAST assessment  
 
Risk of Bias Applicability  
concerns 
Overall  
Judgements 
Domain/ 
Study 
1.
 
Pa
rti
ci
pa
n
t 
Se
le
ct
io
n
 
2.
 
Pr
e
di
ct
o
rs
 
3.
 
O
u
tc
o
m
e
 
4.
 
Sa
m
pl
e
 
Si
ze
 
& 
Fl
o
w
 
5.
 
An
a
lys
is
 
1.
 
Pa
rti
ci
pa
n
t 
Se
le
ct
io
n
 
2.
 
Pr
e
di
ct
o
rs
 
3.
 
O
u
tc
o
m
e
 
R
is
k 
o
f B
ia
s 
Ap
pl
ic
a
bi
lity
 
 
Us
a
bi
lity
 
Braun 2015            
 = low risk/concerns;  = high risk/concerns 
  
                                            
12
 The inclusion of this PROBAST version in the thesis appendices was approved by Dr Wolff 
(personal communication, 17/12/2015). 
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6.8.5 RISK OF BIAS 
As shown in Table 6.21, I rated the risk of bias as low for four domains (1, 2, 3 and 4) 
and as high for one (domain 5). I judged my study overall as at high risk of bias, which 
was primarily due to issues related to the analysis (domain 5). Most of the signalling 
questions relating to risk of bias could be answered positively (with “yes”) (see 
Appendix 6.14), which strengthens the internal validity of the study. The design of the 
study was informed by the most current available methodological guidance on 
prognosis research as available at the time of planning (see Chapter 2 section 2.11.1). 
This helped me to avoid various potential sources of bias which have also been 
addressed in the prognostic systematic review (Chapter 3).  
6.8.5.1 Participant selection 
Patients were consecutively enrolled in a prospective cohort study, as recommended 
for studies developing prognostic models (Steyerberg et al. 2013). Due attention was 
given to the appropriate inclusion and exclusion of participants. The assessment of 
patients’ eligibility was exclusively done by Dr Betthäuser, which ensured consistency 
of the assessments and diagnostic criteria. Patients were excluded in case of any 
uncertainty about their eligibility. Also, any changes of symptoms or diagnosis that 
occurred during the observation period were monitored and discussed between 
Dr Betthäuser and me to ensure that eligibility was maintained throughout the 
observation period. This minimised the risk of bias by inappropriate inclusions.  
The study was designed to enrol participants at a similar state of health. Key aspects, 
which were the same for all participants, were the presence of shoulder pain and the 
diagnosis of a PTT at enrolment. It was impossible to determine the precise point in 
time of the development of the PTT. Similarity of some further aspects related to the 
baseline state of health, i.e. in particular symptom duration and history of shoulder 
pain, could not be guaranteed. This similarly applied to baseline measures of pain and 
disability. Any restrictions of these aspects would have threatened recruitment. 
Differences, though, were accounted for by candidate prognostic factors. Thus, while 
similarity of the health status at baseline was as far as possible ensured and partly 
accounted for by prognostic factors, the study cohort could not be a true inception 
cohort (Altman 2009). 
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6.8.5.2 Predictors (i.e. prognostic factors)  
I judged the risk of bias associated with the prognostic factors as low. All were carefully 
defined and assessed in a similar way for all participants. The prospective design of 
the study guaranteed that the assessment of the factors was blinded to the outcome 
assessment. All factors are assessable at the intended time of use of the models, i.e. 
baseline assessment. PROBAST further asks reviewers to rate whether “all relevant 
predictors are analysed” (signalling question 4 of domain 2). On the grounds of the 
insufficient scientific knowledge on relevant prognostic factors, I had coded this 
question as “unanswerable” in the PROBAST coding manual. It was thus not 
considered for the judgements. 
6.8.5.3 Outcome 
As discussed in the report on the prognostic systematic review, risk of bias may be 
introduced through mathematical coupling when one or more prognostic factors are 
either partly or wholly included in the outcome definition (see Chapter 3 section 3.5.2). 
This problem is relevant to my study, too, because I used the WORC both as outcome 
measure and as a prognostic factor measure. In my study, though, I accounted for this 
problem by adjusting the WORC_change for RTM. This adjustment minimised the risk 
of bias related to mathematical coupling.  
All prognostic factors and the outcome were patient-reported. Thus, blinding of the 
outcome assessment to the predictor information could not be guaranteed. The 
substantial period of time, though, by which the baseline (prognostic factor) and follow-
up (outcome) assessments were separated, would tend to decrease the likelihood that 
participants remembered the prognostic factor information. Furthermore, as stated with 
the methods, patients were unaware which of the many parameters assessed at 
baseline were candidate prognostic factors. Thus, I assumed practical blinding. 
Empirical evidence on the effects of knowledge of prognostic information on the 
outcome assessment is yet lacking.  
6.8.5.4 Treatment 
The treatment of all study participants included physiotherapy, but could further include 
adjunctive medical treatment such as oral pain medication or local steroid injections. 
Approximately 40% of participants received a corticosteroid injection, in addition to 
their physiotherapy treatment. The decision to offer the injection may be associated 
with (some of) the prognostic factors (e.g. pain intensity, pain duration, level of 
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catastrophizing), which increases the risk of treatment bias (often referred to as 
confounding by indication). If the injections were effective, this would have influenced 
participants’ outcome, thereby potentially influencing (bias towards the 0) the 
association between prognostic factors and outcome, and potentially reducing the 
predictive performance of the model. 
6.8.5.5 Sample size and participant flow 
The lack of agreement as to what constitutes an appropriate number of outcome 
events or individuals in relation to the number of studied factors, and the related 
difficulty of determining the appropriate sample size for prognostic model studies, have 
been addressed in the methods part (section 6.6.14). The ratio of individuals in relation 
to the number of prognostic factors for the full model in my study was approximately 7. 
By this, it was within the range of 5-10 individuals per prognostic factor that I had 
specified as the minimum number for my study and also for the PROBAST 
assessments in the prognostic systematic review (Chapter 3). Still, the small sample 
size of the study implies that the representativeness of the sample cannot be assured. 
The study should consequently be viewed as an exploratory investigation.  
The number of losses to follow-up was small (five participants, 7%). Of the 65 
participants who completed the study, four (6%) were excluded from the multivariable 
analysis because of missing prognostic factor data. As explained with the results 
(section 6.7.2.3), I considered the loss of precision of the models by excluding these 
four cases as minimal. 
6.8.5.6 Analysis 
I consider my approach to the definition, selection and analysis of the candidate 
prognostic factors a key strength of my study. This includes the avoidance of any 
categorisation of continuous factors and of the selection of factors for inclusion in the 
multivariable analysis based on univariable analysis. These aspects have been 
discussed in the prognostic systematic review (Chapter 3). By using the AICC 
approach, I further avoided any automated selection of prognostic factors within the 
multivariable modelling analysis13. As stated in the introduction to the AIC approach 
(section 6.6.17.5), analysis techniques which rely entirely on statistical criteria, with 
arbitrary cut-offs for “significance”, such as forward, backward and stepwise regression, 
                                            
13
 The method of selecting prognostic factors within the multivariable analysis is as yet not 
addressed in PROBAST. 
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have been linked to biased predictions. In particular, stepwise regression has been 
claimed to be associated with various problems, including biased high (too large) R2 
values, biased high regression coefficients, biased low (too small) standard errors of 
regression coefficients estimates, and falsely (too) narrow CIs for the effects and 
predicted values (Flom & Cassell 2007, Harrell 2001 pp. 56–7). 
Information-theoretic approaches such as the AIC approach avoid these problems, 
thus offering a more rational approach. The advantages of the AIC approach in relation 
to the definition of candidate models are addressed in the discussion of the 
applicability. The AIC approach can be conducted using conventional statistical 
software packages such as SPSS. It is striking that automated factor selection 
methods are, despite the well documented problems associated with their use, still very 
popular and widely used in multivariable prognostic modelling studies (Sainani 2013, 
Steyerberg et al. 2001). Information-theoretic approaches are strikingly less evident in 
the literature: indeed, I am unaware of any prognostic study in the field of 
musculoskeletal shoulder complaints in which the AIC approach has been used. In this 
regard, my use of the approach constitutes an original contribution to knowledge.  
The high risk of bias judgement for the PROBAST domain 5 (analysis), which 
ultimately resulted in the overall high risk of bias judgement, was due to the decision 
not to further evaluate any of the models in my study because of their low performance 
and precision. I did not account for model overfitting, nor did I evaluate the models’ 
internal validity. Thus, the validity and reliability of the models is unclear, which puts 
them at risk of bias.  
6.8.6 APPLICABILITY 
As shown in Table 6.21, I rated concerns about applicability as “low” for all three 
domains, which led to an overall judgement of “low concerns”. 
6.8.6.1 Participant selection 
The population of interest for this study were adults with painful PTTs. As stated in the 
background chapter (Chapter 2 section 2.4), while the term “painful PTT” is used 
throughout the thesis for reasons of simplification, the population was operationalised 
as adults with shoulder pain in the presence of PTTs to acknowledge that the presence 
of shoulder pain cannot unambiguously be linked to the presence of a PTT. The 
eligibility criteria of the study were designed to account for this problem, as far as 
possible, by excluding various other potential sources of shoulder pain. Clearly, 
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though, this approach limits the applicability of the findings to a highly specific 
population, which may be the key reason for the significantly smaller number of eligible 
patients than we had anticipated.  
All PTTs were diagnosed by US. US is more specific (94%) than sensitive (68%) to 
PTTs (Roy et al. 2015). Consequently, while some PTTs might have been missed 
(false negatives), those identified were almost certainly true positives, so that the study 
population would have been homogeneous in this respect. As stated in Chapter 2 
(section 2.2), the supraspinatus tendon is reportedly the most frequently affected 
rotator cuff tendon and also usually the first to tear. This is confirmed by my study, as 
97% of the participants had an isolated supraspinatus PTT. 
An advantage of using US over other imaging modalities such as MRI or MRA is that it 
allows for a quick and inexpensive assessment and that it is a commonly applied, 
widely available procedure (see Chapter 2 section 2.9.3). A limiting factor related to the 
applicability of US for diagnosing rotator cuff tears is that it requires sufficient training 
and experience by the assessor (Lenza et al. 2013). All US assessments within my 
study were conducted by a certified instructor in ultrasonographic shoulder diagnosis, 
which strengthens the validity of the diagnoses, but which also means that it is 
primarily applicable to assessors with similar skills and experience. This also applies to 
the technical standard of the US equipment. 
6.8.6.2 Predictors (i.e. prognostic factors) 
Applicability was enhanced by the careful consideration of the candidate prognostic 
factors and their measurement (see Chapter 5). Their wide applicability in most clinical 
settings and by any health professional was ensured by the fact that all factors are 
easy to assess, as they do not require any special equipment or skills, and as both 
PROMs (WORC and PCS) are readily available in various languages. Most of the 
factors can be assessed in very little time, the only caveat being that the completion 
(and analysis) of the WORC requires comparably more time than other available 
shoulder PROMs. This disadvantage, though, appears to be outweighed by its specific 
tailoring to patients with rotator cuff disorders, its comprehensiveness and the positive 
ratings of its psychometric properties, as shown in Chapter 5 (section 5.5.2.1).  
Using the AICC approach enhanced applicability through the required definition of 
candidate prognostic models. Rather than letting the composition of the model(s) be 
defined by the application of statistical rules, it was me who defined the candidate 
models, which allowed for consideration of clinical aspects such as the distinction 
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between modifiable and non-modifiable factors or the effort required to assess factors 
(e.g. with or without questionnaires; see Table 6.1). Clearly, the nine models I defined 
represent a selection of possible combinations of factors, and this selection was not 
mean to be exhaustive. Defining candidate prognostic models by use of theoretical and 
clinical reasoning avoids a key criticism of automated techniques such as stepwise 
regression, which is that “it [stepwise regression] allows us not to think about the 
problem.” (Harrell 2001 p. 57). Miles and Shevlin (Miles & Shevlin 2001) have 
proposed the following analogy to explain the problem of letting the computer decide 
about the selection of factors within multivariable modelling analysis: “If stepwise 
regression were used to pack your suitcase, it would select the item of clothing that 
seemed to be the best – a pair of trousers, for example. Then it would examine which 
items of clothing fitted, based on what clothes were already packed. Underwear does 
not fit well when trousers are in first, so stepwise regression would reject underwear, 
as it does not fit the model.” (p. 38). 
6.8.6.3 Outcome 
The applicability of the WORC has been addressed with the prognostic factors, i.e. in 
the precedent section.  
6.8.6.4 Treatment 
The approach to the treatment was pragmatic. The physiotherapy treatment followed a 
broad evidence-based protocol. No restrictions were made on the amount or dose of 
the physiotherapy. This approach complied both with evidence-based principles and 
the ethos of an observational study and makes it broadly applicable to conservative 
treatment including exercise-based physiotherapy of varying content and dose. 
Similarly, no restriction was applied to the supplementary medical treatment, as 
supplied by Dr Betthäuser. Clearly, the broad approach may partly explain the 
observed large variability of the outcome. Although I initially considered undertaking 
subgroup analyses to explore the potential effects of treatment-related factors (e.g. the 
amount of physiotherapy or medical treatment), these would have been too small to be 
informative. Arguably, standardising exercises and manual therapy techniques and 
defining the dosage of treatment narrower than I did would have helped to ensure 
uniformity, thus enhancing comparability. However, besides the lack of an evidence-
based justification for any such approach, this was not a primary concern of my 
observational study. Rather, my aim was to achieve a wide applicability across clinical 
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settings by following standard practice informed by the state of evidence on the 
interventions of interest, under consideration of the German healthcare regulations. 
The findings from my intervention systematic review have been confirmed by more 
recently published systematic reviews of manual therapy and exercise interventions for 
impingement related shoulder complaints (Abdulla et al. 2015, Dervey et al. 2014, 
Desjardins-Charbonneau et al. 2015, Littlewood et al. 2015, Ortega-Castillo & Medina-
Porqueres 2016, Wang et al. 2014). Littlewood et al. (2015) reviewed prescription 
parameters related to therapeutic exercises for patients with rotator cuff tendinopathy. 
Based on 14 studies, they found some evidence in support of the inclusion of 
resistance exercises, a higher dose (numbers of sets and repetitions) and a duration of 
at least three months, but confirmed that the specific optimal parameters are unclear. 
6.8.7 USABILITY  
None of the candidate models in my study are usable (in clinical practice). The primary 
reason is that the study was a model development study. The provision of a clinically 
usable model requires several further stages including external validation and 
evaluation of clinical impact (see Chapter 2, section 2.11.2). Thus, developmental 
studies, in particular those that have not been validated in any way, per se do not 
provide models that are ready for use in clinical practice (Steyerberg et al. 2013).  
The overall very low performance of all candidate models in my study further suggests 
that none of them can be considered to provide helpful guidance to clinicians. In the 
light of the lack of knowledge and the difficulties in identifying potentially relevant 
prognostic factors, as evidenced by the report on the prognostic factor selection 
process (see Chapter 5), the maximum achieved performance (R2ADJ = 0.12) may be 
viewed as better than nothing, and a starting point, but it still means that the models 
are not useful to predict the outcome of a course of conservative treatment with 
physiotherapy in patients with painful PTTs. 
6.8.8 DISCUSSING THE FINDINGS 
6.8.8.1 Model performance 
A salient finding of the study is that it could not provide a prognostic model with a 
satisfactory performance. Based on the adjusted R2, the full model, which had the 
highest R2ADJ value, could explain no more than approximately 12% of the variability of 
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the WORC_change, which means that 88% remained unexplained. This is perhaps not 
surprising, considering that a vast number of factors could possibly contribute to the 
prediction of outcomes in individuals, while my investigation was limited to 10 factors. 
While the 10 factors I investigated performed poorly when combined in various 
candidate models, they could explain at least some of the variability of the outcome 
and should thus not be completely discarded based on this study.  
The results of my study, though, appear to illustrate a key challenge of developing 
prognostic models, which is the selection of factors for inclusion in a prognostic model 
study. The rigorous process by which I selected the ten candidate factors for inclusion 
in my study (see Chapter 5) revealed the dearth of knowledge of relevant factors for 
predicting outcomes in the field of the conservative treatment of rotator cuff disorders 
and shoulder pain and the resulting challenge of deciding which factors might 
potentially be relevant for predicting outcomes in adults with painful PTTs.  
As detailed in the chapter on the prognostic factor selection (Chapter 5), I included five 
factors (age, disability, history of shoulder pain, symptom duration, pain) on the 
grounds that there was reasonably consistent support for their prognostic relevance 
through clinical evidence and/or expert consensus from either three or more studies or 
from clinical evidence and expert consensus. The results of the multivariable analyses 
within my study, though, suggest that the prognostic value of these five factors, when 
analysed in combination and in context with other factors, may be limited. Possible 
reasons for this finding may include the fact that I did not assess the methodological 
quality of the included research reports. It has been claimed that many prognostic 
factor studies are methodologically compromised (Riley et al. 2013). Thus, many 
studies may be affected by biased outcomes. In this context, the available systematic 
reviews of prognostic factor studies (Chester et al. 2013, Kuijpers et al. 2004) may 
have failed to detect relevant sources of risk of bias, as no appropriate instrument for 
the assessment of risk of bias in prognostic factor studies was available at the time of 
when they were conducted. Beyond that, I considered any prognostic factor that was 
considered by the study investigators to have a relevant association with a study 
outcome, and did not assess the magnitude of the prognostic performance. 
6.8.8.2 Precision of predictions 
As evidenced by the large SEE and the wide CIs of the regression coefficients, the 
predictions lack precision, which implies that they are affected by considerable 
uncertainty and do not provide reliable estimates of population parameters (Hugh 
2008). The low precision likely relates to the rather small sample size (also see the 
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discussion of risk of bias) and variability in the predictors and outcome (Altman & 
Royston 2000). The low precision adds to the need to interpret the findings with caution 
and to view this study as exploratory. 
6.8.8.3 Prognostic factors  
Pain catastrophizing 
Pain catastrophizing was the only factor in my study that was part of both the two best 
models and the third model that was found to constitute a plausible alternative. As the 
clear intention of my study was to explore and compare prognostic models rather than 
individual prognostic factors, the complementary univariable analysis and its outcome 
should be viewed and interpreted very cautiously. It may, though, provide some 
indication of the relative relevance of pain catastrophizing within the investigated 
candidate factors.  
The potential prognostic relevance of pain catastrophizing is particularly interesting in 
relation to people with diagnosed PTTs as it seems plausible that patients presenting 
with shoulder pain who are confronted with a diagnosis of a structural defect such as a 
PTT may perceive this as threatening. This raises the question of the potential effects 
of diagnostic imaging on clinical outcomes. A qualitative study (Minns Lowe 2015) 
which was conducted alongside the United Kingdom Rotator Cuff Surgery (UKUFF) 
trial tends to support this view as expressed by the following quote from the conference 
abstract (Results): “Many participants spoke of the importance of diagnosis and impact 
of visually seeing a rotator cuff tear on scan/screen. Participants considered tears as 
serious, especially if ‘large’/‘massive’.” However, the observed mean PCS score of 15 
in my study indicates that overall, pain catastrophizing was not to a major issue: most 
(94%) of the participants had a PCS score below the proposed “cut-off score (30) for 
clinically relevant levels of catastrophizing” (Sullivan 2009 p. 7).  
The role of routine diagnostic imaging for assessing musculoskeletal complaints is 
controversial, though the controversy has mainly centred on (non-specific) low back 
pain (Flynn 2011, Karel et al. 2015). In this context, the benefits of advanced 
technological capabilities and the overall increased availability of diagnostic imaging 
have been challenged by concerns about potential detrimental effects of the routine (or 
over-) use of diagnostic imaging (in particular MRI), including e.g. misguided clinical 
decisions based on false-negative diagnoses, increased rates of surgery or stimulation 
of fear-avoidance and catastrophizing behaviours (Elliott 2011, Flynn 2011, Karel et al. 
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2015). However, a recent systematic review on the effects of diagnostic imaging in 
patients with musculoskeletal disorders (Karel et al. 2015) found no relevant studies of 
shoulder pain populations. The benefits and harms of routine diagnostic imaging in this 
area of musculoskeletal complaints therefore remain unknown.  
The role of pain catastrophizing (same as of psychological or psychosocial factors in 
general) in predicting outcomes in people with painful rotator cuff disorders is yet 
insufficiently researched. There is limited evidence from individual heterogeneous 
studies to indicate that pain catastrophizing may be a relevant factor for predicting 
outcomes (i.e. symptom intensity, disability, persistence of complaints and sick leave) 
in people with arm, neck and shoulder complaints (Karels et al. 2007, Larsman et al. 
2009) or nonspecific shoulder pain (Kuijpers et al. 2006). In the recent systematic 
review of primary prognostic factor studies for predicting the outcome of physiotherapy 
in people with musculoskeletal shoulder pain (including rotator-cuff related disorders) 
by Chester et al. (2013), though, neither pain catastrophizing nor any other 
psychosocial factors were identified as showing a consistent association with outcomes 
in at least two studies that met a predefined set of quality criteria. Limited evidence 
from individual studies further provides some preliminary indication of the following: a) 
that pain catastrophizing (among other psychological or psychosocial factors) may 
have a stronger influence on persistent pain and disability in patients with low back 
pain compared to patients with shoulder pain (van der Windt et al. 2007); b) that it may 
be more relevant in chronic compared to acute shoulder pain (Reilingh et al. 2008); 
and c) that it may be similar in people with non-specific compared to specific diagnoses 
of complaints of the arm, shoulder and neck (including specific diagnoses such as 
rotator cuff tendinopathy or tears) (Keijsers et al. 2010).  
To my knowledge, the study by Kromer et al. (2014), one of the included studies in my 
prognostic systematic review (Chapter 3), was the first to investigate the role of two 
psychosocial factors (fear-avoidance beliefs and pain catastrophizing) in a specific 
population of rotator-cuff related shoulder pain. The authors concluded that neither of 
these factors was a significant contributor to the prognosis of disability after a three-
month period of treatment with physiotherapy. As I judged this study to be affected by a 
high risk of bias, though, the validity of its findings is to be questioned. 
Diabetes 
I intended to include all ten candidate prognostic factors in the multivariable analysis, 
but eventually excluded Diabetes in view of the low number of participants (four) who 
had Diabetes. The prevalence in the study sample (6%) was below the estimated 
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overall prevalence of (diagnosed) diabetes of approximately 7% in the German adult 
population (Diabetes Deutschland 2012). (A more recent estimate is 7-8% (Deutsche 
Diabetes-Hilfe 2015)). The role of diabetes as a prognostic factor in rotator cuff 
disorders remains unclear.  
6.8.9 COMPARISON WITH OTHER PROGNOSTIC MODEL STUDIES 
As evidenced by my prognostic systematic review (Chapter 3), this study is the first to 
investigate prognostic models for predicting the outcome of a period of conservative 
treatment with physiotherapy in adults with painful PTTs. Thus, no direct comparisons 
are possible. In the light of the considerable heterogeneity and methodological 
deficiencies of the available studies exploring prognostic models in adults undergoing 
conservative treatment with physiotherapy for any type of painful rotator cuff disorders, 
I considered any further comparison with my study and its findings as uninformative.  
6.8.10 CONCLUSIONS 
6.8.10.1 Implications for clinical practice 
This study is the first to explore prognostic models for the outcome of conservative 
treatment with physiotherapy in adults with painful PTTs. All analysed candidate 
models had low performance and precision. The best-performing model could explain 
only 12% of the variability of the WORC_change. On the grounds of the low 
performance of the analysed candidate models and the low precision of parameter 
estimates, none of the models was further evaluated or validated. Given the fact that 
model development studies per se cannot be considered as clinically usable, the study 
could not provide any model that is ready to be used in clinical practice. 
6.8.10.2 Implications for research 
Further research is needed to enable provision of a high-performing prognostic model 
for predicting the outcome of conservative treatment with physiotherapy in adults with 
painful PTTs. The study was designed in consideration of current methodological 
guidance for prognosis research and was conducted according to the best possible 
methodological standards. Furthermore, it is to my knowledge the first prognostic 
model study in the field of musculoskeletal shoulder complaints in which an 
information-theoretic analysis approach was applied. The study may thereby provide a 
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helpful methodological “template” for future studies. It was meticulously reported 
considering all items required by the TRIPOD statement (Collins et al. 2015, Moons et 
al. 2015). 
The study was limited to the investigation of 10 candidate prognostic factors. Larger 
studies are needed to enable investigations of larger numbers of factors. This appears 
particularly relevant given the dearth of knowledge on relevant prognostic factors within 
the field of shoulder pain and rotator cuff disorders and the implicit challenge of 
selecting candidate factors for prognostic model studies. Prospective cohort studies 
are the preferable study design, but prospectively planned analyses of RCT data may 
also be considered. Collaborative data collection efforts such as multicenter studies, 
prospective health databases or other data sharing approaches could enhance larger 
samples. Given the complexity of the design and analysis of prognosis research, the 
involvement of a statistician with expertise in prognosis research is strongly 
recommended as it can help to minimize the risk of producing biased predictions.  
Further methodological research is needed to determine the most valid and reliable 
methods for the development of prognostic models. Researchers should carefully 
design their studies in accordance with current methodological guidance and should 
keep abreast with the methodological advancements in the field of prognosis research. 
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CHAPTER 7 
Drawing meaningful magnitude-based inferences  
from the prognostic study – Minimal Important 
Difference (MID) and responder analysis 
7.1 INTRODUCTION, AIMS AND OBJECTIVES 
A secondary aim of my prognostic study (Chapter 6) was to enhance interpretation of 
WORC_change scores. To do so, I estimated the MID of the WORC based on the 
prognostic study data. The intention of the MID analysis was to enable magnitude-
based inferences about the WORC_change. I explicitly intended to avoid any 
inferences based on statistical hypothesis tests, i.e. on the statistical significance of the 
outcome, because inferences that are grounded on whether a p value (from a 
statistical null-hypothesis test) is below or above a specific threshold (typically set at 
0.05) are widely held to fall short of meaningful interpretation (Batterham & Hopkins 
2006, Field 2013, George & Batterham 2015, Shrier & Batterham 2002). The statistical 
significance of an outcome reflects “the probability of obtaining any value larger than 
the observed effect (regardless of sign) if the null hypothesis were true” (Batterham & 
Hopkins 2006 p. 51). However, p values do not provide information about the direction 
and magnitude of an outcome (Batterham & Hopkins 2006). Also, as statistical 
significance is affected by sample size and sampling variability, a statistically significant 
outcome does not necessarily represent a clinically relevant outcome, and conversely, 
a statistically non-significant outcome does not necessarily represent a clinically non-
significant outcome (Batterham & Hopkins 2006, Field 2013). Thresholds for p values 
(such as 0.05) are further criticised for their arbitrariness (Batterham & Hopkins 2006, 
Field 2013). Considering these issues, it has been posited that “an overreliance on p 
values might … lead to unethical errors of interpretation” (Batterham & Hopkins 2006 p. 
51).  
PROMs like the WORC allow for the comprehensive assessment of those aspects of 
health status that are relevant to patients (Michener 2011, St-Pierre et al. 2016). 
PROM change scores quantitatively estimate the direction and magnitude of the 
change in health status over time; but they do not contextualise this magnitude relative 
to patients’ perception of important change (Guyatt et al. 2002, Schünemann et al. 
2006). The consequence is a crucial missing link in interpretation. For example, WORC 
total scores can range between 0 and 2100 (see Chapter 5 section 5.5.2.1). The 
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sample mean (SD) WORC_changeADJ score in the prognostic study was -363 (341), 
and the individual outcome scores ranged between -1102 and +387 (Chapter 6 Table 
6.9). What do these scores mean? How can they be interpreted meaningfully? It would 
clearly help both investigators and clinicians to have some guidance about what 
magnitude of a change translates to a clinically important change, i.e. in particular to a 
change that is important to patients (Brozek et al. 2006, Jevsevar et al. 2015).  
Estimates of the MID of an outcome measure offer a threshold for a clinically important 
outcome in a particular context (Brozek et al. 2006, Guyatt et al. 2002), thereby 
facilitating responder analysis, “in which a continuous primary efficacy [outcome] 
measure is dichotomized into ‘responders’ and ‘non-responders’.” (Snapinn & Jiang 
2007 Abstract). This approach is somewhat crude, however. I therefore complemented 
the MID analysis by adopting a more rational magnitude-based approach to inferences 
about the observed WORC_change scores based on the MID estimate. This entailed 
applying the MID estimate to an exploratory responder analysis of the study 
participants’ individual WORC_changeADJ scores using the method proposed by 
Hopkins, Batterham et al. (Batterham & Hopkins 2006, Hopkins 2002, 2004, 2007, 
2015, Hopkins et al. 2009)14. My aim was to illustrate a more sophisticated approach to 
magni- tude-based inferences that goes beyond the crude dichotomisation of observed 
outcome values by the MID. To my knowledge, this approach has not yet been applied 
in the context of shoulder/musculoskeletal outcome MIDs; it thus represents an original 
contribution to knowledge.  
In this chapter, I separately report the MID analysis and the complementary exploratory 
responder analysis. Accordingly, the chapter is divided into two sub-chapters (sections 
7.2 and 7.3), each structured into a background, methods, results and discussion 
section. The discussion sections consider both strengths and limitations of the 
respective analysis and end with implications for practice and research. Within the 
discussion of the responder analysis, the other secondary outcomes of the prognostic 
study, i.e. tear progression and adverse events, are also addressed. 
                                            
14
 This analysis reflects a deviation from protocol; see Appendix 6.4. 
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7.2 ESTIMATING THE MID OF THE WORC 
7.2.1 SPECIFIC BACKGROUND 
In 1989, a group of researchers at McMaster University, Canada (Jaeschke et al. 
1989), provided a first description of what became known as the “Minimal Clinically 
Important Difference” (MCID). The MCID was initially defined as “the smallest 
difference in score in the domain of interest which patients perceive as beneficial and 
which would mandate, in the absence of troublesome side effects and excessive cost, 
a change in the patient’s management” (Jaeschke et al. 1989 p. 408). In 2005, the 
same group suggested a revised definition: “the smallest difference in score in the 
outcome of interest that informed patients or proxies perceive as important, either 
beneficial or harmful, and which would lead the patient or clinician to consider a 
change in the management” (Schünemann & Guyatt 2005 p. 594). They removed the 
C from MCID, thus terming it MID in order to emphasise the intended focus on 
“patients’ experience in their day-to-day lives” rather than on the “clinical area” 
(Schünemann & Guyatt 2005 p. 594).  
The MID is still described variously in the literature, and the label M(C)ID encompasses 
a variety of constructs (Beaton et al. 2002). There are also numerous alternative or 
related terms, including “Minimum Important Change” (MIC), “Minimal Clinically 
Important Difference” (MCID), “Minimal Clinically Important Change” (MCIC), “Minimally 
Practically Important Difference” and “Minimum Worthwile Reduction” (Ferreira et al. 
2012 p. 254, George & Batterham 2015 p. 1). However, a review of the M(C)ID 
literature (Beaton et al. 2002) notes that, “despite different definitions, the common 
thread is that it is the lower boundary of change that has been defined, in some way, to 
be important” (p. 110).  
Various methodological approaches to the estimation of the MID have been proposed, 
and the topic is somewhat contentious as knowledge about the best approach is yet 
lacking (Beaton et al. 2002, Brozek et al. 2006, Jevsevar et al. 2015, Schünemann et 
al. 2006, Turner et al. 2010, Wright et al. 2012). However, the methodological 
approaches are commonly broadly categorised into anchor-based and distribution-
based approaches (Brozek et al. 2006, Turner et al. 2010, Wright et al. 2012). Anchor-
based approaches are generally recommended as the preferable strategy for the MID 
estimation, but may be combined with distribution-based methods (Revicki et al. 2008, 
Turner et al. 2010).  
CHAPTER 7 177 
 
 
 
Anchor-based approaches estimate the MID by linking the observed outcome to an 
external criterion, the anchor (Brozek et al. 2006, Jevsevar et al. 2015, Revicki et al. 
2008, Wright et al. 2012). This anchor may be a clinical (e.g. range of motion or 
strength) or patient-reported (e.g. global rating of change) measure, or a combination 
of both (Revicki et al. 2008, Turner et al. 2010). Patient-reported anchors are generally 
considered the preferable choice (Revicki et al. 2008, Schünemann & Guyatt 2005). 
The most widely used patient-based anchor is a Global Perceived Change (GPC) scale 
(Brozek et al. 2006, Jevsevar et al. 2015, Revicki et al. 2008, Turner et al. 2010, Wright 
et al. 2012). As described in Chapter 6 (section 6.6.9.2), GPC scales, which may vary 
in their design and wording, ask patients to rate their perception of the change in their 
health status related to a particular context over a particular period of time by choosing 
from various categories that reflect either no change or different levels (e.g. “little” or 
“much”) of improvement or deterioration (Kamper et al. 2009). It seems intuitive to 
derive the MID from the smallest (“minimum”) change, but researchers have also used 
larger changes (e.g. “moderate”) (Turner et al. 2010 p. 29), and the precise number 
and labels of related GPC categories varies according to the design of the GPC scale 
used (Turner et al. 2010). 
Distribution-based approaches estimate the MID by relying on the statistical properties 
of the sample such as effect size statistics, the standardized response mean or the 
standard error of measurement (SEM). They do not apply an external criterion (Brozek 
et al. 2006, Jevsevar et al. 2015, Revicki et al. 2008, Turner et al. 2010, Wright et al. 
2012).  
Prior searches of the literature for published estimates of the MID for the WORC 
(Braun et al. 2013) yielded two estimates determined in studies on populations of 
adults with impingement-related shoulder pain and by different methods (see further). 
7.2.2 METHODS 
7.2.2.1 Overall approach and definition of MID 
I took an anchor-based approach to estimating the MID for the WORC using the data 
from the prognostic study: specifically, the data from the 64 participants for whom both 
the WORC_change and a GPC rating were available. The seven-point GPC scale, one 
of the secondary outcomes of the prognostic study (see Chapter 6 section 6.6.9.2 for 
details), was used as the anchor.  
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The MID estimate, which was intended to represent a clinically important positive 
(beneficial) outcome, was established by logistic regression. The GPC was 
dichotomised into “improved” or “unimproved”. “Improved” comprised +1, +2 or +3 
responses on the GPC scale, and thus included all ratings of at least „slightly 
improved“. “Unimproved” comprised GPC ratings of 0, -1, -2 or -3, thus including all 
unchanged or deteriorated ratings. The MID was derived from the „improved“ category 
using a two stage approach. The first stage involved a logistic regression analysis. In 
the second stage, the probabilities of being improved were calculated for different 
thresholds of WORC_change. 
7.2.2.2 Logistic regression analysis 
I conducted a logistic regression analysis with the dichotomised GPC scale 
(improved/unimproved) as the dependent variable and the WORC_change as the 
independent variable. As in the prognostic modelling analysis, this was conducted on 
the RTM-adjusted WORC_change (WORC_changeADJ) scores (see Chapter 6 section 
6.6.17.8 for details). The analysis was further adjusted for sex and age, but there was 
insufficient power to permit presentation of age- and sex-specific MID estimates.  
7.2.2.3 Probabilities of being improved for different thresholds of 
change_WORC 
From the regression analysis, I estimated the MID by calculating predicted probabilities 
of being improved for four WORC_changeADJ thresholds: -100, -200, -300 and -400. 
The question posed, in other words, was “What is the probability of being ‘improved’ if 
WORC_changeADJ is -100, -200, -300 and -400 respectively?”. I chose a probability of 
90% (a WORC_changeADJ at which nine patients out of 10 would be responders) as a 
reasonable and intuitive target. In this manner, the WORC_changeADJ threshold with 
the probability nearest to 90% was designated to represent the MID. I calculated a 95% 
CI for the probability to provide a measure of variability of the true probability. The 
analysis was conducted in STATA (version 13.1).  
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7.2.3 RESULTS 
7.2.3.1 Probabilities of being improved for different thresholds of 
change_WORC 
Table 7.1 displays the probabilities of being improved as derived from the logistic 
regression and calculated for the thresholds of the WORC_changeADJ total scores of -
100, -200, -300 and -400. The threshold of -300 for the WORC_changeADJ precisely 
matched the pre-specified probability of 90%; it was thus accepted as the MID.  
Table 7.1: Probabilites of being improved at different WORC_change 
thresholds  
  (n = 64) 
Level* of 
WORC_changeADJ 
Probability 
 
95% CI 
Lower limit Upper limit 
-100 0.78 0.65 0.92 
-200 0.85 0.74 0.96 
-300 0.90 0.81 0.99 
-400 0.94 0.86 1.01 
 
*relates to margins in STATA 
7.2.3.2 Responders based on the MID 
Applying the MID of -300 to classify the 65 study participants as either responders 
(those whose improvement in the WORC was greater in magnitude than the MID) or 
non-responders (those whose improvement in the WORC was smaller in magnitude 
than the MID) resulted in 39 responders (60% of the participants). This is further 
addressed in the discussion of the responder analysis, in which the implications of 
different responder definitions, i.e. of different thresholds for being a responder, are 
compared. 
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7.2.4 DISCUSSION  
7.2.4.1 MID analysis in context 
As stated in the background section, both the definition of the MID and the statistical 
analysis approaches to its determination vary across the research literature, and there 
is yet no agreement on the best methods. Individual researchers must choose, but it is 
important to consider that MID estimates are context-dependent: different methods 
yield different MID estimates (Beaton et al. 2002, Copay et al. 2007, Wright et al. 
2012). Also, MID estimates may vary across populations and interventions (Revicki et 
al. 2008) and also depend on baseline scores (Beaton et al. 2002). It is crucial for 
researchers to be transparent and explicit about their methods and their specific study 
contexts. Even so, no single MID estimate will be valid for all applications in which the 
outcome measure is used (Beaton et al. 2002, Revicki et al. 2008).  
7.2.4.2 MID analysis approach 
I chose an anchor-based approach for the determination of the MID of the WORC, 
because, as stated in the background section, anchor-based approaches are generally 
recommended as the preferable strategy for MID estimation. Moreover, it seemed most 
reasonable to use an approach in which the WORC_change values were linked to a 
patient-reported measure of the change of their shoulder problem. A particular strength 
of this approach is that the probability of a patient being a responder can be calculated 
at different threshold levels of WORC_change.  
Recent reviews of shoulder PROMs which included available MID estimates of various 
shoulder PROMs suggest that the provision of measures of variability are yet 
uncommon in shoulder-related MID studies (Roy & Esculier 2011, St-Pierre et al. 2016, 
Wright & Baumgarten 2010). The approach described here does present CIs, and, 
moreover, these are easy to interpret: the probability that a patient with a 
WORC_changeADJ of  -300 was “improved” was 0.81 to 0.99, or put simply, a 
WORC_changeADJ of -300 would signify improvement in between 8 out of 10 people 
and everyone.  
7.2.4.3 MID definition 
As stated in the background section, GPC scales are the most commonly used anchor 
to define the threshold of clinical importance in anchor-based MID analyses. I used a 
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seven-point GPC scale for my MID estimation. The participants’ GPC ratings provided 
estimates of their impression of the overall change of their shoulder problem over time, 
which I then correlated with the WORC_changeADJ scores in order to provide an 
estimate of what patients consider a minimal important difference, termed the MID, and 
to thereby enhance the interpretation of the WORC. 
Although GPC scales are the most common anchors, there are some limitations to 
their use for this purpose. One is related to the fact that GPC ratings need to be 
translated into an MID definition. This definition is usually made by the researcher 
(Ferreira et al. 2012). Consequently, while patients provide estimates of how they 
perceive the change in their complaint, the MID definition ultimately still reflects the 
researchers’ rather than the patients’ views (Ferreira et al. 2012). Indeed, this applied 
to my own analysis, but by accepting a perceived change of at least slightly improved 
as the mid definition, I aimed for relative robustness. Consequently, MID estimates 
derived from anchor-based approaches using GPC scales cannot unconditionally be 
viewed as representing patients’ views of the threshold of clinical importance.  
As previously outlined (Chapter 6), GPC scales have some further limitations. These 
include the overall yet insufficient knowledge on their validity and reliability, the 
possible influence of recall bias on patients’ ratings (Kamper et al. 2009, Wright et al. 
2012) and the concern that GPC scales may not adequately reflect change over time, 
i.e. that they primarily reflect patients’ current health status rather than change 
(Kamper et al. 2009 & 2010, Wright et al. 2012).  
A caveat related to my MID analysis, which relates to the dichotomisation of the GPC 
ratings into “improved” and “unimproved” in my study (see also further), was that the 
two categories were unbalanced as most participants (55/64 or 86%) were in the 
“improved” category, whereas only 9/64 (14%) were in the “unimproved” category, 
which decreases power (Frazier et al. 2004). 
These various limitations and uncertainties should be borne in mind. 
7.2.4.4 Comparison with other available MID estimates for the WORC 
At the time when I planned this MID analysis two other MID estimates of the WORC 
were available (Ekeberg et al. 2010, Kirkley et al. 2003a)15 (see also Braun et al. 2013). 
To my knowledge, and as confirmed by two recent systematic reviews on the 
psychometric properties of shoulder questionnaires including the WORC (Huang et al. 
                                            
15
 The precise origin of the MID analysis presented by Kirkley et al. (2003a), which is a review of 
various shoulder questionnaires, is unclear as it is not referenced. 
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2015, St-Pierre et al. 2016), no MID estimates of the WORC have been published 
since.  
The comparison of the approaches to the MID analysis as reported by Ekeberg et al. 
(2010), Kirkley et al. (2003a) and my own approach provide an illustrative example of 
the variability of definitions and approaches. A summary of key characteristics and the 
results of the two studies is presented in Table 7.2, which shows that there were both 
similarities and differences between these studies and my own. Both Kirkley et al. 
(2003a) and Ekeberg et al. (2010) provide one final MID point estimate. The MID 
estimate by Ekeberg et al. (2010), though, represents an overall estimate that was 
established through use of two different approaches.  
Table 7.2: Characteristics and results of other WORC MID studies 
Study ID Key characteristics  Analysis approach GPC and MID  
definition 
MID 
Ekeberg 
2010 
“Rotator cuff disease” 
(clinical diagnosis, no 
mention of 
inclusion/exclusion of 
tears); 
n = 121; treatment: 
corticosteroid injection 
(local versus systemic); 
follow-up: after 3 
months 
Two approaches 
1) Mixed anchor-
based/distribution-
based approach (two 
estimates);  
2) Mean change 
score of “improved” 
(3 and 4 points on 
“main complaint” 
scale) patients  
Initial rating: 
18-point “change in 
main complaint” scale 
from -9 = “worst 
possible” to +9 = “best 
possible” 
  if changed: patients 
were asked “if they 
believed that degree of 
change experienced 
after treatment of 
importance to their 
shoulder condition” 
(yes/no)? 
MID: “yes” rating 
275 
 
Kirkley 
2003 
“Chronic cuff tendinitis 
without tear” (not 
further specified), n = 
44; treatment: 
subacromial injection 
(no further information); 
follow-up: after 6 weeks  
Anchor-based  
  
Initial rating: 
better/worse/same 
  if changed: five-point 
change scale from 1 = 
“very little different” to 5 
= “a great deal 
different”; 
MID: “minimal different” 
= rating of 1 or 2 
245 
Study ID = first author, yr 
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The MID estimate of (-)300 which I established is close to the other two. This 
estimates’ proximity suggests convergent validity, despite differences in the 
characteristics and methods between the three studies.  
On the basis of the known context-dependence as well as the lack of knowledge about 
the best methodological approach for the determination of the MID, it seems important 
not to rely on a single estimate but to consider, if possible, a range of MID estimates 
from various studies and different approaches. Consequently, the MID estimate which I 
determined should not be viewed as the MID and should always be considered within 
its context, i.e. my study and this specific approach to the MID analysis.  
7.2.4.5 Conclusions 
Implications for practice 
The MID estimate which I established based on the data of my prognostic study 
provides the first MID estimate of the WORC in adults with painful PTTs who undergo 
conservative treatment with physiotherapy. It may thus be used by clinicians to 
enhance the interpretation of WORC_change scores in patients with characteristics 
that are comparable to those of my study, and within a similar context. Clinicians 
should be aware, though, of the limitations of MID estimates and should not view the 
estimate as the definitive MID.  
Implications for research 
Further investigations of MID estimates of the WORC are needed to provide a range of 
estimates. Further methodological research is need to determine the best methods of 
determining the MID. In their review of the M(C)ID, (Wright et al. 2012) recommend: 
“Cautious application of the MCID score both in the clinical setting and in research is 
prudent until a consensus can be reached on calculation to address the limitations in 
methodology, population, and baseline.” (p. 165). Efforts should be undertaken to 
increase homogeneity of terminology. 
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7.3 RESPONDER ANALYSIS 
7.3.1 SPECIFIC BACKGROUND 
A responder analysis classifies individuals as either responders or non-responders (to 
treatment) based on the magnitude of their outcome value in relation to a defined 
threshold of clinical relevance (Jevsevar et al. 2015, Snapinn & Jiang 2007), thereby 
enabling an easy interpretable measure of benefit. In their guidance on the use of 
PROMs in clinical trials, the American Food and Drug Administration (FDA) promotes 
the use of responder analyses as follows (FDA 2009 pp. 24-5): “Regardless of whether 
the primary endpoint for the clinical trial is based on individual responses to treatment 
or the group response, it is usually useful to display individual responses, often using 
an a priori responder definition (i.e., the individual patient PRO [PROM] score change 
over a predetermined time period that should be interpreted as a treatment benefit). 
The responder definition is determined empirically and may vary by target population or 
other clinical trial design characteristics.”  
The method for the complementary responder analysis was based on a body of work 
by Hopkins, Batterham and others (Batterham & Hopkins 2006, Hopkins 2002, 2004, 
2007, 2015, Hopkins et al. 2009), who have developed a sophisticated approach to the 
magnitude-based interpretation of outcomes. The key principle is that inferences 
should reflect the uncertainty in the true outcome value (Hopkins 2007). Accordingly, 
the probability that a true outcome value is within a certain level of magnitude takes 
into account not only the MID, but also the “typical error” of the outcome measurement 
(see further). Additionally, while the MID is widely used to assign outcomes to one of 
two levels of magnitude, depending on whether their magnitude is below or above the 
MID, Batterham and Hopkins (2006) have proposed a three-level scale of magnitude: 
“clinically beneficial”, “clinically trivial” and “clinically harmful”. These levels are defined 
by the positive and negative MID thresholds, which are by default considered equal 
with opposite signs (Hopkins 2006). Figure 7.1 illustrates the levels and thresholds 
(adapted from Hopkins 2006 p. 2). A clinically beneficial outcome reflects any outcome 
value with a magnitude above the positive MID threshold (i.e. exceeding it in 
magnitude); a clinically harmful outcome represents any outcome value with a 
magnitude below the negative MID threshold; and a clinically trivial outcome reflects a 
outcome value with a magnitude between the positive and negative MID thresholds. 
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Figure 7.1: Clinically beneficial, trivial and harmful outcomes based on MID 
thresholds 
For individuals’ outcome values, the probabilities (from 0.0 to 1.0) can be calculated 
that the true outcome value is clinically beneficial, trivial or harmful. This is illustrated 
by Figure 7.2 (adapted from Hopkins (2006) p. 2). The calculations are based on a t 
distribution and can be performed in a publicly available, purpose-designed 
spreadsheet (Hopkins 2007) (see further).  
 
Figure 7.2: Probabilities of a beneficial, trivial or harmful outcome 
Hopkins has proposed stratification of the probabilities (or odds) into different levels, 
each with a qualitative description to enhance meaning (Hopkins 2002). These are 
shown in Table 7.3.  
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Table 7.3: Levels and qualitative descriptions of probabilities of clinical 
outcomes 
Probability Odds Qualitative description 
>0.99 >99:1 almost certainly… 
0.95-0.99 19:1-99:1 very likely to be… 
0.75-0.95 3:1-19:1 likely to be… 
0.25-0.75 1:3-3:1 possibly not… 
0.05-0.25 1:19-1:3 unlikely to be… 
0.01-0.05 1:99-1:19 very unlikely to be… 
<0.01 <1:99 not… (almost certainly not…) 
 
As mentioned above, a further feature of the analysis approach is that it considers the 
typical (or standard) error of the individuals’ outcomes. The simple dichotomisation of 
observed outcome values based on their magnitude in relation to the MID ignores the 
typical random variation of the measurement, termed the typical error by Hopkins 
(Hopkins 2004), which expresses the uncertainty in a measurement when it is 
repeatedly obtained (Hopkins 2004). PROMs, like practically all measurements used in 
physiotherapy practice and research, have some measurement error, and knowledge 
of this error helps to distinguish a likely true change from a change that may be 
primarily due to the error (Revicki et al. 2008). When an individual’s outcome value is 
smaller than the error, it is uncertain whether the change represents a true change or 
just the error (Beaton 2000). Also, the typical error should ideally be smaller than the 
MID (Hopkins 2004).  
The typical error of a measurement is commonly represented by the SEM, and typically 
determined in a (test-retest) reliability study, in which the time interval between the 
repeat measurements must be sufficiently short for the participants not to have 
changed substantially (Hopkins 2004). In case of studies with longer periods of follow-
up, such as my study, Hopkins proposes that the reliability data should reflect the same 
period of time (Hopkins 2004), meaning that the typical error in such cases represents 
the typical random variation of the measurement over time (in an untreated group) 
rather than its test-retest variability. Ideally, the data would be derived from an 
untreated control group within an RCT. In the absence of such a group within my own 
study, I could not establish an estimate of the typical error of the WORC from it and 
thus obtained one from the literature (see further).  
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The responder analysis presented here should be viewed as illustrative. The aim is to 
show how the interpretation of outcomes based on the MID can be enhanced by 
considering the uncertainty in the true values.  
7.3.2 METHODS 
For the purposes of my illustrative responder analysis, I explored the probabilities of 
the individuals’ true WORC_changeADJ scores being clinically beneficial, i.e. exceeding 
the positive MID in magnitude, given the typical error of the WORC. The analysis 
involved two steps: identifying a suitable estimate of the typical error of the WORC and 
then conducting the responder analysis. 
7.3.2.1 Identification of an estimate of the typical error of the WORC 
I conducted literature searches in Medline (PubMed), Embase and Cinahl up to week 
2, July 2015, for a suitable estimate of the typical error of the WORC. The aim was to 
identify, if possible, an estimate of the typical error of the WORC from a study with an 
untreated cohort of patients and comparable characteristics to those of my own study, 
i.e. in particular with respect to the population (PTTs or impingement-related shoulder 
pain) and length of follow-up (three to four months). I initially searched for any primary 
studies of populations of adults with painful rotator cuff disorders in which the WORC 
was used. Accordingly, I used a pragmatic and broad strategy, in which I combined the 
terms “Western Ontario Rotator Cuff Index” and “WORC” with terms related to the 
population of interest (as used in my prognostic systematic review, see Appendix 3.1 
eTable 2), e.g. “rotator cuff”, “shoulder impingement”. The searches were 
supplemented by hand-searches of previously obtained primary studies and systematic 
reviews in which the WORC was assessed. The findings were then inspected. 
Relevant studies were required to present repeat measures of the WORC in an 
untreated cohort of patients. Further, relevant studies had to present either the SEM, 
the mean WORC_change score with its SD, or the mean WORC pre and post scores 
with their SDs.  
7.3.2.2 Responder analysis 
The analysis was based on the WORC_changeADJ values of all study participants (n = 
65). The calculations were performed in the purpose-designed spreadsheet by Hopkins 
(2007) using analysis option 2, “Precision of a change in a measurement based on 
typical (standard) error of measurement from a reliability study”. The spreadsheet is 
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freely accessible16. The calculations require the individuals’ baseline and follow-up 
WORC or WORC_change values, the MID estimate and the following data from a 
reliability study (or control group): the number of subjects, the number of 
measurements and the typical error (SEM). Based on these data, the spreadsheet:  
 provides individuals’ probabilities (also expressed in chances and odds) for a 
clinically beneficial, trivial and harmful outcome;  
 assigns those probabilities to descriptive levels (see Table 7.3); and  
 provides CIs at different levels of confidence for the individual WORC_change 
values (see further). 
I intended to obtain and present the following data: 
 the probabilities (and descriptive levels) of the individuals’ true WORC_changeADJ 
scores being clinically beneficial (i.e. exceeding the MID in magnitude, given the 
typical error of the WORC);  
 the numbers (proportions) of participants at each level of probability related to a 
beneficial outcome;  
 the number (proportion) of participants with a probability of  0.75 of a beneficial 
outcome, which I used as the ultimate threshold for dichotomising participants to 
responders and non-responders; and  
 the descriptive level of probability of a harmful outcome for all participants whose 
probability of a beneficial outcome was < 0.10. This was to acknowledge the 
increasing probability of a harmful outcome with decreasing probability of a 
beneficial outcome. 
In addition to the calculations for the responder analysis, I determined the following 
measures of variability to describe the uncertainty in the individual and sample true 
WORC_changeADJ scores (George & Batterham 2015, Hopkins 2015): an SD for the 
individual responses across the whole sample (SDIR, see further) and CIs for the mean 
(sample) and individual WORC_changeADJ values.  
7.3.2.3 SD for the individual responses across the whole sample  
To summarise the individual WORC_change outcomes across the whole sample, and 
as proposed by Hopkins (2015), I determined an SD (SDIR) by calculating the square 
root of the difference between the squares of the standard deviations of the 
                                            
16
 Available at: http://www.sportsci.org/resource/stats/index.html (Spreadsheets  Assessing 
an individual) [Last accessed 22 June 2016] 
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WORC_changeADJ scores in my study cohort (SDSTUDY) and the control group 
(SDCONTROL from de Witte et al. (2012): SDIR = (SDSTUDY2 – SDCONTROL2). This SD can 
be considered as “the amount by which the net mean effect of the treatment differs 
typically between individuals” (Hopkins 2015 p. 1444). 
7.3.2.4 CIs for the mean (sample) and individual WORC_change values 
The 95% CI for the mean (sample) WORC_change was established by a paired-
samples t test (between the WORC1ADJ and WORC_2 scores). The 95% CIs for the 
individuals’ WORC_change values were obtained from the spreadsheet (Hopkins 
2007).  
7.3.3 RESULTS 
7.3.3.1 Identification of an estimate of the typical error of the WORC  
I identified 18 potentially relevant studies from the searches. A list of these studies, the 
results of their screening and the references are provided in Appendix 7.1. For 
completeness, the references are also provided in the reference list of this chapter. 
None of the studies fully complied with the criteria of my own study. In particular, no 
data was available from an untreated cohort with a comparable length of follow-up. 
Three studies were unsuitable because the WORC was assessed only once, and ten 
further studies were unsuitable because there was no untreated cohort. The remaining 
five studies appeared potentially suitable, the main caveat being that the length of 
follow-up in these studies, all of which assessed the test-retest reliability of the WORC, 
was limited to one to two weeks. In three of these studies it was unclear whether or not 
participants received treatment between the initial assessment and the follow-up. The 
studies investigated rotator cuff disorders, but none investigated a distinct population of 
adults with painful PTTs. 
I compared my findings to the findings of two recent systematic reviews on the 
measurement properties of shoulder PROMS for use in populations with rotator cuff 
disorders (Huang et al. 2015, St-Pierre et al. 2016). Both included comprehensive 
syntheses of the available psychometric evidence for the WORC. The review by  
St-Pierre et al. (2016) was the most current and comprehensive one; it included all five 
reliability studies. No further relevant studies were found. In consequence of these 
findings, I decided to obtain the most conservative (highest) estimate of the typical 
error of the WORC from the reliability studies based on the systematic review by  
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St- Pi err e et al. ( 2 0 1 6), a n d t o u s e t hi s a s t h e t y pi c al err or i n m y e x pl or at or y r e s p o n d er 
a n al y si s. T h e c a v e at w a s t h at t h e d at a w o ul d c o m e fr o m a st u d y t h at di d n ot f ull y 
m at c h t h e c h ar a ct eri sti c s of m y o w n st u d y a n d h a d a s h ort er f oll o w- u p.  
T h e hi g h e st a v ail a bl e e sti m at e of t h e t y pi c al err or of t h e W O R C c a m e fr o m a st u d y b y 
d e Witt e et al. ( 2 0 1 2). I n t hi s st u d y, v ari o u s p s y c h o m etri c pr o p erti e s of t h e W O R C w er e 
a s s e s s e d i n 9 2 p ati e nt s wit h r ot at or c uff di s e a s e ( 3 5 wit h r ot at or c uff t e ar s, 3 5 wit h 
c al cifi c t e n di niti s a n d 2 2 wit h s h o ul d er i m pi n g e m e nt), all of w h o m w er e c o n si d er e d f or 
p arti ci p ati o n i n o n e of t hr e e i n d e p e n d e nt r e s e ar c h pr oj e ct s. T h e st u d y w a s c o n d u ct e d 
i n a s e c o n d ar y c ar e s etti n g. T h e p arti ci p a nt s’ m e a n a g e ( S D) w a s 5 5 ( 9) y e ar s, a n d 
5 3 % w er e f e m al e. T e st-r et e st r eli a bilit y w a s e st a bli s h e d b y a d mi ni st eri n g t h e W O R C t o 
t h e p arti ci p a nt s t wi c e “ wit hi n 3 t o 1 4 d a y s” ( p. 1 6 1 6). T h e q u e sti o n n air e w a s fir st s e nt 
t o t h e p ati e nt s b y c o n v e nti o n al m ail, r e q u e sti n g t h e m t o c o m pl et e it s e v e n t o 1 4 d a y s 
pri or t o a s c h e d ul e d o ut p ati e nt vi sit, a n d w a s t h e n a d mi ni st er e d a g ai n at t h e a ct u al 
vi sit. It i s u n cl e ar w h et h er p arti ci p a nt s r e c ei v e d a n y tr e at m e nt b et w e e n t h e t w o 
a s s e s s m e nt s.  
D e Witt e et al. ( 2 0 1 2)  pr o vi d e d t e st-r et e st r eli a bilit y d at a f or 8 3 p arti ci p a nt s; t h er e w a s 
n o s e p ar at e a n al y si s of t h e t hr e e p ati e nt s u b gr o u p s. T e st-r et e st r eli a bilit y w a s 
a s s e s s e d b y c al c ul ati n g t h e i ntr a cl a s s c orr el ati o n c o effi ci e nt (I C C). T h e S E M w a s 
c al c ul at e d b y t h e f oll o wi n g f or m ul a: S E M = S D x √ ( 1 - I C C) ( p. 1 6 1 3). T h e r e s ulti n g 
S E M  f or t h e t ot al W O R C w a s 6. 9. A s t hi s e sti m at e r e pr e s e nt e d a p er c e nt a g e s c or e of 
t h e W O R C, I tr a n sl at e d it i nt o t h e a b s ol ut e s c or e b y m ulti pl yi n g it b y 2 1, t h e r e s ult a nt 
s c or e b ei n g 1 4 4. 9. I u s e d t hi s v al u e a s t h e t y pi c al err or of t h e W O R C i n t h e r e s p o n d er 
a n al y si s.  
7. 3. 3. 2  R e s p o n d er a n al y si s 
Pr o b a biliti e s of b ei n g a r e s p o n d er 
T h e r e s ult of t h e a s si g n m e nt of t h e p arti ci p a nt s t o t h e diff er e nt l e v el s of pr o b a bilit y 
b a s e d o n t h eir i n di vi d u al pr o b a biliti e s ar e s h o w n i n T a bl e 7. 4 . A c o m pr e h e n si v e t a bl e 
s h o wi n g t h e i n di vi d u al W O R C _ c h a n g e A D J  v al u e s a n d pr o b a biliti e s f or all 6 5 p arti ci p a nt s 
c a n  b e vi e w e d i n A p p e n di x 7. 2 . T w e nt y-fi v e p arti ci p a nt s ( 3 8 %) h a d a pr o b a bilit y of  
≥  0. 7 5 of a b e n efi ci al o ut c o m e a n d w er e t h u s cl a s sifi e d a s r e s p o n d er s ( s e e s e cti o n 
7. 3. 2. 2  f or t h e r e s p o n d er d efi niti o n). T w el v e p arti ci p a nt s h a d a < 0. 1 0 pr o b a bilit y of a 
b e n efi ci al o ut c o m e. T h e d e s cri pti v e l e v el of pr o b a bilit y f or a h ar mf ul o ut c o m e w a s 
“ u nli k el y” f or ei g ht a n d “ p o s si bl y” f or f o ur ( s e e A p p e n di x 7. 2 ). 
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Table 7.4: Probabilities of a clinically beneficial outcome  
  (n = 65)  
Probability Qualitative description N % 
>0.99 almost certainly 8 12 
0.95-0.99 very likely to be 6 9 
0.75-0.95 likely to be 11 17 
0.25-0.75 possibly 22 34 
0.05-0.25 unlikely to be 10 15 
0.01-0.05 very unlikely to be 4 6 
<0.01 almost certainly not 4 6 
SD for individual responses across the sample 
The SDIR for the WORC_changeADJ was 273. 
CIs for the mean (sample) and individual WORC_change values 
The 95% CI for the sample WORC_changeADJ (x  = -363) was -448 to -279. The 95% 
CIs for the individual WORC_changeADJ values can be viewed in Appendix 7.2.  
7.3.4 DISCUSSION 
7.3.4.1 Comparison of different responder definitions 
As stated in the introduction to this chapter, the aim of conducting the responder 
analysis was to illustrate an approach to magnitude-based inferences that goes beyond 
the dichotomisation of outcome values based on the MID. By accounting for the 
probabilities of individuals’ outcomes based on the MID and also the typical error of the 
outcome measurement, this approach gains in rigor as well as real-world clinical 
relevance. This may be seen in Table 7.5, where it is compared against cruder, but still 
legitimate, methods to classify responders and non-responders. The availability of a 
purpose-designed spreadsheet makes the calculations straightforward and should 
facilitate uptake. Despite this, I am unaware of any published study in the 
musculoskeletal field in which the approach has been applied. It is important to 
consider the applied responder definition, in particular when outcomes of responder 
analyses are compared across studies.   
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Table 7.5: Summary of different approaches to the interpretation of the 
WORC_change 
Approach (n)  Responder definition Improved 
N % 
Any improvement in WORC (65)  Negative WORC_change score (WORC2 < WORC1) 55 85 
Improvement according to GPC (64) GPC rating of 
+1, +2 or +3 
55 86 
Improvement exceeding the typical 
error (65) 
WORC_change score 
exceeding -144.9  49 75 
Improvement exceeding the MID (65)  WORC_change score 
exceeding -300 39 60 
Improvement based on probabilities of 
beneficial outcome (65) 
 0.75 (likely, very likely or 
almost certainly beneficial) 25 38 
 
Considering that the responder analysis relates to the outcome of a single-group cohort 
study, it was not my intention to make a statement about the effectiveness of the 
intervention. A strong caveat is that the estimate of the typical error of the WORC was 
taken from a different study with limited comparability to my own study, including, in 
particular, a shorter follow-up. The magnitude of the variability of the WORC in an 
untreated cohort of patients with painful PTTs (matching the criteria of my study) over a 
period of three to four months is unknown, but is likely that it is larger than the value 
used.  
Furthermore, the disadvantages of dichotomising continuous variables (such as loss of 
information and power), which have been addressed in the context of the prognostic 
systematic review and the prognostic study, likewise apply to responder analyses and 
need to be borne in mind (Jevsevar et al. 2015, Snapinn & Jiang 2007).  
7.3.4.2 Balancing benefits against potential downsides or harms 
The responder definition which I suggested for this exploratory analysis was based on 
a  0.75 probability of a beneficial outcome. Thus, it did not further consider the 
probabilities of a harmful outcome. The presented levels of probabilities of harmful 
outcome for those participants who had a < 0.10 probability of a beneficial outcome 
provides evidence that the probability of a harmful outcome was very low in the 
sample. Without doubt, the response to an intervention needs to be viewed in the 
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context of potential downsides such as the costs or any inconveniences that may be 
associated with the intervention (Schünemann et al. 2006). As described in Chapter 4 
(section 4.3.3), apart from temporary exacerbations of symptoms, no known risks or 
serious side effects are reported in the literature on the physiotherapy treatment 
(manual therapy and exercises) of adults with painful rotator cuff disorders. The 
documentation of adverse events in my study showed that a small number of 
participants experienced temporary exacerbations of symptoms, but besides, no other 
adverse events were reported. This indicates that the treatment was overall tolerated 
well by the participants. Tear progression was another secondary outcome associated 
with the potential downsides of conservative treatment with physiotherapy. Again, 
though, the number of participants whose PTT progressed to an FTT over the 
observation period was very low. Whether the observed progression was related to the 
treatment or not is unclear. 
7.3.4.3 Conclusions  
The exploratory responder analysis presented in this part chapter illustrates a 
sophisticated, robust approach to magnitude-based inferences about outcomes based 
on the uncertainty in the true outcome value, which enables a realistic interpretation of 
responders to an intervention. Clinicians and researchers need to be aware that 
reported rates of responders often fall short of factoring in the typical error of the 
measurement and of considering the probabilities of being responders, and thus likely 
overestimate the rates of responders.  
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ONE 
1 General introduction, aims, 
content and structure of the 
thesis 
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topic 
2. To summarise the aims, content and 
structure of the thesis 
2 Background To provide the relevant topical and 
conceptual background to the programme 
of research 
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3 Prognostic models in adults 
undergoing physiotherapy for 
rotator cuff disorders - a 
systematic review 
To establish the state of evidence on 
prognostic models in adults 
undergoing physiotherapy for painful rotator 
cuff disorders 
4 Developing and validating the 
physiotherapy protocol for the 
prognostic study 
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effectiveness of physiotherapy 
interventions for adults with painful 
atraumatic PTTs  
2. To develop and validate the 
physiotherapy treatment protocol  
5 Selecting and defining the 
candidate prognostic factors 
for the prognostic study  
1. To identify and select the candidate 
factors for the prognostic model study 
2. To define the specific measures for the 
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6 Predicting the outcome of 
physiotherapy in adults with 
painful partial-thickness rotator 
cuff tears (PTTs) – a 
prognostic model study 
To develop a prognostic model for the 
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treatment with physiotherapy in adult 
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Minimal Important Difference 
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(WORC), the primary outcome of the 
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2. To apply the estimated MID to an 
exploratory responder analysis  
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8 Overall summary and 
conclusions 
1. To summarise the research 
2. To provide overall conclusions and 
consider implications 
FOUR  Appendices Appendices to Chapters 3-7 
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CHAPTER 8 
Overall summary and conclusions 
8.1 OVERALL SUMMARY OF THE RESEARCH  
The programme of research presented in this thesis was designed to explore the role 
of conservative treatment in the management of people with painful PTTs. The primary 
aim was to develop a prognostic model for the outcome of physiotherapy in adults with 
painful PTTs. This was addressed by a prospective prognostic model study (Chapter 
6), the need for which was underpinned by a systematic review of studies exploring 
prognostic models for predicting outcomes in adults undergoing conservative treatment 
with physiotherapy for rotator cuff disorders (Chapter 3). Five heterogeneous studies, 
of which none addressed a distinct population of PTTs, were included in this review. All 
of these studies were judged as at high risk of bias, and none of the analysed models 
was found to be usable in practice.  
The prognostic study was informed by the most current available methodological 
guidance on prognosis research (see Chapter 2), which helped to prevent various 
potential sources of bias. The physiotherapy treatment protocol for the study was 
based on two systematic reviews on the effectiveness of manual therapy and exercises 
for impingement-related shoulder pain (Chapter 4). These reviews, which included 
eight systematic reviews and 15 subsequent RCTs, showed that, while there was 
evidence that exercises with or without manual therapy are effective in improving 
clinical outcomes in these patients, it was not possible to conclude on the optimal 
treatment parameters such as the type and dose of manual therapy or exercises. In 
view of these findings, the physiotherapy protocol was kept broad. It was piloted and 
validated by several physiotherapists. 
The selection of 10 candidate prognostic factors for inclusion in the study followed a 
rigorous process by which I aimed to give preference to factors for which there was 
supporting evidence for their relevance to the study question (Chapter 5). Selection 
involved comprehensive searches of the literature and considered clinical evidence, 
expert consensus and peer consensus. The searches focussed on painful rotator cuff 
disorder populations, but evidence from general shoulder pain populations was also 
considered for systematic reviews and expert consensus studies. Inclusion was limited 
to factors elicited at the baseline assessment. Selection further considered the 
relevance of the factors to the study population, the properties of their available 
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measurements and their applicability/practicability in clinical practice. Twenty-three 
primary studies, a systematic review of prognostic studies and a study involving a 
Delphi (expert) consensus process were identified from the searches and informed the 
selection, providing overall limited guidance. The evidence base for most factors was 
very weak. The factors were very heterogeneous, as were the approaches used for 
their measurement. Age, disability and symptom duration were the only factors with 
reasonably consistent evidence of prognostic value pertaining to clinical outcomes of 
conservative treatment in patients with rotator cuff disorders. Thereby, the prognostic 
relevance of most of the candidate factors in my study was unclear. The 10 factors 
which I investigated were: age, sex, physical demands, disability, pain, history of 
shoulder pain, symptom duration, diabetes, smoking and pain catastrophizing.  
The prognostic model study was conducted within a secondary care setting in 
Hamburg, Germany. Following initial assessment by an orthopaedic medial specialist, 
participants were followed over a three-month period of physiotherapy, with or without 
adjunctive medical treatment. Follow-up was after three to four months. Sixty-five 
participants completed the study, and the data from 61 participants were included in 
the multivariable modelling analysis. Eight pre-defined candidate models were 
analysed by multivariable regression and by applying an information-theoretic 
approach (AICC). The resulting best models were: pain catastrophizing (PCS) and 
smoking, and disability (WORC_1ADJ) and pain catastrophizing (PCS). One further 
model was found to represent a plausible alternative: pain and pain catastrophizing 
(PCS). All models had a poor performance (as shown by their R2ADJ values) and 
precision (as shown by their SEE). As pain catastrophizing was part of all best models, 
it was analysed by a complementary univariable analysis, which showed a similar 
performance as the multivariable models. Given the low performance and precision of 
the analysed candidate models, any further analyses or internal validation were 
unjustified. The relatively small sample size precluded any informative subgroup 
analysis and implies that the study should be viewed as exploratory.  
Complementary to the prognostic study, I aimed to enhance interpretation of the 
observed WORC_change (i.e. primary outcome) scores by estimating the MID of the 
WORC. The estimate was determined through an anchor-based approach and using 
logistic regression. A GPC scale was used as the anchor. The estimated MID was -300 
(at the 90% level of probability). A caveat of the analysis was that the two categories 
(“improved”/”unimproved”) into which I dichotomised the GPC scale were unbalanced 
as most participants were in the “improved” category. 
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I applied the MID to a more sophisticated exploratory responder analysis based on the 
probabilities of the participants’ true WORC_changeADJ values being clinically 
beneficial, i.e. exceeding the (positive) MID in magnitude, given the typical error of the 
WORC. I determined an estimate of the typical error from the literature. Based on a 
responder definition of a  0.75 probability of having a beneficial outcome, 38% of the 
participants were responders. I contrasted this result with several other responder 
definitions. I further established several measures of variability to describe the 
uncertainty in the individual and sample true WORC_changeADJ scores. A caveat of the 
responder analysis was that the typical error of the WORC was obtained from a 
different study with a shorter follow-up.  
I acknowledged the importance of balancing beneficial outcomes against potential 
downsides or harms by attention to the secondary study outcomes. In terms of 
benefits, 86% of the participants rated their shoulder problem on the GPC scale as 
“improved”, and 58% rated it as either “much better” or “completely recovered”. In 
terms of harms, the incidence of tear progression (to an FTT) at follow-up was 4%, and 
physiotherapy-related adverse events, which were reported for 9% of the participants, 
were limited to temporary exacerbations of the shoulder symptoms. These findings 
provide some preliminary indication that conservative treatment with physiotherapy 
may be both beneficial and safe for most adults with painful PTTs, the caveat being 
that the findings relate to data from an uncontrolled cohort study, which means that 
they do not reflect the effectiveness of the provided treatment.  
8.2 OVERALL SUMMARY OF ORIGINAL CONTRIBUTIONS TO 
KNOWLEDGE 
The originality of the contribution to knowledge provided by the programme of research 
presented in this thesis is evidenced by the following key components, namely: 
 the first systematic review on prognostic models for predicting outcomes in adults 
undergoing conservative treatment with physiotherapy for painful rotator cuff 
disorders; 
 the first prognostic model study exploring prognostic models for the outcome of 
conservative treatment with physiotherapy in adults with painful PTTs; 
 the first analysis of an estimate of the MID of the WORC in a population of adults 
with painful PTTs; and 
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 the first application of a responder analysis based on the probabilities of a 
beneficial outcome beyond the MID given the typical error of the WORC in a 
population of adults with a painful shoulder disorder. 
These key components are complemented by the novel application of various 
methodological aspects as described in the individual reports. 
8.3 OVERALL CONCLUSIONS  
Traditionally, shoulder pain has been classified by clinical diagnosis for research (as in 
the present prognosis study) and clinical decision-making; but there have been 
criticisms of this model, clearly crystallised by Schellingerhout et al. (2008). They 
argued that the diagnostic labeling model was failed, largely because of non-uniform 
diagnostic criteria, and proposed a general “shoulder pain” label, which might 
eventually be sub-grouped according to prognosis. Superficially, my study, which was 
grounded in a specific diagnosis, may appear at odds with their proposals; but closer 
scrutiny reveals broad compatibility and common purpose. First, the diagnosis in my 
study was not merely a label, but true - due to the high specificity of diagnostic 
ultrasound for detecting PTTs, this diagnosis could confidently be ascribed to the whole 
sample. Second, though within a known sub-population rather than a general shoulder 
pain population, I expressly set out to investigate prognostic models that might 
ultimately help to inform useful clinical subgrouping. 
8.3.1 Implications for practice 
As yet, no clinically usable multivariable model of baseline factors is available for 
predicting the outcome of conservative treatment with physiotherapy in adults with 
painful PTTs (i.e. any type of painful rotator cuff disorder). Therefore, the prediction of 
the likely outcome of treatment in clinical practice remains difficult. The estimated MID 
of the WORC can be used to facilitate the interpretation of WORC outcome scores in 
contexts that are similar to that of my study. The responder analysis provides a means 
to enhance interpretation by considering the uncertainty in individuals’ true outcome 
values.  
CHAPTER 8 205 
 
 
 
8.3.2 Implications for research 
The lack of a clinically usable prognostic model for predicting the outcome of 
conservative treatment with physiotherapy in adults with painful PTTs (same as with 
any other type of rotator cuff disorder) highlights the need for further prognostic 
research. Larger studies are needed. The methodological deficiencies of primary 
prognostic model studies, as evidenced by the prognostic systematic review, point to 
the need for further methodologically sound (and adequately reported) studies. 
Prognosis research is an evolving field, and researchers should be receptive to the 
developing methods. A growing amount of guidance is available. Researchers need to 
be conscious of the fact that the provision of a clinically usable prognostic model 
requires a comprehensive programme of research involving development, (external) 
validation and assessment of clinical impact (Steyerberg et al. 2013). The 
methodological advances will hopefully also decrease the heterogeneity of methods 
which constitutes a considerable barrier to the comparability of studies and their 
findings, and thereby, to the construction of a homogenous body of evidence.  
Besides the need for methodological improvements, the selection of candidate factors 
for prognostic model studies remains an important research issue. Due to the 
demonstrated dearth of knowledge on relevant factors within the field of shoulder pain 
and rotator cuff disorders, the selection of candidate factors for inclusion in a 
prognostic model study remains difficult. The optimal method for selecting factors is yet 
unclear. Systematic reviews of prognostic factor studies may facilitate the identification 
of established or promising factors. The usefulness of systematic reviews, though, 
depends on the availability of a sufficient number of methodologically sound primary 
studies. In this context, while I did not evaluate the risk of bias of the prognostic factors 
studies which I used to inform the selection of factors for my study, prognostic factors 
studies have been claimed to be commonly affected by methodological deficiencies, 
which puts them at risk of bias, i.e. of providing invalid results (Riley et al. 2013). 
Beyond that, the evaluation of risk of bias of prognostic factors studies was until very 
recently difficult due to a lack of consensus on the assessment of risk of bias in 
prognostic studies (Hayden et al. 2006, Hayden et al. 2009). Both primary prognostic 
factor studies and systematic reviews of these studies are likely to benefit from the 
recently published instruments for the assessment of risk of bias in prognostic factor 
studies, such as the “Quality In Prognostic Studies” tool (QUIPS) (Hayden et al. 2013). 
This similarly applies to systematic reviews of prognostic model studies, for which 
PROBAST (Wolff et al. 2015) is likely to be publicly available soon. 
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The identification of putative prognostic factors may further be enhanced by consensus 
studies such as Delphi procedures, i.e. by considering different perspectives such as 
those of clinical experts, patients and researchers. Consensus is also needed on the 
definition and standardization of factors and their measurement to lay the foundations 
for the creation of a sufficiently homogeneous body of evidence. 
Further methodologically sound MID studies are needed to provide a range of 
estimates for use in populations of adults with painful PTTs. Further research is 
needed to establish the best methods of determining the MID. Researchers need to be 
aware that reported rates of responders to treatment are likely to vary depending on 
the responder definition used, and that a responder definition based on the 
probabilities that an individual’s true outcome value is clinically beneficial as defined by 
the MID and given the typical error of the outcome measure represents a more realistic 
approach to the interpretation of outcomes.  
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Appendix 3.3 
Filter for screening of titles and abstracts 
In the title or abstract:  
3) Key terms in the free text, and the context in which they are used, suggest that 
prognostic modelling may have been conducted.   
  
Examples of key terms include “prognosis”, “predictor”, “follow-up” and 
“correlation” among numerous others.  
4) It appears that the study may have been a longitudinal cohort study, an RCT or 
a quasi-RCT. 
5) It appears that the study may have evaluated impingement and or rotator cuff 
disease.  
6) It appears that the study evaluated a conservative intervention including 
physiotherapy. 
7) It appears that the study was, or may have been, prospective.  
Tend towards over-inclusivity in cases of uncertainty. 
Rate as: 
“yes” (includes “unsure”): retain record and obtain full text; or  
“no”: delete record. 
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Eligibility form for screening of full texts 
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Appendix 3.7 
PROBAST version 09/10/201417 
 
                                            
17
 The inclusion of this PROBAST version in the thesis appendices was approved by Dr Robert 
Wolff (personal communication, 17/12/2015). 
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Appendix 3.9 
Detailed results of PROBAST assessment 
See Appendix 3.8 for the PROBAST coding manual  
Abbreviations and symbols used in the table: 
Y = yes; PY = probably yes; N = no; NI = no information; N/A = not applicable; 
UNANSW = unanswerable (see coding manual);  = low risk/concerns;  = high 
risk/concerns (usability: not usable); ? = unclear risk/concerns  
PROBAST items & judgements Ratings 
(see above for 
explanations) 
Hallgren et al. 2014 
Domain 1: Participant selection 
1. Were appropriate data sources used, e.g. cohort, RCT or nested case-
control study data? 
Y 
2. Were all inclusions and exclusions of participants appropriate? Y 
3. Were participants enrolled at a similar state of health, or were predictors 
considered to account for differences? 
Y* 
Risk of bias judgement   
Justification of bias rating:  
*State of health is assumed to be similar: point of failed conservative treatment with referral 
for surgery (single study centre may be viewed as ensuring consistent approach in selecting 
participants for surgery) (even though duration of complaints (> 6 months as inclusion 
criterion) was not considered as a predictor). 
Applicability judgement  
Justification of applicability rating: -- 
Domain 2: Predictors 
1. Were predictors defined and assessed in a similar way for all 
participants? 
Y 
2. Were predictor assessments blinded to outcome data? Y 
3. Are all predictors available at the time the model is intended to be 
used? 
Y 
4. Were all relevant predictors analysed? UNANSW. 
Risk of bias judgement   
Justification of bias rating: -- 
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PROBAST items & judgements Ratings 
(see above for 
explanations) 
Applicability judgement  
Justification of applicability rating: -- 
Domain 3: Outcome 
1. Was a pre-specified outcome definition used? Y 
2. Were predictors excluded from the outcome definition? Y 
3. Was the outcome defined and determined in a similar way for all 
participants? 
Y 
4. Was the outcome determined blind to predictor information? Y 
5. Were all pre-specified outcomes determined and analysed? Y 
Risk of bias judgement   
Justification of bias rating: -- 
Applicability judgement  
Justification of applicability rating: -- 
Domain 4: Sample size and participant flow 
1. Was the number of outcome events per studied predictor reasonable? N† 
2. Was the time interval between predictor assessment and outcome 
determination appropriate? 
Y 
3. Were all enrolled participants included in the analysis? Y‡ 
4. Were participants with missing data handled appropriately? NI 
Risk of bias judgement   
Justification of bias rating: 
†Number of events/predictors: 41 outcome events (having sugery); appropriateness of the 
ratio between outcome events and predictors depending on the models, but the model with 
the largest predictive performance had nine predictor variables: 9 x 5 = 45, so the minimum 
threshold was not met for this model. 
‡Data sheet: 93-97 cases, study report: 95; all fit the defined threshold, though. 
Domain 5: Analysis 
1. If categorisation of predictors was used, was it pre-specified or justified? Y 
2. Was selection of predictors based on univariable analysis avoided? Y 
3. Was optimism in the model performance accounted for, e.g. using 
bootstrapping or shrinkage techniques? 
NI 
4. Were complications in the data (e.g. competing risks, multiple events 
per individual) accounted for appropriately? 
NI 
5. Do predictors and their assigned weights in the final model correspond 
to the results from multivariable analysis? 
N/A 
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PROBAST items & judgements Ratings 
(see above for 
explanations) 
6. Were the relevant model performance measures (e.g. calibration, 
discrimination, (re-) classification, net benefit) of the model (or any 
simplified score) evaluated? 
NI 
7. Were non-linear associations between predictors and the outcome 
considered and handled appropriately? 
NI 
8. Was the model recalibrated or was it stated that recalibration was not 
needed? 
 
Risk of bias judgement ? 
Justification of bias rating: -- 
Overall judgments 
Risk of bias   
Applicability   
Usability  
Hung et al. 2010 
Domain 1: Participant selection 
1. Were appropriate data sources used, e.g. cohort, RCT or nested case-
control study data? 
Y 
2. Were all inclusions and exclusions of participants appropriate? PY 
3. Were participants enrolled at a similar state of health, or were predictors 
considered to account for differences? 
PY§ 
Risk of bias judgement   
Justification of bias rating: 
§With respect to the selection process (see above), and due to lack of (further) information, it 
seems not completely clear whether the participants were enrolled at a similar state of health, 
but they probably were, and baseline functional state as well as the duration of symptoms are 
presented and were (at least initially) considered as predictors. 
Applicability judgement ? 
Justification of applicability rating: 
 “SIS diagnosis”, but partly unclear (partly lack of details on the actual population, but also on 
lack of details with eligibility criteria): exclusion of participants with capsulitis-type disorders 
(and other exclusion criteria such as cervical spine involvement, signs of bony degeneration)? 
Traumatic cases (unlikely)? Acute inflammation? To be considered: rather young population, 
males only, i.e. limited representativeness. 
Domain 2: Predictors 
1. Were predictors defined and assessed in a similar way for all 
participants? 
NI 
2. Were predictor assessments blinded to outcome data? Y 
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PROBAST items & judgements Ratings 
(see above for 
explanations) 
3. Are all predictors available at the time the model is intended to be 
used? 
Y 
4. Were all relevant predictors analysed? UNANSW. 
Risk of bias judgement  ? 
Justification of bias rating: -- 
Applicability judgement  
Justification of applicability rating: 
 Two predictors, one of which was included in the final model, were not defined. Some 
concerns about the definition, psychometric properties and (types of) assessments of some of 
predictors: Limited reproducibility due to partly insufficient specification; doubts specifically 
about the validity of some of the measurements (e.g. scapular assessments); use of “special 
equipment” (e.g. FASTREK system) that usually cannot be expected to be available or 
accessible clearly limits applicability in “everyday clinical practice”. 
Domain 3: Outcome 
1. Was a pre-specified outcome definition used? Y 
2. Were predictors excluded from the outcome definition? Y 
3. Was the outcome defined and determined in a similar way for all 
participants? 
Y 
4. Was the outcome determined blind to predictor information? N|| 
5. Were all pre-specified outcomes determined and analysed? Y 
Risk of bias judgement   
Justification of bias rating: 
||Asks for perception of change (from baseline to follow-up). “An independent trained 
measurer blinded to treatment assessed the outcomes”, but it is unclear whether the 
assessor was blinded to predictor information. Also unclear are the specific scapular 
kinematic conditions evaluated: these are not comprehensively listed. 
Applicability judgement ? 
Justification of applicability rating:  
Main critique: dichotomisation of outcome with arbitrary cut-off between “improvement” and 
“non-improvement” tends to potentially limit applicability. 
Domain 4: Sample size and participant flow 
1. Was the number of outcome events per studied predictor reasonable? Y# 
2. Was the time interval between predictor assessment and outcome 
determination appropriate? 
Y 
3. Were all enrolled participants included in the analysis? Y 
4. Were participants with missing data handled appropriately? NI 
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PROBAST items & judgements Ratings 
(see above for 
explanations) 
Risk of bias judgement  ? 
Justification of bias rating:  
#See coding manual: in relation to final model. 
Domain 5: Analysis 
1. If categorisation of predictors was used, was it pre-specified or justified? N** 
2. Was selection of predictors based on univariable analysis avoided? N 
3. Was optimism in the model performance accounted for, e.g. using 
bootstrapping or shrinkage techniques? 
NI 
4. Were complications in the data (e.g. competing risks, multiple events 
per individual) accounted for appropriately? 
NI 
5. Do predictors and their assigned weights in the final model correspond 
to the results from multivariable analysis? 
N/A 
6. Were the relevant model performance measures (e.g. calibration, 
discrimination, (re-)classification, net benefit) of the model (or any 
simplified score) evaluated? 
NI 
7. Were non-linear associations between predictors and the outcome 
considered and handled appropriately? 
NI 
8. Was the model recalibrated or was it stated that recalibration was not 
needed? 
 
Risk of bias judgement  
Justification of bias rating: 
**Effectively not. While the method for dichotomising the predictors was pre-specified, this 
was data-driven.  
Overall judgments 
Risk of bias   
Applicability   
Usability  
Kromer et al. 2014 
Domain 1: Participant selection 
1. Were appropriate data sources used, e.g. cohort, RCT or nested case-
control study data? 
Y 
2. Were all inclusions and exclusions of participants appropriate? Y 
3. Were participants enrolled at a similar state of health, or were predictors 
considered to account for differences? 
PY†† 
Risk of bias judgement   
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PROBAST items & judgements Ratings 
(see above for 
explanations) 
Justification of bias rating:  
††Patients referred by general practitioners and those referred by orthopaedic surgeons may 
be at a different stage of disease. However, predictors were included which accounted for 
this. (Also, consider “German pathways”, which allow for both ways: seeing a GP and seeing 
a specialist from the outset). 
Applicability judgement  
Justification of applicability rating:  
The exclusion criterion > 1/3 restriction of elevation versus the unaffected shoulder lacks 
sufficient definition: the exclusion of frozen shoulder as diagnosis + the baseline data as 
provided in the 2013 report p.491, though, suggest that the criteria matched the review 
question/criteria. 
Domain 2: Predictors 
1. Were predictors defined and assessed in a similar way for all 
participants? 
Y 
2. Were predictor assessments blinded to outcome data? Y 
3. Are all predictors available at the time the model is intended to be 
used? 
Y 
4. Were all relevant predictors analysed? UNANSW. 
Risk of bias judgement   
Justification of bias rating: -- 
Applicability judgement  
Justification of applicability rating: -- 
Domain 3: Outcome 
1. Was a pre-specified outcome definition used? Y 
2. Were predictors excluded from the outcome definition? N‡‡ 
3. Was the outcome defined and determined in a similar way for all 
participants? 
Y 
4. Was the outcome determined blind to predictor information? PY 
5. Were all pre-specified outcomes determined and analysed? Y 
Risk of bias judgement   
Justification of bias rating: 
‡‡Incorporation bias/mathematical coupling/RTM, which was not accounted for at the analysis 
stage  
Applicability judgement  
Justification of applicability rating: -- 
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PROBAST items & judgements Ratings 
(see above for 
explanations) 
Domain 4: Sample size and participant flow 
1. Was the number of outcome events per studied predictor reasonable? Y 
2. Was the time interval between predictor assessment and outcome 
determination appropriate? 
Y 
3. Were all enrolled participants included in the analysis? Y 
4. Were participants with missing data handled appropriately? NI 
Risk of bias judgement  ? 
Justification of bias rating: --  
Domain 5: Analysis 
1. If categorisation of predictors was used, was it pre-specified or justified? Y 
2. Was selection of predictors based on univariable analysis avoided? N 
3. Was optimism in the model performance accounted for, e.g. using 
bootstrapping or shrinkage techniques? 
NI 
4. Were complications in the data (e.g. competing risks, multiple events 
per individual) accounted for appropriately? 
NI 
5. Do predictors and their assigned weights in the final model correspond 
to the results from multivariable analysis? 
N/A 
6. Were the relevant model performance measures (e.g. calibration, 
discrimination, (re-)classification, net benefit) of the model (or any 
simplified score) evaluated? 
NI 
7. Were non-linear associations between predictors and the outcome 
considered and handled appropriately? 
NI 
8. Was the model recalibrated or was it stated that recalibration was not 
needed? 
 
Risk of bias judgement  
Justification of bias rating: -- 
Overall judgments 
Risk of bias   
Applicability   
Usability  
Merolla et al. 2011 
Domain 1: Participant selection 
1. Were appropriate data sources used, e.g. cohort, RCT or nested case-
control study data? 
Y 
2. Were all inclusions and exclusions of participants appropriate? NI§§ 
Appendix 3.9 266 
 
 
 
PROBAST items & judgements Ratings 
(see above for 
explanations) 
3. Were participants enrolled at a similar state of health, or were predictors 
considered to account for differences? 
NI|||| 
Risk of bias judgement:  ? 
Justification of bias rating: 
§§Insufficient information on recruitment and inclusion process (+ discrepancy between 
eligibility criteria and some predictors);  
||||insufficient information, e.g. no information on duration of complaints (baseline assessment 
and predictors) 
Applicability judgement ? 
Justification of applicability rating:  
Unclear due to lack of details about the actual sample characteristics. 
Domain 2: Predictors 
1. Were predictors defined and assessed in a similar way for all 
participants? 
NI## 
2. Were predictor assessments blinded to outcome data? Y 
3. Are all predictors available at the time the model is intended to be 
used? 
Y 
4. Were all relevant predictors analysed?  
Risk of bias judgement  ? 
Justification of bias rating: 
##Lack of operational definitions 
Applicability judgement  
Justification of applicability rating:  
Overall very poor definitions of predictors and measurements. 
Domain 3: Outcome 
1. Was a pre-specified outcome definition used? N*** 
2. Were predictors excluded from the outcome definition? PN††† 
3. Was the outcome defined and determined in a similar way for all 
participants? 
NI 
4. Was the outcome determined blind to predictor information? NI‡‡‡ 
5. Were all pre-specified outcomes determined and analysed? NI‡‡‡ 
Risk of bias judgement   
Justification of bias rating: 
***No, as the outcome of interest is unclear (see those listet + surgery yes/no + quality of life 
mentioned somewhere in the text);  
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PROBAST items & judgements Ratings 
(see above for 
explanations) 
†††CM was used as one outcome (?), which includes (active) ROM, which was a predictor. As 
it is unclear what outcome(s) were assessed, though, we rated this as PN.  
‡‡‡Rated as NI due to lack of information/clarity about assessed outcomes…; see PROBAST 
coding manual. Not all outcomes are mentioned in the analysis and results section: unclear 
and confusing report… 
Applicability judgement ? 
Justification of applicability rating: Unclear due to poor reporting. 
Domain 4: Sample size and participant flow 
1. Was the number of outcome events per studied predictor reasonable? PN$$$ 
2. Was the time interval between predictor assessment and outcome 
determination appropriate? 
NI 
3. Were all enrolled participants included in the analysis? PY 
4. Were participants with missing data handled appropriately? NI 
Risk of bias judgement   
Justification of bias rating: 
 
$$$See coding manual. 17 predictors (plus dummy variables!). 
Domain 5: Analysis 
1. If categorisation of predictors was used, was it pre-specified or justified? Y 
2. Was selection of predictors based on univariable analysis avoided?  
3. Was optimism in the model performance accounted for, e.g. using 
bootstrapping or shrinkage techniques? 
 
4. Were complications in the data (e.g. competing risks, multiple events 
per individual) accounted for appropriately? 
NI 
5. Do predictors and their assigned weights in the final model correspond 
to the results from multivariable analysis? 
 
6. Were the relevant model performance measures (e.g. calibration, 
discrimination, (re-)classification, net benefit) of the model (or any 
simplified score) evaluated? 
NI 
7. Were non-linear associations between predictors and the outcome 
considered and handled appropriately? 
NI 
8. Was the model recalibrated or was it stated that recalibration was not 
needed? 
NI 
Risk of bias judgement ? 
Justification of bias rating:  
Overall: Fair and in line with coding manual to give an “unclear” (?) rating – due to the 
inappropriate presentation and results it could have been rated as high risk, too… 
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PROBAST items & judgements Ratings 
(see above for 
explanations) 
Overall judgments 
Risk of bias   
Applicability   
Usability  
Taheriazam et al. 2005 
Domain 1: Participant selection 
1. Were appropriate data sources used, e.g. cohort, RCT or nested case-
control study data? 
Y 
2. Were all inclusions and exclusions of participants appropriate? PY|||||| 
3. Were participants enrolled at a similar state of health, or were predictors 
considered to account for differences? 
PY|||||| 
Risk of bias judgement   
Justification of bias rating: 
||||||See study report (p. 3/6 table 1): 18/89 participants were found to have either moderately 
impaired (n = 12) or severely impaired (n = 6) active ROM. Seems a bit unclear, thus the PY 
ratings. 
Applicability judgement ? 
Justification of applicability rating: see justification of bias rating 
Domain 2: Predictors 
1. Were predictors defined and assessed in a similar way for all 
participants? 
PY### 
2. Were predictor assessments blinded to outcome data? Y 
3. Are all predictors available at the time the model is intended to be 
used? 
Y 
4. Were all relevant predictors analysed? UNANSW. 
Risk of bias judgement   
Justification of bias rating: 
###Some uncertainty about ROM measurement (lack of details on measurement) as well as 
few information on some other predictors; seems though, that probably, predictors were 
defined and assessed in a similar way, i.e. we agreed to give a PY. 
Applicability judgement ? 
Justification of applicability rating: 
Some concerns regarding insufficient definition of some of the predictors. Seems fair, though, 
to give an intermediate rating = unclear, as for the majority of predictors, these concerns 
appear not to apply (see predictors). 
Domain 3: Outcome 
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PROBAST items & judgements Ratings 
(see above for 
explanations) 
1. Was a pre-specified outcome definition used? Y 
2. Were predictors excluded from the outcome definition? N**** 
3. Was the outcome defined and determined in a similar way for all 
participants? 
Y 
4. Was the outcome determined blind to predictor information? PY 
5. Were all pre-specified outcomes determined and analysed? Y 
Risk of bias judgement:   
Justification of bias rating:  
****Incorporation bias/mathematical coupling/RTM, which was not accounted for at the 
analysis stage 
Applicability judgement  
Justification of applicability rating: -- 
Domain 4: Sample size and participant flow 
1. Was the number of outcome events per studied predictor reasonable? Y 
2. Was the time interval between predictor assessment and outcome 
determination appropriate? 
Y 
3. Were all enrolled participants included in the analysis? Y 
4. Were participants with missing data handled appropriately? NI 
Risk of bias judgement  ? 
Justification of bias rating: -- 
Domain 5: Analysis 
1. If categorisation of predictors was used, was it pre-specified or justified? Y 
2. Was selection of predictors based on univariable analysis avoided? Y 
3. Was optimism in the model performance accounted for, e.g. using 
bootstrapping or shrinkage techniques? 
NI 
4. Were complications in the data (e.g. competing risks, multiple events 
per individual) accounted for appropriately? 
NI 
5. Do predictors and their assigned weights in the final model correspond 
to the results from multivariable analysis? 
N/A 
6. Were the relevant model performance measures (e.g. calibration, 
discrimination, (re-)classification, net benefit) of the model (or any 
simplified score) evaluated? 
NI 
7. Were non-linear associations between predictors and the outcome 
considered and handled appropriately? 
Y 
8. Was the model recalibrated or was it stated that recalibration was not  
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PROBAST items & judgements Ratings 
(see above for 
explanations) 
needed? 
Risk of bias judgement ? 
Justification of bias rating: -- 
Overall judgments 
Risk of bias   
Applicability  ? 
Usability  
Key: Y = yes; PY = probably yes; N = no; NI = no information; N/A = not applicable; UNANSW = 
unanswerable (see coding manual);  = low risk/concerns;  = high risk/concerns (usability: 
not usable); ? = unclear risk/concerns 
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Appendix 4.1 
Braun et al. 2013 
Due to copyright issues, this thesis version does not include appendices 3.1 and 4.1. 
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Appendix 4.2 
Physiotherapy report form 
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Appendix 5.1 
Primary search strategy for identification of factors 
Search ID Search terms* 
#1 rotator cuff (MeSH) OR (shoulder AND cuff) OR supraspinatus OR 
infraspinatus OR teres minor OR subscapularis 
#2 (tear OR defect OR impairment OR degeneration OR injury) 
#3 partial OR partial-thickness OR incomplete OR bursal side* OR bursal-side* 
OR joint side* OR joint-side* OR intratend* 
#4 conservative treatment OR non-operative treatment OR non-surgical 
treatment OR physiotherapy* OR physical therap* OR rehabil* 
#5 predict* OR determin* OR prognos*    
and PubMed ‘Clinical Queries’: ‘Clinical Study Category: Prognosis’ filter 
Example  
combinations 
(#1 and (#2 or #3)) and #4 and #5; #1 and #4 and #5; #1 and #5 
 
*The search terms were used in all possible permutations. The searches were 
supplemented by “related articles” searches and hand searches of reference lists.  
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Appendix 5.2 
Primary study reports and other articles used to 
identify prognostic factors 
Articles are listed by type - primary (clinical) study, systematic review, expert 
consensus. The references are also provided in the chapter reference list. 
No Study ID*  Reference 
Primary study 
1 Bartolozzi 1994 Bartolozzi A., Andreychik D., Ahmad S. (1994). Determinants of 
outcome in the treatment of rotator cuff disease. Clin Orthop Relat 
Res, (308), 90-7.  
2 Chard 1988 Chard M. D., Sattelle L. M., Hazleman B. L. (1988). The long-term 
outcome of rotator cuff tendinitis--a review study. Br J Rheumatol, 
27(5), 385-9.  
3 Conroy 1998 Conroy D. E., Hayes K. W. (1998). The effect of joint mobilization 
as a component of comprehensive treatment for primary shoulder 
impingement syndrome. J Orthop Sports Phys Ther, 28(1), 3-14. 
doi:10.2519/jospt.1998.28.1.3. 
4 Cummins 2009 Cummins C. A., Sasso L. M., Nicholson D. (2009). Impingement 
syndrome: Temporal outcomes of nonoperative treatment. J 
Shoulder Elb Surg, 18(2), 172-7. doi:10.1016/j.jse.2008.09.005. 
5 Ekeberg 2010 Ekeberg O. M., Bautz-Holter E., Juel N. G., Engebretsen K., 
Kvalheim S., Brox J. I. (2010). Clinical, socio-demographic and 
radiological predictors of short-term outcome in rotator cuff 
disease. BMC Musculoskelet Disord, 11(1), 239. doi:10.1186/1471-
2474-11-239. 
6 Engebretsen 
2010 
Engebretsen K., Grotle M., Bautz-Holter E., Ekeberg O. M., Brox J. 
I. (2010). Predictors of shoulder pain and disability index (SPADI) 
and work status after 1 year in patients with subacromial shoulder 
pain. BMC Musculoskelet Disord, 11, 218. doi:10.1186/1471-2474-
11-218. 
7 Hardy 1986 Hardy D. C., Vogler J. B., White R. H. (1986). The shoulder 
impingement syndrome: prevalence of radiographic findings and 
correlation with response to therapy. AJR Am J Roentgenol, 
147(3), 557-61. doi:10.2214/ajr.147.3.557. 
8 Hawkins 1995 Hawkins R. H., Dunlop R. (1995). Nonoperative treatment of rotator 
cuff tears. Clin Orthop Relat Res, (321), 178-88.  
9 Hung 2010 Hung C.-J., Jan M.-H., Lin Y.-F., Wang T.-Q., Lin J.-J. (2010). 
Scapular kinematics and impairment features for classifying 
patients with subacromial impingement syndrome. Man Ther, 
15(6), 547-51. doi:10.1016/j.math.2010.06.003. 
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No Study ID*  Reference 
10 Itoi 1992 Itoi E., Tabata S. (1992). Conservative treatment of rotator cuff 
tears. Clin Orthop Relat Res, (275), 165-73.  
11 Kennedy 2006a Kennedy C. A., Haines T., Beaton D. E. (2006). Eight predictive 
factors associated with response patterns during physiotherapy for 
soft tissue shoulder disorders were identified. J. Clin. Epidemiol., 
59(5), 485–96. doi:10.1016/j.jclinepi.2005.09.003. 
12 Kennedy 2006b Kennedy C. A., Manno M., Hogg-Johnson S., Haines T., Hurley L., 
McKenzie D., Beaton D. E. (2006). Prognosis in soft tissue 
disorders of the shoulder: predicting both change in disability and 
level of disability after treatment. Phys. Ther., 86(7), 1013–1032; 
discussion 1033–1037.  
13 Maman 2009 Maman E., Harris C., White L., Tomlinson G., Shashank M., 
Boynton E. (2009). Outcome of nonoperative treatment of 
symptomatic rotator cuff tears monitored by magnetic resonance 
imaging. J Bone Joint Surg Am, 91(8), 1898-906. 
doi:10.2106/JBJS.G.01335. 
14 Morrison 1997 Morrison D. S., Frogameni  a D., Woodworth P. (1997). Non-
operative treatment of subacromial impingement syndrome. J Bone 
Joint Surg Am, 79(5), 732-7.  
15 Safran 2011 Safran O., Schroeder J., Bloom R., Weil Y., Milgrom C. (2011). 
Natural history of nonoperatively treated symptomatic rotator cuff 
tears in patients 60 years old or younger. Am J Sports Med, 39(4), 
710-4. doi:10.1177/0363546510393944. 
16 Selvanetti 1998 Selvanetti A., Giombini A., Caruso I. (1998). Nonoperative 
treatment of partial-thickness rotator cuff tears in overhead 
athletes. Med Sci Sports Exerc, 30(5), S260. 
17 Taheriazam 
2005 
Taheriazam A., Sadatsafavi M., Moayyeri A. (2005). Outcome 
predictors in nonoperative management of newly diagnosed 
subacromial impingement syndrome: a longitudinal study. 
MedGenMed, 7(1), 63.  
18 Tanaka 2010 Tanaka M., Itoi E., Sato K., Hamada J., Hitachi S., Tojo Y., Honda 
M., Tabata S. (2010). Factors related to successful outcome of 
conservative treatment for rotator cuff tears. Ups J Med Sci, 
115(3), 193-200. doi:10.3109/03009734.2010.493246. 
19 Vad 2002 Vad V. B., Warren R. F., Altchek D. W., O’Brien S. J., Rose H. A., 
Wickiewicz T. L. (2002). Negative prognostic factors in managing 
massive rotator cuff tears. Clin J Sport Med, 12(3), 151-7.  
20 Virta 2009 Virta L., Mortensen M., Eriksson R., Möller M. (2009). How many 
patients with subacromial impingement syndrome recover with 
physiotherapy? A follow-up study of a supervised exercise 
programme. Adv Physiother, 11(3), 166-73. 
doi:10.1080/14038190802460481. 
21 Wang 2000 Wang J. C., Horner G., Brown E. D., Shapiro M. S. (2000). The 
relationship between acromial morphology and conservative 
treatment of patients with impingement syndrome. Orthopedics, 
23(6), 557–559.  
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No Study ID*  Reference 
22 Wu 2003 Wu H. P., Dubinsky T. J., Richardson M. L. (2003). Association of 
shoulder sonographic findings with subsequent surgical treatment 
for rotator cuff injury. J Ultrasound Med, 22(2), 155-61.  
23 Yamanaka 1994 Yamanaka K., Matsumoto T. (1994). The joint side 
tear of the rotator cuff. A followup study by 
arthrography. Clin Orthop Relat Res, (304), 68–73.  
Systematic review 
24 Kuijpers 2004 Kuijpers T., van Der Windt D. A. W. M., van Der Heijden G. J. M. 
G., Bouter L. M. (2004). Systematic review of prognostic cohort 
studies on shoulder disorders. Pain, 109(3), 420-31. 
doi:10.1016/j.pain.2004.02.017. 
Expert consensus 
25 Vergouw 2011 Vergouw D., Heymans M. W., de Vet H. C., van der Windt D. A., 
van der Horst H. E. (2011). Prediction of persistent shoulder pain in 
general practice: Comparing clinical consensus from a Delphi 
procedure with a statistical scoring system. BMC Fam Pract, 12(1), 
63. doi:10.1186/1471-2296-12-63. 
* First author, year 
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Appendix 5.3 
Excluded factors (selection stage 2) with reasons 
Articles are listed in the same order (and using the same numbers) as in Table 5.1.  
1 Factor Main criterion not met by factor and main reason 
for exclusion 
Factors related to history of symptoms/shoulder pain 
11 Aetiology of symptoms (history 
of trauma to the shoulder, type 
of rotator cuff disease and 
overuse) 
Relevance to study   
Considered as largely irrelevant to my study, as 
inclusion was restricted to PTTs, i.e. a specific type 
of rotator cuff disease, and as trauma-related tears 
were an exclusion criterion.  
Factors from physical examination 
14 Impingement sign 
(presence/absence) 
Relevance to study   
This was among the clinical signs as part of the 
diagnostic criteria. 
15 Muscle strength (serratus 
anterior; abduction; rotation) 
Applicability/practicability   
Valid measurement would have required equipment 
that was not available to Dr Betthäuser in his 
practice (and that is normally not available in the 
standard practice setting). 
16 Range of motion (active: 
abduction, external rotation; 
passive) 
Relevance to study   
Not considered a relevant issue to the study 
population. Also, significant restriction of range of 
movement was an exclusion criterion. 
17 Scapular kinematics: internal 
rotation 
Applicability/practicability   
Valid measurement would have required specialist 
equipment that was not available to Dr Betthäuser in 
his practice (and that is normally not available in the 
standard practice setting). 
Factors related to comorbidities and (self-reported) health status  
19 Glenohumeral arthritis Relevance to study   
Glenohumeral arthritis was an exclusion criterion.  
21 Multisite pain Relevance to study   
Multisite pain was an exclusion criterion. 
Psychological factors 
23 Fear-avoidance beliefs Measurement properties   
Non-availability of an appropriate validated German 
questionnaire.  
Structural factors (shoulder) 
26 Acromion type/morphology Applicability/practicability   
Assessment requires special X-ray images that are 
not part of standard practice within German statutory 
healthcare. 
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1 Factor Main criterion not met by factor and main reason 
for exclusion 
27 Humeral head migration Measurement properties   
Concerns about validity of ultrasound measurement 
(insufficient evidence); other imaging techniques are 
not part of standard practice within German statutory 
healthcare.  
28 Osseous abnormalities (not 
further specified)  
Relevance to study   
Clinically relevant glenohumeral degeneration or 
disease was an exclusion criterion. 
Rotator cuff specific factors 
29 Fatty infiltration  Relevance to study   
Relates mainly to (large) FTTs 
30 Muscle atrophy Relevance to study   
Relates mainly to (large) FTTs  
31 Tear size (extent) Measurement properties  
Concerns about validity of measurement of tear size 
by ultrasound 
32 Type of rotator cuff pathology 
or tear; tendon integrity 
Relevance to study   
Inclusion into the study was restricted to patients 
with PTTs. 
Interventional factors 
33 Corticosteroid injections 
(response to initial injection; 
previous) 
Applicability/practicability   
Response to initial injection requires all participants 
to have an injection; this does not comply with 
standard practice within German statutory 
healthcare. 
Validity and reliability of measurement   
Asking about previous injections was considered 
difficult (participants can’t be expected to know what 
type of injections they have received). 
34 Medication (regular 
medication; over-the-counter 
medication) 
Relevance to study   
Dr Betthäuser’s patients (with PTTs) usually do not 
take any oral pain medication. 
Economical factors 
35 Insurance (worker’s 
compensation) claims 
Relevance to study   
Dr Betthäuser considered this not to be of any 
relevance for the study population. 
36 Sick leave Relevance to study   
The patients presenting to Dr Betthäuser are usually 
not on sick leave. 
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Appendix 5.4 
Shoulder PROMs 
PROMs are ordered by type of questionnaire. The full references are provided in the 
chapter reference list. 
No PROM Abbreviation Article ID* 
General 
Upper extremity-related 
1 Disabilities of the Arm, 
Hand and Shoulder 
Questionnaire  
DASH  
(& Quick-DASH) 
Bot 2004, Desai 2010, Kirkley 2003, 
Michener 2001, Roy & Esculier 
2011, Roy 2009, Wright 2010 
2 Upper Extremity Functional 
Index (Scale) 
UEFI (UEFS) Bot 2004, Michener 2001, Roy 2011 
3 Upper Extremity Functional 
Limitation Scale 
UEFL Bot 2004, Roy 2011 
4 Upper Limb Functional 
Index 
ULFI Roy 2011 
Shoulder-related 
5 American Shoulder and 
Elbow Surgeons Shoulder 
Score 
ASES Bot 2004, Habermeyer 2006, Kirkley 
2003, Michener 2001, Oh 2009, Roy 
2011, Roy 2009, Wright 2010 
6 Constant (Shoulder) Score  Habermeyer 2006, Michener 2001, 
Oh 2009, Wright 2010 
7 Oxford Shoulder Score OSS Desai 2010, Ekeberg 2008, 
Habermeyer 2006, Kirkley 2003, 
Roy 2011 
8 Penn Shoulder Score PSS Michener 2001, Roy 2011 
9 Shoulder Activity Level  Wright 2010 
10 Shoulder Disability 
Questionnaire 
SDQ Bot 2004, Desai 2010, Michener 
2001 
11 Shoulder Rating 
Questionnaire 
SRQ Bot 2004, Desai 2010, Habermeyer 
2006, Kirkley 2003, Roy 2011 
12 Shoulder Severity Index SSI Bot 2004, Michener 2001 
13 Simple Shoulder Test SST Bot 2004, Habermeyer 2006, 
Michener 2001, Oh 2009, Roy 2011, 
Roy 2009 
14 Shoulder Pain and 
Disability Index 
SPADI Bot 2004, Desai 2010, Ekeberg 
2008, Habermeyer 2006, Michener 
2001, Roy 2011, Roy 2009 
15 Single Assessment SANE Wright 2010 
Appendix 5.4 280 
 
 
 
No PROM Abbreviation Article ID* 
Numeric Evaluation 
16 Subjective Shoulder Rating 
System 
SSRS Michener 2001 
17 University of California at 
Los Angeles Shoulder 
Score 
UCLA Habermeyer 2006, Kirkley 2003, Oh 
2009 
Specific  
Disease-specific 
18 Rating Scale for Bankart 
Repair 
ROWE Habermeyer 2006, Kirkley 2003, Oh 
2009 
19 Rotator Cuff Quality of Life 
Index 
R-QOL Bot 2004, Habermeyer 2006, Kirkley 
2003, Razmjou 2006, Roy 2011, 
Wright 2010 
20 Western Ontario 
Osteoarthritis Shoulder 
Index 
WOOS Bot 2004, Habermeyer 2006, Kirkley 
2003, Roy 2011, Wright 2010 
21 Western Ontario Rotator 
Cuff Index 
WORC Ekeberg 2008, Habermeyer 2006, 
Kirkley 2003, Razmjou 2006, Roy 
2011, Wright 2010 
Condition-specific 
22 Melbourne Shoulder 
Instability Scale 
MISS Roy 2011 
23 Oxford Shoulder Instability 
Score 
 Habermeyer 2006 
24 Shoulder Instability 
Questionnaire 
SIQ Bot 2004, Roy 2011 
25 Walch-Duplay Score for 
instability of the shoulder 
 Habermeyer 2006 
26 Western Ontario Shoulder 
Instability Index 
WOSI Bot 2004, Habermeyer 2006, Kirkley 
2003, Oh 2009, Roy 2011, Wright 
2010 
* First author, year 
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Appendix 5.5 
Western Ontario Rotator Cuff Index (WORC) 
 
Appendix 5.5 282 
 
 
 
Appendix 5.5 283 
 
 
 
Appendix 5.5 284 
 
 
 
Appendix 5.5 285 
 
 
 
Appendix 5.5 286 
 
 
 
Appendix 5.5 287 
 
 
 
Appendix 5.5 288 
 
 
 
Appendix 5.5 289 
 
 
 
Appendix 5.6 290 
 
 
 
Appendix 5.6 
Pain Catastrophizing Scale (PCS)18 
 
                                            
18
 Retrieved from: http://sullivan-painresearch.mcgill.ca/pcs.php [Last accessed 11 June 2016] 
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Appendix 6.1 
Teesside University ethics approval letter 
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Appendix 6.2 
Hamburg Medical Council ethics approval letter 
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Appendix 6.3 
Prognostic study protocol  
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Appendix 6.4 
Deviations from the study protocol 
No Aspect Deviation, with key reason and reference to  
relevant thesis sections (Chapters 6 and 7) 
1 Study personnel: collaborating 
physiotherapist practices 
The initial number of collaborating physiotherapy 
practices was expanded to improve recruitment.  
See section 6.6.3.2 
2 Sample size consideration, 
analysis of primary outcome 
The initial sample size consideration was based on 
the analysis of the WORC_change as a binary 
outcome based on the estimated MID derived from 
the sample data. Subsequently, to avoid the 
unnecessary loss of information that would result 
from dichotomisation of the outcome, I decided to 
analyse the WORC_change on a continuous scale.  
See section 6.6.14 
3 Univariable analysis of pain 
catastrophizing (PCS) 
I conducted a supplementary analysis to explore the 
contribution of this factor alone in predicting the worc 
change. This was justified by the observation that, 
alone among the factors, pain catastrophizing was 
part of the two “best” models and the further 
“plausible” alternative model. 
See section 6.7.7.4 
4 Responder analysis The decision to complement the MID analysis by the 
exploratory responder analysis was made after the 
protocol had been completed. The intention was to 
enhance the interpretation of the WORC_change 
scores based on the MID estimate.  
See Chapter 7 (sections 7.1, 7.3) 
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TRIPOD Checklist: Prediction Model Development 
Section/ 
Topic 
Item Checklist Item Key section  
in Ch. 6 
Title and abstract 
Title 1 
Identify the study as developing and/or validating a 
multivariable prediction model, the target population, 
and the outcome to be predicted. 
 Title, 6.6.9.1 
Abstract 2 
Provide a summary of objectives, study design, 
setting, participants, sample size, predictors, 
outcome, statistical analysis, results, and 
conclusions. 
n/a (thesis 
abstract 
only) 
Introduction 
Background 
and 
objectives 
3a 
Explain the medical context (including whether 
diagnostic or prognostic) and rationale for developing 
or validating the multivariable prediction model, 
including references to existing models. 
6.1 
3b 
Specify the objectives, including whether the study 
describes the development or validation of the model 
or both. 
6.2 
Methods 
Source of 
data 
4a 
Describe the study design or source of data (e.g., 
randomized trial, cohort, or registry data), separately 
for the development and validation data sets, if 
applicable. 
6.6.1 
4b 
Specify the key study dates, including start of 
accrual; end of accrual; and, if applicable, end of 
follow-up.  
6.7.1 
Participants 
5a 
Specify key elements of the study setting (e.g., 
primary care, secondary care, general population) 
including number and location of centres. 
6.6.2-3 
5b Describe eligibility criteria for participants.  6.6.4 
5c Give details of treatments received, if relevant.  6.6.6 
Outcome 6a Clearly define the outcome that is predicted by the prediction model, including how and when assessed.  6.6.9.1 
                                            
19
 Retrieved from: https://www.tripod-statement.org/ [Last accessed 27 June 2016] 
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Section/ 
Topic 
Item Checklist Item Key section  
in Ch. 6 
6b Report any actions to blind assessment of the 
outcome to be predicted.  6.6.9.3 
Predictors 
7a 
Clearly define all predictors used in developing or 
validating the multivariable prediction model, 
including how and when they were measured. 
6.6.7 
7b Report any actions to blind assessment of predictors for the outcome and other predictors.  
n/a 
(prospective 
design) 
Sample size 8 Explain how the study size was arrived at. 6.6.14 
Missing data 9 
Describe how missing data were handled (e.g., 
complete-case analysis, single imputation, multiple 
imputation) with details of any imputation method.  
6.6.15, 6.7.2 
Statistical 
analysis 
methods 
10a Describe how predictors were handled in the 
analyses.  6.6.17.1 
10b 
Specify type of model, all model-building procedures 
(including any predictor selection), and method for 
internal validation. 
6.6.17.5-9 
10d 
Specify all measures used to assess model 
performance and, if relevant, to compare multiple 
models.  
6.6.17.7, 
6.6.18, 
(6.6.17.9) 
Risk groups 11 Provide details on how risk groups were created, if done.  n/a 
Results 
Participants 
13a 
Describe the flow of participants through the study, 
including the number of participants with and without 
the outcome and, if applicable, a summary of the 
follow-up time. A diagram may be helpful.  
6.7.1, 6.7.5 
13b 
Describe the characteristics of the participants (basic 
demographics, clinical features, available predictors), 
including the number of participants with missing 
data for predictors and outcome.  
6.7.3 
(charact.), 
6.7.2 
(missing 
data) 
Model 
development  
14a Specify the number of participants and outcome 
events in each analysis.  
6.7.7.1 
14b If done, report the unadjusted association between 
each candidate predictor and outcome. 
n/a 
Model 
specification 
15a 
Present the full prediction model to allow predictions 
for individuals (i.e., all regression coefficients, and 
model intercept or baseline survival at a given time 
point). 
6.7.7.2 
(model 
statistics) 
15b Explain how to the use the prediction model. 
n/a: see 
6.8.7 
Model 
performance 16 
Report performance measures (with CIs) for the 
prediction model. 
6.7.7.2-3 
(model 
statistics) 
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Section/ 
Topic 
Item Checklist Item Key section  
in Ch. 6 
Discussion 
Limitations 18 
Discuss any limitations of the study (such as 
nonrepresentative sample, few events per predictor, 
missing data).  
6.8.4-8 
(discussion) 
Interpretation 19b 
Give an overall interpretation of the results, 
considering objectives, limitations, and results from 
similar studies, and other relevant evidence.  
6.8.9 and 
see above 
(18) 
Implications 20 Discuss the potential clinical use of the model and implications for future research.  6.8.10 
Other information 
Supplementa
ry 
information 
21 
Provide information about the availability of 
supplementary resources, such as study protocol, 
Web calculator, and data sets.  
6.4 (protocol) 
Funding 22 Give the source of funding and the role of the funders for the present study.  n/a (none) 
We recommend using the TRIPOD Checklist in conjunction with the TRIPOD Explanation and 
Elaboration document. 
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Appendix 6.6 
Statement on cooperation and insurance liability form 
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Appendix 6.7 
Physical assessment of the shoulder - DVSE guideline 
The table provides an overview of the guideline by Deutsche Vereinigung für Schulter- 
und Ellbogenchirurgie (DVSE) (2012) 20  on the assessment of the shoulder. The 
publication includes detailed descriptions of all tests, complemented by illustrative 
images. The components and tests should be chosen based on the individual patient’s 
presentation and are not meant to constitute an exhaustive list.  
Components Recommended tests 
1. General assessment/tests 
Assessment of shoulder 
mobility 
“Neutral-Null” method, goniometry 
Isometric tests Abduction, external rotation, internal rotation 
Muscle strength tests Manual Muscle Functioning Test (MFP) 0-5 
Capsular restrictions Cyriax 
Hyperlaxity Local: anterior/posterior translation (anterior/posterior drawer 
test); sulcus sign, hyperabduction test (Gagey), Coudane-
Walch test, supination-elbow extension test (SEET) 
General: Beighton Score/hypermobility score 
2. Instability 
Ventral Instability Apprehension test, relocation test, surprise test/release test, 
load-and-shift test; 
Dorsal Instability Load- and shift test/Norris test, Jerk test, Kim test 
3. Impingement/rotator cuff lesions 
Impingement Painful arc, Hawkins test, Neer test 
Supraspinatus Codman grip, Jobe test/empty can test/full can test, drop arm 
sign 
Infraspinatus Hornblower’s sign, external rotation lag sign/dropping sign 
Subscapularis Belly press test, belly off sign, bear hug test, lift off test, 
internal rotation lag sign 
Deltoideus Deltoideus extension lag sign 
4. Biceps tests 
Long head of biceps 
(LHB)/Sulcus/Pulley 
Sulcus test (DePalma), Speed’s test, O’Brien test/active 
compression 
                                            
20
 See Chapter 6 reference list for the full reference. 
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Components Recommended tests 
Superior Labrum Anterior 
Posterior (SLAP) tests 
Crank test/sign, O’Brien test/active compression test, supine 
flexion resistance test 
5. Acromioclavicular (AC) joint 
 Finger sign, local pain on palpation, horizontal adduction 
test/cross body sign, LA (injection) test, piano key 
phenomenon, horizontal instability, upper painful arc 
6. Scapular provocation tests 
 Scapular assistance test, lateral scapular slide test, scapular 
dyskinesis (Kibler), scapula alata (“pseudo-winging”, scapular 
winging) 
7. Thoracic outlet tests 
 Adson test, Eden test 
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Appendix 6.8 
Initial assessment questionnaire - prognostic and 
baseline factors 
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Appendix 6.9 
Global Perceived Change (GPC) scale 
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Appendix 6.10 
Patient information sheet (PIS) 
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Appendix 6.11 
Consent form 
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Appendix 6.12 
Residual plots of prognostic models 
Model 1 (nine factors):  
Age + sex + physical demands + disability (and QoL; WORC) + pain + history of 
shoulder pain + symptom duration + smoking + pain catastrophizing (PCS) 
 
Model 2 (two factors):  
Smoking + pain catastrophizing (PCS) 
Appendix 6.12 332 
 
 
 
 
Model 3 (two factors): 
Age + sex 
 
Model 4 (seven factors): 
Age + sex + physical demands + pain + history of shoulder pain + symptom duration + 
smoking 
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Model 5 (two factors): 
Disability (and HrQoL; WORC) + pain catastrophizing (PCS) 
 
Model 7 (two factors): 
History of shoulder pain + symptom duration 
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Model 8 (three factors) 
Pain + history of shoulder pain + symptom duration 
 
Model 9 (two factors) 
Pain + pain catastrophizing (PCS) 
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Complementary pain catastrophizing (PCS) model: 
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Appendix 6.13 
PROBAST version 20/07/201521 
 
                                            
21
 The inclusion of this PROBAST version in the thesis appendices was approved by Dr Robert 
Wolff (personal communication, 17/12/2015). 
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Appendix 6.14 
Detailed results of PROBAST assessment 
See Appendix 3.8 for the PROBAST coding manual 
Abbreviations and symbols used in the table: 
Y = yes; PY = probably yes; N = no; NI = no information; N/A = not applicable; 
UNANSW = unanswerable (see coding manual);  = low risk/concerns;  = high 
risk/concerns (usability: not usable); ? = unclear risk/concerns  
PROBAST items & judgements Ratings 
(see above for 
explanations) 
Domain 1: Participant selection 
1. Were appropriate data sources used, e.g. cohort, RCT or nested 
case-control study data? 
Y 
2. Were all inclusions and exclusions of participants appropriate? PY* 
3. Were participants enrolled at a similar state of health, or were 
predictors considered to account for differences? 
Y 
Risk of bias judgement   
Justification of bias rating: 
*The PY acknowledges the known limitations to the sensitivity/specificity of diagnosing PTT 
by ultrasonography 
Applicability judgement  
Justification of applicability rating: -- 
Domain 2: Predictors 
1. Were predictors defined and assessed in a similar way for all 
participants? 
Y 
2. Were predictor assessments made without knowledge of outcome 
data? 
Y 
3. Are all predictors available at the time the model is intended to be 
used? 
Y 
4. Were all relevant predictors analysed? UNANSW. 
Risk of bias judgement   
Justification of bias rating: -- 
Applicability judgement  
Justification of applicability rating: -- 
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PROBAST items & judgements Ratings 
(see above for 
explanations) 
Domain 3: Outcome 
1. Was a pre-specified outcome definition used? Y 
2. Were predictors excluded from the outcome definition? Y† 
3. Was the outcome defined and determined in a similar way for all 
participants? 
Y 
4. Was the outcome determined without knowledge of predictor 
information? 
PY‡ 
Risk of bias judgement   
Justification of bias rating: 
†This was rated as yes, because the WORC scores were adjusted for 
regression to the mean (RTM) (see body of thesis and PROBAST coding 
manual) 
‡The PY acknowledges the fact that practical blinding was assumed (see 
body of thesis and PROBAST coding manual) 
 
Applicability judgement  
Justification of applicability rating: --  
Domain 4: Sample size and participant flow 
1. Were there a reasonable number of outcome events? Y 
2. Was the time interval between predictor assessment and outcome 
determination appropriate? 
Y 
3. Were all enrolled participants included in the analysis? Y 
4. Were participants with missing data handled appropriately? Y 
Risk of bias judgement   
Justification of bias rating: -- 
Domain 5: Analysis 
1. Were non-binary predictors handled appropriately? Y 
2. Was selection of predictors based on univariable analysis avoided? Y 
3. Was model overfitting (optimism in model performance) accounted for, 
e.g. using bootstrapping or shrinkage techniques? 
N 
4. Were any complexities in the data (e.g. competing risks, multiple 
events per individual) accounted for appropriately? 
N/A 
5. Do predictors and their assigned weights in the final model 
correspond to the results from multivariable analysis? 
N/A 
6. For the model or any simplified score, were relevant performance 
measures evaluated, e.g. calibration, discrimination, (re-) classification 
and net benefit? 
N 
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PROBAST items & judgements Ratings 
(see above for 
explanations) 
7. Was the model recalibrated or was it likely (based on the evidence 
presented, e.g. calibration plot) that recalibration was not needed? 
 
Risk of bias judgement  
Justification of bias rating: -- 
Overall judgments 
Risk of bias   
Applicability   
Usability  
Key: Y = yes; PY = probably yes; N = no; NI = no information; N/A = not applicable; UNANSW = 
unanswerable (see coding manual);  = low risk/concerns;  = high risk/concerns (usability: 
not usable); ? = unclear risk/concerns 
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Appendix 7.1 
Screening of studies to inform the typical error  
of the WORC 
Studies are listed in alphabetical order. The references are provided in the chapter 
reference list. 
No Study ID* Result of screening: 
retained for further 
consideration () or 
exclude () 
Main reason for exclusion  
1 Baskurt 2011  There was no untreated cohort. 
2 Bernhardsson 2011  There was no untreated cohort. 
3 de Witte 2012   
4 Dilek 2016  There was no untreated cohort. 
5 Ekeberg 2010  There was no untreated cohort. 
6 Ekeberg 2008   
7 Haik 2014  There was no untreated cohort. 
8 Holtby 2005  There was no untreated cohort. 
9 Kirkley 2003   
10 Kuhn 2013  There was no untreated cohort. 
11 Lopes 2008   
12 Martins 2012  There was no untreated cohort. 
13 Provencher 2012  WORC was assessed only once. 
14 Razmjou 2008  WORC was assessed only once. 
15 Razmjou 2006  There was no untreated cohort. 
16 Subasi 2012  There was no untreated cohort. 
17 Wessel 2005  WORC was assessed only once. 
18 Wiertsema 2013   
* First author, year 
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Appendix 7.2 
Probabilities and confidence intervals (CIs) of 
individual WORC_change values 
Values are ordered by magnitude (from the highest to the lowest WORC_changeADJ 
value), and are consecutively numbered (from 1 to 65).  
No WORC_ 
ChangeADJ 
value 
Probability 
descriptor* 
Probability 95% CI 
lower limit  upper limit  
1 -1102 alm_cert 1.0 -1510 -695 
2 -964 alm_cert 1.0 -1372 -556 
3 -948 alm_cert 1.0 -1355 -540 
4 -946 alm_cert 1.0 -1354 -539 
5 -872 alm_cert 1.0 -1280 -465 
6 -861 alm_cert 1.0 -1269 -453 
7 -841 alm_cert 1.0 -1249 -434 
8 -792 alm_cert 0.99 -1200 -385 
9 -770 very_lik 0.99 -1178 -363 
10 -748 very_lik 0.98 -1155 -340 
11 -724 very_lik 0.98 -1131 -316 
12 -713 very_lik 0.98 -1121 -305 
13 -682 very_lik 0.97 -1090 -275 
14 -652 very_lik 0.96 -1060 -244 
15 -629 likely 0.94 -1036 -221 
16 -607 likely 0.93 -1015 -200 
17 -602 likely 0.93 -1009 -194 
18 -591 likely 0.92 -999 -183 
19 -561 likely 0.90 -968 -153 
20 -523 likely 0.86 -931 -115 
21 -504 likely 0.84 -911 -96 
22 -503 likely 0.84 -911 -95 
23 -499 likely 0.83 -906 -91 
24 -479 likely 0.81 -887 -71 
25 -440 likely 0.75 -847 -32 
26 -432 possibly 0.74 -840 -25 
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No WORC_ 
ChangeADJ 
value 
Probability 
descriptor* 
Probability 95% CI 
lower limit  upper limit  
27 -419 possibly 0.72 -826 -11 
28 -413 possibly 0.71 -820 -5 
29 -406 possibly 0.70 -814 2 
30 -400 possibly 0.69 -808 8 
31 -400 possibly 0.69 -807 8 
32 -398 possibly 0.68 -805 10 
33 -386 possibly 0.66 -794 21 
34 -351 possibly 0.60  -759 57 
35 -345 possibly 0.59  -753 62 
36 -335 possibly 0.57  -743 73 
37 -333 possibly 0.56  -740 75 
38 -308 possibly 0.52  -716 99 
39 -302 possibly 0.50  -710 106 
40 -294 possibly 0.49  -702 113 
41 -280 possibly 0.46  -688 128 
42 -250 possibly 0.40  -658 157 
43 -242 possibly 0.39  -650 165 
44 -233 possibly 0.37  -640 175 
45 -232 possibly 0.37  -640 175 
46 -179 possibly 0.28  -587 228 
47 -175 possibly 0.27  -583 232 
48 -154 unlik 0.24  -562 254 
49 -152 unlik 0.24  -560 255 
50 -114 unlik 0.18  -521 294 
51 -104 unlik 0.17  -512 303 
52 -73 unlik 0.14  -480 335 
53 -48 unlik 0.11  -456 360 
54 -24 unlik_harm† 0.09  -431 384 
55 -6 unlik_harm† 0.08 -414 401 
56 26 unlik_harm† 0.06  -381 434 
57 42 unlik_harm† 0.05  -366 449 
58 108 unlik_harm‡ 0.02  -300 515 
59 110 unlik_harm‡ 0.02  -298 518 
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No WORC_ 
ChangeADJ 
value 
Probability 
descriptor* 
Probability 95% CI 
lower limit  upper limit  
60 120 unlik_harm‡ 0.02  -288 527 
61 125 unlik_harm‡ 0.02 -283 533 
62 197 poss_harm‡‡ 0.01  -210 605 
63 288 poss_harm‡‡ 0.00  -120 695 
64 321 poss_harm‡‡ 0.00  -87 728 
65 387 poss_harm‡‡ 0.00  -21 794 
*Key: alm_cert = almost certainly beneficial; very_lik = verly likely beneficial; likely = likely 
beneficial; possibly = possibly beneficial; unlik = unlikely beneficial; unlik_harm = unlikely 
harmful; poss_harm = possibly harmful; 
†the verbal description related to a beneficial outcome for this case was “unlikely beneficial”; 
‡the verbal description related to a beneficial outcome for this case was “very unlikely 
beneficial”; ‡‡the verbal description related to a beneficial outcome for this case was „almost 
certainly not beneficial“. 
 
 
